Recent Forum Topics Forums Search Search Results for 'patient'

Viewing 30 results - 151 through 180 (of 934 total)
  • Author
    Search Results
  • Avatar photonittany ram
    Moderator

    Link: https://www.genengnews.com/news/sars-cov-2-lurked-for-decades-where-others-like-it-lurk-still/

    Future pandemics—and suffering of the kind inflicted by COVID-19—could be avoided if we troubled ourselves to see where dangerous pathogens lie in wait. We could, two unrelated studies suggest, save ourselves untold woe and conserve our fortunes if we were to look into matters geographic, zoologic, and genomic. More specifically, we need to keep our eyes wide open when we venture into the planet’s last wild places. There, we may run into wild animals that are infected with pathogens harboring wild genetic traits—which is to say, genetic traits that evolved naturally, beyond our gaze, and that waited patiently, perhaps decades, for a chance to strike.

    Recognizing the potential for outbreaks

    According to an international research team of Chinese, European, and U.S. scientists, the SARS-CoV-2 lineage responsible for the COVID-19 pandemic has been circulating in bats for 40–70 years and likely includes other viruses with the ability to infect humans. This finding, which is derived from a newly constructed evolutionary history of SARS-CoV-2, has implications for the prevention of future pandemics stemming from this lineage.

    To put together SARS-CoV-2’s evolutionary history, the scientists had to account for recombination events, which occur frequently in coronaviruses and which complicate inquiries into a pathogen’s origins.

    “Coronaviruses have genetic material that is highly recombinant, meaning different regions of the virus’s genome can be derived from multiple sources,” explained Maciej Boni, associate professor of biology at Penn State and the lead author of a study that appeared July 28 in Nature Microbiology. “This has made it difficult to reconstruct SARS-CoV-2’s origins. You have to identify all the regions that have been recombining and trace their histories. To do that, we put together a diverse team with expertise in recombination, phylogenetic dating, virus sampling, and molecular and viral evolution.”

    The study, titled “Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic,” described how the team used three different bioinformatic approaches to identify and remove the recombinant regions within the SARS-CoV-2 genome. The article also detailed how the team reconstructed phylogenetic histories for the nonrecombinant regions and compared them to each other to see which specific viruses have been involved in recombination events in the past.

    “We find that the sarbecoviruses—the viral subgenus containing SARS-CoV and SARS-CoV-2—undergo frequent recombination and exhibit spatially structured genetic diversity on a regional scale in China,” the article’s authors wrote. “SARS-CoV-2 itself is not a recombinant of any sarbecoviruses detected to date, and its receptor-binding motif, important for specificity to human ACE2 receptors, appears to be an ancestral trait shared with bat viruses and not one acquired recently via recombination.”

    The authors maintained that the results generated by the three bioinformatic approaches were consistent with Bayesian evolutionary rate and divergence date estimates as well as with two different prior specifications of evolutionary rates based on HCoV-OC43 and MERS-CoV. In addition, the authors estimated that divergence dates between SARS-CoV-2 and the bat sarbecovirus reservoir were 1948 (95% highest posterior density (HPD): 1879–1999), 1969 (95% HPD: 1930–2000), and 1982 (95% HPD: 1948–2009).

    These findings led the scientists to conclude that viruses closely related to SARS-CoV-2 have been circulating in horseshoe bats for many decades. The scientists added, “The unsampled diversity descended from the SARS-CoV-2/RaTG13 common ancestor forms a clade of bat sarbecoviruses with generalist properties—with respect to their ability to infect a range of mammalian cells—that facilitated its jump to humans and may do so again.”

    The team found that one of the older traits that SARS-CoV-2 shares with its relatives is the receptor-binding domain (RBD) located on the spike protein, which enables the virus to recognize and bind to receptors on the surfaces of human cells.

    The team emphasized that preventing future pandemics will require better sampling within wild bats and the implementation of human disease surveillance systems that are able to identify novel pathogens in humans and respond in real time.

    “The key to successful surveillance is knowing which viruses to look for and prioritizing those that can readily infect humans,” said the article’s senior author, David L. Robertson, PhD, professor of computational virology, MRC-University of Glasgow Centre for Virus Research. “We should have been better prepared for a second SARS virus.”

    “We were too late in responding to the initial SARS-CoV-2 outbreak,” added Boni, “but this will not be our last coronavirus pandemic. A much more comprehensive and real-time surveillance system needs to be put in place to catch viruses like this when case numbers are still in the double digits.”

    Investing in prevention

    A surveillance system of the kind suggested by Boni is in line with recommendations from another recent study, one that argues for investments in preventive efforts. The study, prepared by scientists from Boston University, Princeton University, Duke University, Conservation International, and other institutions, indicated that “preventive efforts would be substantially less than the economic and mortality costs of responding to these pathogens once they have emerged.”

    The scientists assessed the cost of monitoring and preventing disease spillover that is driven by the unprecedented loss and fragmentation of tropical forests and by the burgeoning wildlife trade. They discovered that significantly reducing transmission of new diseases from tropical forests would cost, globally, between $22.2 and $30.7 billion each year.

    In stark contrast, they found that the COVID-19 pandemic will likely end up costing between $8.1 and $15.8 trillion globally—roughly 500 times as costly as what it would take to invest in proposed preventive measures. To estimate the total financial cost of COVID-19, researchers included both the lost gross domestic product and the economic and workforce cost of hundreds of thousands of deaths worldwide.

    These findings appeared in Science, in a policy brief titled, “Ecology and economics for pandemic prevention.” The brief emphasized that “we invest relatively little toward preventing deforestation and regulating wildlife trade, despite well-researched plans that demonstrate a high return on their investment in limiting zoonoses and conferring many other benefits.”

    For decades, scientists and environmental activists have been trying to draw the world’s attention to the many harms caused by the rapid destruction of tropical forests. One of these harms is the emergence of new diseases that are transmitted between wild animals and humans, either through direct contact or through contact with livestock that is then eaten by humans. The SARS-CoV-2 virus—which has so far infected more than 15 million people worldwide—appears to have been transmitted from bats to humans in China.

    “Much of this traces back to our indifference about what has been occurring at the edges of tropical forests,” said Les Kaufman, PhD, one of the article’s co-authors and a Boston University professor of biology.

    To reduce disease transmission, Kaufman and his collaborators propose expanding wildlife trade monitoring programs, investing in efforts to end the wild meat trade in China, investing in policies to reduce deforestation by 40%, and fighting the transmission of disease from wild animals to livestock.

    The researchers also propose to increase funding for creating an open-source library of the unique genetic signatures of known viruses, which could help quickly pinpoint the source of emerging diseases and catch them more quickly, before they can spread.

    “The pandemic gives an incentive to do something addressing concerns that are immediate and threatening to individuals, and that’s what moves people,” argued Kaufman. “There are many people who might object to the United States fronting money, but it’s in our own best interest. Nothing seems more prudent than to give ourselves time to deal with this pandemic before the next one comes.”

    #118430
    Avatar photozn
    Moderator

    from https://www.vox.com/2020/7/23/21335549/covid-19-coronavirus-us-hospitalizations-record-florida-texas-california

    “The hospitalization number is the best indicator of where we are,” Eric Topol, a professor of molecular medicine and director of the Scripps Research Translational Institute said. “We’re going to go to new heights in the pandemic that we haven’t seen before. Not that what we saw before wasn’t horrifying enough.”

    The growth has been driven by accelerating spread in Arizona, California, Florida, Georgia, and Texas in particular. On April 15, when New York City hospitals were nearly being overrun with Covid-19 patients, Texas had about 1,500 patients hospitalized with the disease. Today, more than 10,000 Texans are hospitalized with Covid-19.

    Some areas are reaching a woeful tipping point of hospitals stretched to maximum capacity, scrambling to find beds in other facilities for Covid-19 patients. Miami-Dade County reported this week that the number of patients in need of ICU care had exceeded the number of available ICU beds. More than 50 hospitals across the state say they have no ICU beds available.

    Four million Americans have had confirmed cases of Covid-19. More than 143,000 of them have died. With hospitalizations surging and several states still reporting thousands of new cases a day, experts say we are in for a difficult August and fall.

    “We’ve still got 91 to 92 percent of people who are still vulnerable, who have not been infected,” said Topol. “And so that just shows how many more people can be hurt. Obviously many won’t get so sick, but many will.”

    The new hospitalizations, and the untenable pressure they’re putting on the health care system, are also a reminder of how critical it is for states to implement and enforce measures like mandatory face masks, and for the federal government to solve testing and contact tracing problems. “It should be an all-points bulletin to really bear down on this because otherwise there’s no limit on where this might go,” said Topol.

    Hospitals in hot spots across the country are expanding and even maxing out their staff, equipment, and beds, with doctors warning that the worst-case scenario of hospital resources being overwhelmed is on the horizon if their states don’t get better control of the coronavirus.

    “With Covid, a lot of times people who aren’t sick enough yet get pushed to the back, and then they can become really, really sick unfortunately because we were focusing our efforts on the people who are on the brink of death,” an emergency room doctor at the Banner Health system in the Phoenix metro area, who asked to go unnamed fearing retaliation from his employer, told Vox recently.

    Other doctors in Arizona, where 85 percent of hospital beds statewide were in use as of Thursday, have said the scarcity of resources means they’ll soon be rationing medical care, as doctors in Italy were forced to do.

    “The fear is we are going to have to start sharing ventilators, or we’re gonna have to start saying, ‘You get a vent, you don’t.’ I’d be really surprised if in a couple weeks we didn’t have to do that,” says Murtaza Akhter, an emergency medicine physician at Valleywise Health Medical Center in Phoenix.

    #118266
    Avatar photozn
    Moderator

    What scientists are learning about how long Covid-19 immunity lasts
    Covid-19 antibody testing, long-term immunity, vaccines, herd immunity (and more!), explained.

    https://www.vox.com/2020/7/22/21324729/getting-covid-19-twice-immunity-antibodies-vaccine-herd-immunity

    Covid-19 continues to confound us all, with a growing list of symptoms, unexpected modes of transmission, and a wide range of outcomes, from benign to severe.

    More than 600,000 people around the world have been killed by the virus, as of July 22. And for many survivors, Covid-19 is becoming a long-term condition too, with symptoms lasting for months.

    Yet the majority of people infected with the virus recover on their own. And without a vaccine or much in the way of treatment options, the human immune system — a vast network of cells and tissues — remains the most potent defense against infection.

    Scientists’ rapidly evolving understanding of this human immune response to Covid-19 is critical for answering some of the most important questions at this stage in the pandemic, including:

    Can you catch Covid-19 twice?
    What is the threshold for herd immunity — after which the pandemic might burn out?
    Why are some people getting sicker than others?
    How might a vaccine work, and how effective will it be?

    Back in April, when the virus was only known to have been infecting humans for a few months, we wrote about Covid-19 and immunity, and we were told, over and over, it was too early to know what it would look like in the long term. Long-term impacts of a virus can’t be known when a virus is so new. We had to wait.

    Since then, scientists have learned a lot about how the immune system responds to Covid-19, from the specific cells the body generates to fight the virus, to what this all means for a vaccine. The results aren’t all encouraging, but they are illuminating.
    Here are some of the recent major findings about how human bodies respond to Covid-19, the implications for treating the disease and developing a vaccine against future infections, and how the pandemic could end.

    Antibodies to SARS-CoV-2 wane over time. This is normal.

    A recent study out of the United Kingdom sparked some scary headlines: “Covid-19 immunity from antibodies may last only months, UK study suggests,” as CNN put it.

    Before this study, scientists knew that most people infected with SARS-CoV-2 — the virus that causes Covid-19 — generate antibodies. (Antibodies are the immune system proteins that seek out, stick to, and potentially deactivate viruses floating throughout the body. They can stop an infection in its tracks.)

    Critically, they knew “the vast majority of individuals also develop neutralizing antibodies, which are that important subclass of antibodies that are able to basically independently kill the virus,” says Elitza Theel, the director of the infectious diseases serology laboratory at the Mayo Clinic, who was not involved with the research.

    The study — which has not yet been peer-reviewed — asked: What happens to those neutralizing antibodies over time? The researchers followed 65 Covid-19 patients for up to 94 days after their symptoms started, analyzing their blood for antibodies, and found that in these patients, the antibodies declined over the three months.

    “What we’re seeing with SARS-CoV-2 is that antibodies will peak at about 20 to 30 days after symptom onset, and then they decline,” Theel says of this and other recent evidence. “They seem to decline much more rapidly in individuals that were asymptomatic or had mild forms of the disease.”

    It’s easy to read the results of this study, and wonder: Do people become vulnerable to reinfection over time?

    If the answer is “yes,” that’s concerning. It means more reinfections. It could also result in delays in building herd immunity — the threshold at which new infections decline because fewer people are transmitting the virus or being infected. A less-than-robust human immune response after one exposure to the virus could also have implications for the effectiveness of an eventual vaccine. (More on that later.)

    Also scary: There have been some anecdotal reports of people getting reinfected with the virus after recovering from a first infection and getting sick again after being exposed to the virus a second time. (But it’s still hard to tell how common reinfections will be. Ideally, doctors could collect viral genetic and antibody data from both bouts of infection and ask, “Is this the same virus flaring up again in my patient or a different one?” and, “Did my patient develop antibodies to the first infection, and did they wane before the second infection?”)

    A pattern of declining antibodies after infection is typical, scientists say, and is seen in coronaviruses that cause the common cold. “This mostly looks normal,” Shane Crotty, an immunologist at the La Jolla Institute for Immunology, says.

    The takeaway: We need not interpret the UK paper as evidence herd immunity is out of our reach or that everyone who has already had Covid-19 is necessarily at risk of reinfection three months later.

    According to immunologists Nina Le Bert and Antonio Bertoletti at the Duke-NUS Medical School in Singapore, the media hype of fading antibodies is “a little pointless. … It is perfectly normal that antibodies are decreasing,” they tell Vox in an email.

    And antibodies are, reassuringly, not the only part of the immune system that protects us from reinfection.

    The immune system is more than just antibodies. A lot more.

    That immunity doesn’t depend solely on antibodies is quite lucky for us. In fact, there are several parts of the immune system that may contribute to lasting protection against SARS-CoV-2.

    One is killer T-cells. “Their names give you a good hint what they do,” says Alessandro Sette, who collaborates with Crotty at the La Jolla institute for Immunology. “They see and destroy and kill infected cells.”

    Antibodies, he explains, can clear virus from bodily fluids. “But if the virus gets inside the cell, then it becomes invisible to the antibody,” he says.

    That’s where killer T-cells come in: They find and destroy these hidden viruses.

    While antibodies can prevent an infection, killer T-cells deal with an infection that’s already underway. So they play a huge role in long-term immunity, stopping infections before they have time to get a person very sick.

    And it’s not just killer T-cells and antibodies. There are also helper T-cells, which facilitate a robust antibody cell response. “They are required for the antibody response to mature,” Sette says.

    But wait, there’s more! There’s another group of cells called memory B-cells. B-cells are the immune system cells that create antibodies. Certain types of B-cells become memory B-cells. These save the instructions for producing a particular antibody, but they aren’t active. Instead, they hide out — in your spleen, in your lymph nodes, perhaps at the original site of your infection — waiting for a signal to start producing antibodies again.

    When you are exposed to a new virus, it can take up to two weeks for your immune system to make the right antibody to destroy the infection. With the memory B-cells in reserve, instead of waiting two weeks or more to get antibody production going, it may only take a few days.

    “Immunity” can mean many different things

    From this bewildering array of factors, the bottom line is that “immunity” doesn’t mean just one thing: There are many types of immunity.

    Immunity could mean a strong antibody response, which prevents the virus from establishing itself in cells. But it could also mean a good killer T-cell response, which could potentially stop an infection very quickly: before you feel sick and before you start spreading the virus to others.

    “In many infections, the virus does reproduce a little bit, but then the immune response stops this infection in its tracks,” Sette explains. Also possible: “You do get infected, you do get sick, but your immune system does enough of a job curbing the infection, so you don’t get as sick,” Sette says.

    Or immunity results from an awakening of memory B-cells. If an individual has memory B-cells and they’re exposed to the virus again, “that infection will stimulate a much faster antibody response to the virus, which would, theoretically lead to faster clearance of the virus and potentially less severe infection,” Theel says.

    So reinfection may still be possible, but it may not be catastrophic. When a virus invades a body, generally, the body remembers.

    Scientists still don’t know a lot about T-cells and Covid-19, but what they’ve learned is encouraging
    Scientists don’t yet have data on long-term T-cells and memory B-cell response when it comes to SARS-CoV-2, but what they’ve seen so far is encouraging.

    Crotty, Sette, and colleagues in June published a paper in the journal Cell looking at T-cell response in Covid-19 cases that did not require hospitalization.

    “What we showed is that in average cases of Covid-19, where people got sick but didn’t have to go to the hospital, basically all of them made a CD4 T-cell [i.e., a helper T-cell] response,” Crotty says. “And most of them made a CD8 T-cell [i.e., a Killer T-cell] response. And so that looks pretty good.”

    What’s left to figure out is how long these cells persist, too.

    “We don’t know what happens in terms of memory,” Crotty says. Scientists still need more time to test the blood of those who have recovered. “Durability of immunity is a big question and really the only way to answer it is to wait. And so that’s a really hard thing.”

    As for the persistence of memory B-cells? That also isn’t known (though studies show people are making them). But we do know B-cells generally seem to retain their memory for a long time. One report found that survivors of the 1918 flu pandemic had memory B-cells 80 years later.

    All said, there’s reason for optimism that humans, at large, will achieve some form of lasting immunity to Covid-19 after an infection. “T cells response against coronaviruses appears long-lasting,” Le Bert and Bertoletti write. In their studies, they’ve found that people who recovered from the original SARS 17 years ago still have T-cells that can respond to the virus. That’s encouraging.

    In their view, falling levels of antibodies aren’t so concerning. “What is important is that a level of B and T cell memory remain to be present,” they write.

    They’ve also found that T-cells created to fight other coronaviruses may be useful in fighting Covid-19. So “a level of pre-existing immunity against SARS CoV-2 appears to exist in the general population,” they write. “What remained unresolved is whether pre-existing T cells are sufficient for protection.” (There’s some speculation that, in East Asia, Covid-19 may be less deadly because the population has greater previous exposure to other types of coronaviruses, which could grant them more preexisting immunity.)

    Scientists have so far avoided risky human challenge trials of vaccines. They can’t intentionally reinfect people to see if they are protected, but they can do that with monkeys. And the results here are reassuring: Rhesus macaques did not get sick a second time after an initial bout of Covid-19.

    The big question about long-term immunity

    The big question lurking behind all this science is: What is the right mix — both in number and type — of antibodies, T-cells, and B-cells that lead to lasting, robust immunity to SARS-CoV-2? For instance, it could be that you don’t need a very high concentration of antibodies in your blood to successfully fight off the virus. It could be that T-cells play a bigger role in protection.

    The answer to this big question is what scientists call the “correlate of immunity,” and for SARS-CoV-2, it’s not yet known.

    “One thing that’s really I think important to kind of clarify is: Is there a minimum level of antibodies that are correlated to protective immunity?” Theel says.

    But, also, true immunity to Covid-19 is unlikely to just require or need antibodies.

    “There are people who, for example cannot make antibodies, and there are at least a couple of people in Italy who had Covid-19 and they survived and recovered [without having antibodies],” Crotty says. These patients got sick with pneumonia. “Nothing was measured about their immune response, but the implication there was that their T-cells presumably protected them in absence of antibody.”

    Again, it’s unfortunately too soon to know the whole picture on Covid-19 immunity six months into the pandemic.

    “We don’t really know exactly which pieces are required for protection; we don’t know how long they stay around,” Crotty says. “But, yeah, we’re trying our best to gather those data.”

    Researchers are also making gains trying to understand how a dysfunctional immune response can lead one person to severe symptoms and need a ventilator, and another person to recover more easily. Recently scientists observed three different immune profiles that partially explain what makes the difference.

    “There was no perfect correlation between immunotype and severe disease,” Nuala Meyer, a physician and researcher at the University of Pennsylvania says of the study. But some clues emerged. Those who had some of the worst outcomes, and spent some of the most time on a hospital ventilator, were more likely to have dysregulated T-cell response, she says. This may lead to (or just be correlated with) increased lung problems and poorer outcomes.

    “The fear is that either too persistent an [immune] activation or too robust an activation might contribute to the organ damage that we see,” she says. The hope is, with a better understanding of the immune response to the SARS-CoV-2 virus, doctors could possibly prevent this overreaction from happening.

    Does an antibody test tell you if you’re immune?

    If you’ve read this far, congrats! That was a lot.

    A more practical question people will have on their minds is what this all means on an individual basis. If you get a Covid-19 antibody test back and it’s positive, are you immune?

    Sadly, these tests cannot confirm how protected a person is against Covid-19 and for what duration. “What’s important to understand is that all of the tests that are out there on the market right now, they detect antibodies, but they do not differentiate between binding antibodies or neutralizing antibodies,” the Mayo Clinic’s Theel says.

    So all you really can conclude from an antibody test is that you’ve been exposed to the virus. (Plus, these tests are not perfectly accurate to begin with and their accuracy can change depending on the prevalence of the virus.) It can’t tell you about reinfection risks or immunity.

    “That’s the wish, right, that you get a positive antibody result and you think ‘I’m immune,’ but I think we cannot say that. So in my opinion, antibody testing at the individual patient level is really limited in utility,” Theel says.

    As a result of antibody testing, “you shouldn’t change any of your masking or other personal protective equipment or strategies,” she says. If you want to do something proactive with your positive test result, you can see if you can donate blood plasma. The antibodies in your plasma could potentially help a Covid-19 patient recover.

    What our evolving understanding of immunity means for a Covid-19 vaccine
    Take all that complicated nuance about the immune system, think about deliberately tweaking all those parts to do exactly what we want them to do, and you’ll get a sense of the challenge that vaccine researchers face.

    A vaccine is a drug that teaches the immune system to counter a threat like a virus without causing illness. It can reduce the likelihood of a severe disease or prevent an infection altogether. That makes vaccines powerful, life-saving tools. But developing them is a costly, slow, and tedious process. Many attempts at making vaccines will fail.

    While there is no guarantee that a successful Covid-19 vaccine will be made, some scientists are optimistic that one or more will be available in record time.

    One big reason: Most people survive the infection on their own, showing that the immune system can be coached to fend off the pathogen. The task now is to figure out just what kind of target the immune system needs to practice on to ensure it’s ready to handle the real threat when it arrives.

    At the moment, there is an unprecedented global effort to create a Covid-19 vaccine at an astonishing speed. More than 150 candidates are under development and many already in human trials just months after the virus was discovered. Research groups have already posted some promising results and are beginning large-scale testing. Manufacturers are building out factories to make billions of doses and governments are investing billions of dollars.

    Just this week, research teams in China and the UK published a pair of papers in the journal The Lancet showing their results from early trials of Covid-19 vaccines. They both used a version of the adenovirus — a different virus from SARS-CoV-2 — modified to ensure that it doesn’t cause disease. Instead, the adenovirus vector presented a piece of SARS-CoV-2 as a way to induce an immune response.

    Both research teams found that their Covid-19 vaccines using the adenovirus were safe, with minimal complications in test subjects. The vaccines also generated immune responses with antibodies and T-cells in the study group.

    “As far as the results that have been published [this week], they are really exciting, and I’m cautiously optimistic about what they mean for the development of an effective coronavirus vaccine,” says Naor Bar-Zeev, an associate professor of international health and a vaccine researcher at the Johns Hopkins Bloomberg School of Public Health, who published a commentary article about the findings.

    But nothing about this pandemic is simple, and the push to develop a vaccine is no exception. “Lots of unanswered questions remain and obviously we need to go through the difficult process of large-scale phase 3 trials,” Bar-Zeev says.

    For one thing, the wide spectrum of immune responses to the SARS-CoV-2 virus means that there will likely be a range of responses to a vaccine. Not everyone will receive the same level of protection from a given vaccine and some may not get any protection at all. What’s more, the immune response in older people is different from that in children, for example, so it’s hard to make a one-size-fits-all vaccine.

    “Some people simply won’t have the genetic equipment to recognize a particular pathogen well. That’s part of why people react differently to diseases,” said Benjamin Neuman, a virologist at Texas A&M University Texarkana, in an email. “For this reason, we will ideally need to have different vaccines available for different people.”

    Right now, most of the vaccines being investigated are aiming at just one protein from the virus, most commonly the spike protein of the SARS-CoV-2. This protein is what the virus uses to get inside human cells, making it an important target. Getting lasting protection from Covid-19 may require multiple doses of these types of vaccines, or vaccines targeted to different parts of the virus. The results of inoculation can vary, from sterilizing immunity, which completely prevents an infection, to protection only against severe outcomes from the virus but not mild ones.

    The question of whether a vaccine will lead to effective immunity can only be answered with large randomized controlled clinical trials. Thousands of people will have to receive doses of the vaccine and be compared to thousands of people who didn’t to see how well it keeps the virus at bay. It’s time-consuming and expensive, but it’s essential for bringing a vaccine to fruition.

    Overall, from what Crotty has seen from his studies on the immune response to the virus, he feels “optimistic about a vaccine.” The immune profile suggests that vaccine development strategies have worked in the past. “Our data show people can recognize this virus and make reasonable [immune] responses to it,” Crotty says. “And that’s the type of thing you’d need to be trying to mimic with a vaccine. So that was encouraging.”

    What will it take to get to herd immunity?

    To end the pandemic, it’s clear simply having a vaccine isn’t going to be enough. An effective vaccine would certainly be a vital tool, but how it’s deployed and what people do in the meantime will shape how the crisis fades away.

    In the end, we will still need some form of herd immunity to durably curtail transmission, where a large enough share of a population is immune to the virus such that new infections decline significantly because the virus can’t be continually passed on. That kind of protection is critical for people who cannot be vaccinated but are vulnerable to the illness, like the immunocompromised. Once achieved, there may be small outbreaks, but the raging pandemic will subside and eventually, life can return to something approaching normal.

    Depending on how readily a disease can spread, the threshold for herd immunity can be anywhere from 60 percent to 90 percent of a population. Some models of Covid-19 have found that herd immunity could be achieved at 20 percent.

    And it’s not a firm endpoint; an epidemic can recede on its own before herd immunity is reached, or an uncontrolled pandemic can rage well past this benchmark.

    One way to reach this point is to allow a virus to run rampant within a population until sufficient numbers of people have been infected, but this is a costly and deadly path. That has been clear in Sweden, which took a less extreme version of this approach.

    Letting a virus loose also increases the chances that it will overshoot the herd immunity threshold and continue spreading even if 70, 80, or 90 percent of the population is immune. Most parts of the world are still in single-digit percentages when it comes to the number of Covid-19 cases, so herd immunity by uncontrolled exposure is still a long way off.

    The alternative scenario requires mass vaccination. But even with this route, it’s not as simple as whether we have a vaccine or not.

    “It’s important to realize that a vaccine is not a binary thing,” says Bruce Y. Lee, a professor of health policy and management at the CUNY School of Public Health. “It can vary in terms of its characteristics for how effective it can be.”

    Using computer models, Lee found that there’s a sliding scale between how effective a vaccine is and how many people have to get it to achieve herd immunity. Effectiveness in this case means the share of vaccinated people who are immune to the virus out of all who received the vaccine. He co-authored a paper in the American Journal of Preventive Medicine with his findings last week.

    The results showed that if you can achieve a vaccination rate of 100 percent across a population, a vaccine needs to be at least 60 percent effective. If coverage falls to 75 percent, then a vaccine needs to have at least 70 percent efficacy.

    “People should not look at a vaccine like they would a treatment. It’s not just that I get it, but other people have to get it as well,” Lee says. “The more people that get vaccinated in general in the population, the less the virus gets an opportunity to spread.”

    However, these results are predicated on a mass vaccination strategy alone. Other measures — social distancing, wearing masks, rigorous hygiene, testing, tracing, and isolation — can also play an important role in stopping the virus within a population. While they won’t change the threshold of herd immunity, these tactics can limit the number of people who are infected with Covid-19 at a given moment, according to Lee. By reducing the number of people infected, it’s easier to ensure that the susceptible people around them are protected by a vaccine. This highlights the need to maintain many of the pandemic control measures deployed right now even after a vaccine starts to become widely available.

    Herd immunity might also be achievable in the case there is no vaccine, and even if reinfections occur.

    “My expectation is that reinfections will actually be normal — but it doesn’t mean herd immunity is not achievable,” Michael Mina, an epidemiologist at Harvard, tells Vox in an email. He expects second infections will typically be mild, and “will not transmit much and will serve as immunological boosting events more than they do as transmission events that chip away in any substantial fashion against herd immunity.” Which is to say: Reinfections may serve to increase immunity in individuals.

    Another variable to consider is how long immunity from a vaccine would last. Even if it isn’t permanent, if immunity lasts longer than the acute phase of the pandemic — say, around two years — that’s still useful and could drive infections down. But if a vaccine provides immunity that lasts only a few months, shorter than the duration of a vaccination campaign, that would likely mean people would need regular re-vaccinations or booster shots. Otherwise, even the immunized would face risks of reinfection.

    And the current state of the pandemic adds yet another confounding factor for vaccination, particularly in the United States, with so many people infected and with the number of new cases continuing to rise.

    “The problem is that since there are already so many people that are not protected and that have the infection, you have to surround yourself with so many people who are protected before you can have this concept of herd immunity,” says Maria Elena Bottazzi, a co-director of the Texas Children’s Hospital Center for Vaccine Development who also co-authored the vaccine modeling study with Lee.

    With numerous clusters of infection like we have now in the United States, far more people need to be vaccinated to contain them, and the vaccine would need to have a higher level of efficacy. It would behoove everyone to try to contain the virus and limit the number of new infections to less than one per 1 million people per day, according to Bottazzi. “If we flatten the curve, we can then probably still try to get the most efficacious vaccine, but then arguably we don’t have to worry about reaching these 80, 90 percent [vaccine efficacies] that we really need,” she says.

    So the prospect of a vaccine, even at a record pace, should not be a reason to relax the effort to contain the virus. It will take years to deliver the vaccine to billions of people around the world, and the virus may continue causing mayhem in the meantime. While we can’t control the immune response inside our bodies, we can set the stage for herd immunity by reducing the spread of Covid-19 now.

    Our first line of defense against the virus is the cells within us, but stopping the outbreaks will depend on the whole world working together.

    Avatar photozn
    Moderator

    from link above

    ===

    Senate Democrats’ political machine has spent more than $15 million to help more moderate Senate candidates defeat progressive primary challengers in the 2020 election cycle.

    With the help of the party, its major donors, and the Senate Majority PAC (SMP) — a super PAC funded by labor unions, corporate interests and Wall Street billionaires — candidates endorsed by Senate Minority Leader Chuck Schumer’s Democratic Senatorial Campaign Committee have won contested primaries in four battleground states.

    While the DSCC’s chair, Nevada Sen. Catherine Cortez Masto, said last year the party would support progressive incumbent Massachusetts Sen. Ed Markey if he faced a primary challenger, he hasn’t seen any outside help yet from the DSCC or SMP in his tough battle with Rep. Joseph Kennedy III.

    Colorado was the most emblematic example of the party putting its thumb on the scale against progressives: There, former Gov. John Hickenlooper cruised to a primary victory over former Colorado House Speaker Andrew Romanoff. In the final weeks of the race, SMP spent $1 million to boost Hickenlooper, after he spent his failed presidential campaign attacking key tenets of progressives’ legislative agenda, including Medicare for All and the Green New Deal.

    At the time of the cash infusion, Hickenlooper was losing ground in the polls and engulfed in scandals: He had just been fined by Colorado’s Independent Ethics Commission for violating state ethics law as governor, the local CBS station uncovered evidence of his gubernatorial office raking in cash from oil companies, and a video circulated showed Hickenlooper comparing his job as a politician to a slave on a slave ship, being whipped by a scheduler.

    With the help of SMP and the endorsement of the DSCC, Hickenlooper held off the more progressive Romanoff to win a 17 point primary victory.

    Unions, Billionaires, and Corporate Interests
    SMP is led byformer top staffers at the DSCC. The super PAC has raised a staggering $118 million this cycle, pooling cash from both organized labor and business titans to promote corporate-aligned candidates over more progressive primary challengers.

    Working for Working Americans, a super PAC funded by the United Brotherhood of Carpenters and Joiners, has donated $5 million. The Laborers’ International Union of North America’s super PAC has given $1.5 million. The International Brotherhood of Electrical Workers’s political action committee has chipped in $1.3 million. SMP has received also big donations from groups affiliated with labor unions like the Service Employees International Union ($1 million), the National Association of Letter Carriers ($750,000), and Communications Workers of America ($500,000).

    Overall, the top donor to SMP so far this cycle has been Democracy PAC — a super PAC that’s bankrolled by billionaire George Soros and the Fund for Policy Reform, a nonprofit funded by Soros. Democracy PAC has contributed $8.5 million to SMP.

    Other donors from the financial industry include: Renaissance Technologies founder and billionaire Jim Simons ($3.5 million) and billionaire D. E. Shaw & Co. founder David Shaw ($1 million).

    Some major donors have financial stakes in current and future legislation.

    For instance: SMP received a $1 million donation from billionaire Jonathan Gray, an executive at Blackstone, which owns the hospital staffing chain, TeamHealth. SMP also received $2 million from the Greater New York Hospital Association.

    In late 2019, Schumer helped stall Senate legislation that would have kept patients from receiving “surprise medical bills,” the hefty charges that occur when they visit hospitals that are in their insurance network but are unknowingly treated by providers who are considered out-of-network.

    SMP is affiliated with Majority Forward, a dark money group focused on attacking Republican Senate candidates. Majority Forward received $450,000 in 2018 from pharmacy giant CVS Health — which also owns health insurer Aetna. The group also received $300,000 from the American Health Care Association (AHCA), a trade association that represents the nursing home industry.

    The Democratic primary candidates backed by the DSCC have expressed reservations about Medicare for All, arguing they believe people should be allowed to keep their private health insurance if they want it. Many of the DSCC’s favored candidates do support creating a public health insurance option.

    Meanwhile, the Real Estate Roundtable, a trade group for real estate investors, donated $50,000 to Majority Forward. Schumer and Senate Democrats recently helped Republicans unanimously pass pandemic relief legislation that included a special, little-noticed provision that amounted to $170 billion worth of new tax breaks for wealthy real estate investors.

    Deciding Primaries
    In addition to the Colorado race, SMP has waded into at least three other Senate primaries this year.

    In North Carolina, SMP funded Carolina Blue, a super PAC that spent $4.5 million to help veteran and former state senator Cal Cunningham win the primary in March. Cunningham handily defeated his chief opponent, state senator Erica Smith, who was running to his left. (Republicans, for their part, also tried to influence the primary, spending $2.7 million to boost Smith.)

    In Iowa, SMP spent nearly $7 million to promote real estate developer Theresa Greenfield. She easily bested her two primary opponents, including progressive Kimberly Graham, who campaigned in support of Medicare for All and the Green New Deal.

    SMP has already spent more than $2 million in Maine, including nearly $500,000 to promote House Speaker Sara Gideon in the Democratic primary. Some of the group’s advertising against Republican Senator Susan Collins was also designed to boost Gideon.

    On Tuesday, Gideon won the primary decisively, defeating two candidates, including Betsy Sweet, a former lobbyist for progressive advocacy groups who supported the Green New Deal and Medicare for All.

    #117962
    Avatar photozn
    Moderator

    from US man, 30, dies from virus after attending ‘COVID party’

    https://www.yahoo.com/news/us-man-30-dies-virus-attending-covid-party-230251335.html

    A 30-year-old man who believed the coronavirus was a hoax and attended a “Covid party” died after being infected with the virus, according to the chief medical officer at a Texas hospital.

    The official, Dr. Jane Appleby of Methodist Hospital in San Antonio, said the man died after deliberately attending a gathering with an infected person to test whether the coronavirus was real.

    In her statements to news organizations, Dr. Appleby said the man had told his nurse that he attended a Covid party. Just before he died, she said the patient told his nurse: “I think I made a mistake. I thought this was a hoax, but it’s not.”

    ==

    ‘The curve is no longer flat’: Nearly half of Florida’s ICUs are at least 90% full

    https://www.usatoday.com/story/news/health/2020/07/09/coronavirus-florida-nearly-half-states-icus-least-90-full/5409773002/

    ===

    from An ICU boss in the hardest-hit part of Italy says many patients who recover from COVID-19 still have ‘chronic damage’

    https://www.businessinsider.com/head-icu-bergamo-italy-epicentre-lifelong-damage-recovered-covid-patients-2020-7

    He did not specify how many were affected. Several studies have shown problems in patients who had COVID-19 but have yet to reach firm conclusions.

    A July 8 study from University College London observed delirium, rare brain inflammation, and strokes in recovered COVID-19 patients.

    Issues with the gut, heart, and kidneys have also been reported after recovery, Independent reported, citing doctors and researchers. Experts are also concerned about effects on the mental health of severely ill patients.

    #117927
    Avatar photowv
    Participant

    This just sounds so stupid it might be Dem-fake-news.
    I dunno:https://www.theguardian.com/world/2020/jul/13/30-year-old-dies-covid-party-texas

    30-year-old dies after attending ‘Covid party’ in Texas

    Patient said: ‘I think I made a mistake, I thought this was a hoax, but it’s not’, according to health official

    “….“Just before the patient died, they looked at their nurse and said ‘I think I made a mistake, I thought this was a hoax, but it’s not,’” said Dr Jane Appleby, the chief medical officer at Methodist hospital in San Antonio.

    Appleby said: “I don’t want to be an alarmist, and we’re just trying to share some real-world examples to help our community realise that this virus is very serious and can spread easily.”

    Florida reports 15,000 new coronavirus cases, a record single-day total in the US
    Read more

    A “Covid party” is a gathering held by somebody diagnosed with coronavirus to see if the virus is real and to see if anyone gets infected, she explained.

    Appleby said in her filmed comments at the weekend that she had been spurred to reveal the case after seeing a “concerning” rise in infections. She said 22% of tests were revealing a case of Covid-19, up from just 5% a few weeks ago…”

    Avatar photoZooey
    Moderator

    How to Reopen Schools: What Science and Other Countries Teach Us
    The pressure to bring American students back to classrooms is intense, but the calculus is tricky with infections still out of control in many communities.

    By Pam Belluck, Apoorva Mandavilli and Benedict Carey
    July 11, 2020

    link https://www.nytimes.com/2020/07/11/health/coronavirus-schools-reopen.html?fbclid=IwAR1eaVtVh7cg625vf46u6klRJlQQg3AorJP-v2opXz5BatF85Qz4vp6HuGE

    As school districts across the United States consider whether and how to restart in-person classes, their challenge is complicated by a pair of fundamental uncertainties: No nation has tried to send children back to school with the virus raging at levels like America’s, and the scientific research about transmission in classrooms is limited.

    The World Health Organization has now concluded that the virus is airborne in crowded, indoor spaces with poor ventilation, a description that fits many American schools. But there is enormous pressure to bring students back — from parents, from pediatricians and child development specialists, and from President Trump.

    “I’m just going to say it: It feels like we’re playing Russian roulette with our kids and our staff,” said Robin Cogan, a nurse at the Yorkship School in Camden, N.J., who serves on the state’s committee on reopening schools.

    Data from around the world clearly shows that children are far less likely to become seriously ill from the coronavirus than adults. But there are big unanswered questions, including how often children become infected and what role they play in transmitting the virus. Some research suggests younger children are less likely to infect other people than teenagers are, which would make opening elementary schools less risky than high schools, but the evidence is not conclusive.

    The experience abroad has shown that measures such as physical distancing and wearing masks in schools can make a difference. Another important variable is how widespread the virus is in the community over all, because that will affect how many people potentially bring it into a school.

    For most districts, the solution won’t be an all-or-nothing approach. Many systems, including the nation’s largest, New York City, are devising hybrids that involve spending some days in classrooms and other days online.

    “You have to do a lot more than just waving your hands and say make it so,” said Dr. Joshua Sharfstein, a professor of the practice at Johns Hopkins Bloomberg School of Public Health. “First you have to control the community spread and then you have to open schools thoughtfully.”

    The transmission puzzle
    Though children are at much lower risk of getting seriously ill from the coronavirus than adults, the risk is not zero. A small number of children have died and others needed intensive care because they suffered respiratory failure or an inflammatory syndrome that caused heart or circulatory problems.

    The larger concern with reopening schools is the potential for children to become infected, many with no symptoms, and then spread the virus to others, including family members, teachers and other school employees. Most evidence to date suggests that even if children under 12 are infected at the same rates as the adults around them, they are less likely to spread it. The American Academy of Pediatrics has cited some of this data to recommend that schools reopen with proper safety precautions.

    But the bulk of the evidence was collected in countries that were already in lockdown or had begun to implement other preventive measures. And few countries have systematically tested children for the virus or for antibodies that would indicate whether they had been exposed to the virus.

    Infectious disease specialists have been modeling schools’ impact on community spread beginning as far back as February.

    In March, most modelers agreed that closing schools would slow the progression of infections. But wider measures, like social distancing, proved to have a far greater containing effect, overshadowing the results of school closings, according to recent analyses.

    The risk of reopening “will depend on how well schools contain transmission, with masks, for instance, or limiting occupancy,” said Lauren Ancel Meyers, a professor of biology and statistics at the University of Texas, Austin, who has been consulting with the city and school districts. “The background community transmission rate in August will also be a factor.”

    In Austin, for example, which like cities in Florida and Arizona has seen a recent acceleration in new cases, the estimated infection rate now is about seven per 1,000 residents. That means a school with 500 students would have about four carrying the coronavirus. “The school might be able to contain those, depending on the measures it takes,” Dr. Meyers said.

    If not, schools could help incubate outbreaks, given that they’re enclosed facilities where students, especially younger ones, are likely to have great difficulty social distancing, never mind wearing masks. Even if it turns out that children do not spread the virus efficiently, all it would take is one or two to seed new chains.

    The evidence from abroad
    So far, countries that reopened schools after reducing infection levels — and imposed requirements like physical distancing and limits on class sizes — have not seen a surge in coronavirus cases.

    Norway and Denmark are good examples. Both reopened their schools in April, a month or so after they were closed, but they initially opened them only for younger children, keeping high schools shut until later. They strengthened sanitizing procedures, and have kept class size limited, children in small groups at recess and space between desks. Neither country has seen a significant increase in cases.

    There have not yet been rigorous scientific studies on the potential for school-based spread, but a smattering of case reports, most of them not yet peer-reviewed, bolster the notion that it is not inevitably a high risk.

    One snapshot comes from a study in Ireland of six infected people (two high school students, an elementary student and three adults) who spent time in schools before they were closed in March. The researchers analyzed 1,155 contacts of the six patients to see if any had been found to have confirmed coronavirus infection. The contacts included participants in school activities that could be fertile ground for transmission, like music lessons on woodwind instruments, choir practice and sports. None of the students appeared to have infected any other people, the authors reported, adding that the only documented transmission of the virus was to two adults who were in contact with one of the infected adults outside of school.

    But there have been school-based outbreaks in countries with higher community infection levels and countries that apparently eased safety guidelines too soon. In Israel, the virus infected more than 200 students and staff after schools reopened in early May and lifted limits on class size a few weeks later, according to a report by University of Washington researchers.

    Case studies in some countries suggest differences in virus transmission in younger children compared to older children.

    In one community in northern France, Crépy-en-Valois, two high school teachers became ill with Covid-19 in early February, before schools closed. Scientists from the Institut Pasteur later tested the school’s students and staff for coronavirus antibodies. They found antibodies in 38 percent of the students, 43 percent of the teachers, and 59 percent of other school staff, said Dr. Arnaud Fontanet, an epidemiologist at the institute who led the study and is a member of a committee advising the French government.

    “Clearly you know that the virus circulated in the high school,” Dr. Fontanet said.

    Later, the team tested students and staff from six elementary schools in the community. The closure of schools in mid-February provided an opportunity to see if younger children had become infected when schools were in session, the point when the virus struck high school students.

    Researchers found antibodies in only 9 percent of elementary students, 7 percent of teachers and 4 percent of other staff. They identified three students in three different elementary schools who had attended classes with acute coronavirus symptoms before the schools closed. None appeared to have infected other children, teachers or staff, Dr. Fontanet said. Two of those symptomatic students had siblings in the high school and the third had a sister who worked in the high school, he said.

    The research also indicated that when an elementary school student tested positive for coronavirus antibodies, there was a very high probability that the student’s parents had also been infected, Dr. Fontanet said. The probability was not nearly as high for parents of high school students. “When I look at the timing, we think it started in the high school, moved into the families and then to the young students,” he said.

    Dr. Fontanet said that the findings suggest that older children may be able to transmit the virus more easily than younger children.

    That pattern may also be reflected by the experience in Israel, where one of the largest school outbreaks, involving about 175 students and staff, occurred in Gymnasia Rehavia, a middle and high school in Jerusalem.

    There are different theories about why older children would be more likely to transmit the virus than younger children. Some scientists say that younger children are less likely to have Covid-19 symptoms like coughs and less likely to have strong speaking voices, both of which can transmit the virus in droplets. Other researchers are examining whether proteins that enable the virus to enter lung cells and replicate are less abundant in children, limiting the severity of their infection and potentially their ability to transmit the virus.

    What schools can do
    Testing for infections in schools is essential, public health experts said. The Centers for Disease Control and Prevention recommends testing of students or teachers based only on symptoms or a history of exposure. But that will not catch everyone who is infected.

    “We know that asymptomatic or pre-symptomatic spread is real, and we know that kids are less likely to show symptoms if they’re infected than adults,” said Dr. Megan Ranney, an emergency medicine doctor and expert in adolescent health at Brown University. Schools should randomly test students and teachers, she said, but that may be impossible given the lack of funding and limited testing even in hospitals

    Countries that have reopened schools have implemented a range of safety guidelines.

    Some countries initially brought back only a portion of their students — younger children in Denmark, Norway, Belgium, Switzerland and Greece; older children in Germany, according to the report by University of Washington researchers. Belgium brought back students in shifts on alternate days.

    Several countries limited class size, often allowing a maximum of 10 to 15 students in a classroom. Many place desks several feet apart. Several countries group children in pods or cohorts with social interaction largely restricted to those groups, especially at recess and lunchtime.

    Mask-wearing policies vary. In Asia, where the practice of wearing masks during flu season is common, many countries are requiring masks in school. Elsewhere, some countries required masks for only some students or staff, such as teachers in Belgium and high school students in France, according to the University of Washington report.

    In Germany, students who test negative for the virus do not have to wear masks, according to the report, which said that since opening schools, Germany has seen increased transmission of the virus among students, but not school staff.

    The C.D.C. has outlined steps schools can take to minimize the risks for students, including maintaining a distance of six feet, washing hands and wearing masks.

    “The guidelines are already exceptionally weak,” said Carl Bergstrom, an infectious diseases expert at the University of Washington in Seattle. He and others said they feared that the recommendations would get watered down even more in response to political pressure.

    The C.D.C. has been working on new recommendations for reopening schools for several weeks, in consultation with organizations like the National Association of School Nurses, according to a C.D.C. spokeswoman. The five planned documents include guidance on symptom screening and face masks, and a checklist for parents or guardians trying to decide whether to send their children to school. But they do not include any information on improving ventilation or curtailing airborne spread of the virus.

    Schools will need to ensure that they circulate fresh air, whether by filtering the air, pumping it in from the outside, or simply by opening windows, said Saskia Popescu, a hospital epidemiologist at The University of Arizona. School nurses like Ms. Cogan will also need protective equipment like gloves, gowns and N95 masks.

    There are differences in how other countries are responding when coronavirus cases are identified in schools, with some countries, like Israel, closing entire schools for a single case and others taking the more targeted approach of sending students and teachers in an affected classroom into home quarantine for two weeks.

    Dr. Kathryn Edwards, an infectious disease specialist and professor of pediatrics at Vanderbilt University School of Medicine, is advising Nashville schools on reopening approaches. She said the district is still evaluating how far apart desks should be. “Some people say you only need three feet and others say you need six feet, and others wonder with the aerosol issue, do we need more distance?”

    Dr. Edwards said she was disappointed by Nashville’s decision, announced Thursday, to conduct classes online for the first month of school, at least until Labor Day.

    Keeping schools closed for a prolonged stretch has worrisome implications for social and academic development, child development experts say. It also became evident this spring that denying children a real school day deepened racial and economic inequalities.

    “There is really damage to kids if they don’t go to school,” Dr. Edwards said. “I think we have got to think of the kids and getting them back to school safely.”

    #117889
    Avatar photowv
    Participant

    My high school team (and I played on it for a couple of years–linebacker) was/is burgundy and gold. I’ve always loved burgundy and gold.

    We were called the Brebeuf Braves.
    The school was named after St. Jean de Brebeuf, who was martyred by the Iroquis.

    So “Braves” was an interesting nickname choice.

    A rich donor commissioned a painting in the school cafeteria of a patiently enduring St. Jean tied to a stake and being ruthlessly tortured by Iroquis…braves. The painting was wall sized and took up one entire whole end of the room.

    Fortunately, another rich donor gifted the school a huge curtain to close in front of the painting, so we could eat in peace.

    =============

    All very inter esting. So many tribes on this planet, over the centuries. So many issues. Maybe teams should just go with Vegetable names. Vegetable never committed any atrocities as far as i know.

    The Wiki story below has Too many Ironies to even begin to unvavel. I am in awe of the many ironies.

    And it all ends up on an American high school football helmet.

    “….His efforts to develop a complete ethnographic record of the Huron has been described as “the longest and most ambitious piece of ethnographic description in all The Jesuit Relations”.[10] Brébeuf tried to find parallels between the Huron religion and Christianity, so as to facilitate conversion of the Huron to the European religion.[11] Brébeuf was known by the Huron for his apparent shamanistic skills, especially in rainmaking.[12] Despite his efforts to learn their ways, he considered Huron spiritual beliefs to be undeveloped and “foolish delusions”; he was determined to convert them to Christianity.[8] Brébeuf did not enjoy universal popularity with the Huron, as many believed he was a sorcerer.[13] By 1640, nearly half the Huron had died of smallpox and the losses disrupted their society. Many children and elders died. With their loved ones dying before their eyes, many Huron began to listen to the words of Jesuit missionaries who, unaffected by the disease, appeared to be men of great power.[14]

    Brébeuf’s progress as a missionary in achieving conversions was slow…
    ….
    …..The Jesuits considered the priests’ martyrdom as proof that the mission to the Native Americans was blessed by God and would be successful.[30]

    Throughout the torture, Brébeuf was reported to have been more concerned for the fate of the other Jesuits and of the captive Native converts than for himself. As part of the ritual, the Iroquois drank his blood and ate his heart, as they wanted to absorb Brébeuf’s courage in enduring the pain.[31] The Iroquois mocked baptism by pouring boiling water over his head.[32]….” Wiki
    ===========

    #117859
    Avatar photozn
    Moderator

    It was his dream job. He never thought he’d be bribing doctors and wearing a wire for the feds.
    In an exclusive interview, the man behind a $678 million whistleblower settlement says “drastic action” was needed to shake up the pharmaceutical industry.

    https://www.nbcnews.com/business/economy/it-was-his-dream-job-he-never-thought-he-d-n1232971

    On July 1, Ozzie Bilotta’s years long effort to blow the whistle at Novartis paid off. The Justice Department announced a $678 million settlement with the company over improper inducements it made to doctors to prescribe 10 of the company’s drugs, including the anti-hypertension drug Lotrel. The deal represents the biggest whistleblower settlement under the federal anti-kickback law, Bilotta’s lawyer said.

    “I felt like you needed to take drastic action to turn this system upside down and make it more legit,” Bilotta, 57, said in an exclusive interview with NBC News. “The whole system needed to be blown up and pieced together in a fair way — fair for taxpayers and good for patients.”

    Although the payout Bilotta will get under federal whistleblower laws hasn’t been determined, he could receive a pretax sum of $75 million through the settlement, his attorneys said.

    In the settlement, Novartis admitted to “certain conduct” alleged by the government and will sharply curtail practices exposed by Bilotta that gave doctors incentives to prescribe its drugs. Novartis derived at least $40 million as a result of the conduct, money that was paid by federal health care programs, the government said.

    “For more than a decade, Novartis spent hundreds of millions of dollars on so-called speaker programs, including speaking fees, exorbitant meals, and top-shelf alcohol that were nothing more than bribes to get doctors across the country to prescribe Novartis’s drugs,” said Audrey Strauss, the acting U.S. attorney for southern New York, whose office prosecuted the case.

    Chief Executive Vas Narasimhan said in a statement that Novartis is committed “to resolve and learn from legacy compliance matters. We are a different company today — with new leadership, a stronger culture, and a more comprehensive commitment to ethics embedded at the heart of our company.”

    A Novartis spokesman declined to comment on Bilotta.

    Bilotta, a Novartis sales representative for the eastern end of Long Island, filed his suit in January 2011 under the False Claims Act, detailing remuneration to physicians, such as lavish dinners at restaurants; costly tickets to sporting events and entertainment, including a trip to a Manhattan strip club; gift cards; and catering for events in the lives of doctors’ children, such as graduations or bar mitzvahs.

    On behalf of the government and to prove his case, Bilotta secretly recorded himself making cash payments to two doctors and got confirmation from four others of having accepted prior remuneration.

    The government and New York state took up his case in 2013. It covers activities at Novartis that took place from January 2002 until November 2011. In addition to Bilotta’s evidence, the government interviewed 350 witnesses, he said. The anti-hypertensive drug Valturna and the anti-diabetes drug Starlix were among the 10 or so drugs involved in the kickbacks.

    The federal government’s anti-kickback statute is a criminal law barring remuneration to health care providers for patient referrals or other business involving goods and services covered by health care programs such as Medicare and Medicaid. Kickbacks can result in higher health care costs, overuse of drugs or services and improper patient steering.

    The company’s doctor speaker programs took place at luxury restaurants in New York City, Miami, Chicago and San Francisco where physicians were supposed to educate other practitioners about Novartis’ drugs. Over the period, one doctor received over $320,000 in honoraria and wrote more than 8,000 prescriptions for the company’s drugs, the government said. None of the doctors were identified by the government.

    Bilotta, a child of immigrants from southern Italy, said he felt he had made it when he got the job at Novartis. “The positions are very competitive — they have thousands of applicants per job,” he said. “You felt almost honored to have gotten the position.”

    Right away, however, some things seemed off, Bilotta said. He recalled one doctor presenting him with a page listing 10 patients’ names on his first day visiting doctors’ offices. Confused, he asked what it was. “I was told, ‘Once we get to 10 patients on this drug, we get a $100 gift certificate to a restaurant,'” he said.

    Bilotta said that when he asked about it, his manager didn’t seem concerned and didn’t follow up. Novartis’ ethics policy stated that it was a criminal offense to offer payments or inducements to prescribe its drugs, according to the settlement.

    Keeping high-prescribing doctors happy was an intense focus at Novartis, Bilotta said. At meetings with higher-ups, sales representatives would get hundreds of dollars in American Express gift checks to present to doctors.

    As the years progressed, talk grew among pharmaceutical sales representatives about other drug companies’ buying big-ticket items for doctors — covering the cost of a swimming pool was one rumor Bilotta recalled. Some physicians started asking for more — a television for the waiting room, a donation to a child’s graduation. A top prescriber demanded that Novartis hire his son, which it did. The son didn’t last long on the job, Bilotta said.

    “I saw things evolve,” Bilotta said. “We went from a strictly product focus to one that is more about incentivizing.”

    In the mid-2000s, Novartis began ramping up its doctor speaker programs, at which the company paid physicians to educate other practitioners about a drug’s merits. But some of the drugs Bilotta sold had been around for years and were well-known, making it clear to him that the events were simply a payment system, he said. At the vast majority of the programs, small talk dominated and the drugs weren’t mentioned, Bilotta added.

    “They wanted to have the veneer of conveying medical knowledge,” he said. “But how much education on these old drugs do you need? I’d be stunned if 10 percent of the programs were legitimate.”

    According to the Justice Department, Novartis “hosted tens of thousands of speaker programs and related events under the guise of providing educational content, when in fact the events served as nothing more than a means to provide bribes to doctors.”

    Novartis would repeatedly host the same doctors at promotional programs for the same drugs, the government said. Company records show that “more than 19,235 doctors attended programs with the exact same title three or more times in a six-month period,” the government said.

    In Rockford, Illinois, for example, Novartis held 124 speaker programs over eight years with the same 10 doctors, or a subset, as the only people attending. Novartis paid one doctor to speak at 102 of the events.

    Novartis created a compliance department in 1999, the government said, but until 2001 it had only one person on staff. The company didn’t conduct a full-blown audit of speaker events until 2008, the settlement said, but its compliance training materials discouraged sending emails about the activities, in part, because they put Novartis at risk. The settlement noted that Novartis’ chief compliance officer told company trainees in presentations: “If you don’t have to write it, don’t. Consider using the phone.”

    Every quarter, Novartis would require its sales representatives to spend a budgeted amount, say, $5,000 apiece, on doctor speaker programs, Bilotta said. The funds were allocated immediately.

    But finding enough practitioners to attend the programs was difficult, and sometimes money allotted for the programs wasn’t spent. Then there’d be hell to pay, Bilotta said.

    “I had situations where my sales were good and for some reason I didn’t spend all my money and they would threaten my job,” he said. “They had a specific return on investment they attached to the money they spent.”

    The government said one set of speaker programs generated a 1,200 percent return on investment among the doctors who attended.

    Occasionally, Bilotta had interactions with patients, in a doctor’s waiting room for example, and they’d complain about the high costs of their medications. The conversations upset him, he said, given what he knew about Novartis’ payoffs to doctors and how they increased health care costs. “It was depressing,” he said. “You felt like you were hurting patients.”

    In the mid- to later 2000s, he said, the situation became untenable. “By 2008, I saw this was just a bunch of schemes,” he said. He contemplated leaving Novartis, but job prospects were few during the Great Recession.

    In 2010, Bilotta went to a manager and told him that he had evidence of fraud. He said the manager replied: “I’m sure we could find something on you.”

    “I had to do something, but I didn’t feel there was any avenue,” he said.

    Later that year, he saw a fraud case against another big pharmaceutical company and decided to contact whistleblower lawyers. By early 2011, he’d been debriefed by law enforcement, and before he filed suit, he began wearing a wire to record conversations with six doctors in his territory. Two took $500 each in cash, and the others confirmed receiving prior inducements or being willing to do so in the future.

    Law enforcement was “stunned to hear that doctors were taking cash bribes,” Bilotta said. “They asked: ‘Can you get this on tape?’ I paused momentarily — that’s when the nature of the case really revealed itself to me.”

    At first the case was under seal, but when Bilotta’s name emerged, he started to get death threats and online taunts. He felt he had to move his family out of the New York area, but he said the support he got from peers and strangers far outpaced the criticism. After taking medical retirement from Novartis in 2013 because of Meniere’s disease, he began living on a partial salary and medical insurance.

    Under its settlement with the government, Novartis has agreed to make significant changes to its doctor speaker programs. Going forward, the programs will be in a virtual format only. They may not take place in restaurants, and alcohol can’t be offered. Future programs may occur only for the first 18 months after a new drug or a new indication is approved by the Food and Drug Administration, and the company is limited to paying a total of $100,000 to all speakers for each drug or indication, or $10,000 per physician.

    The changes signify the impact of the Novartis case, said one of Bilotta’s attorneys, James E. Miller, a partner at Shepherd Finkelman Miller & Shah.

    “These limits, as opposed to the tens of millions of dollars often spent by pharmaceutical companies on speaker programs, will substantially diminish the opportunity for a physician’s prescription-writing to be influenced by the payments the physician is receiving from pharmaceutical companies,” Miller said. “We hope that this settlement will serve as a model on how to put a stop once and for all to the mischief and illegal behavior that we believe is rife in pharmaceutical speaker programs — despite the industry’s persistent claims to the contrary.”

    Bilotta said that with the settlement finalized, he wants to work to change health care practices and laws that harm patients and taxpayers. Allowing the reimportation of drugs and letting the government negotiate drug prices would save taxpayers tens of billions of dollars, he said, and he plans to work on promoting those changes.

    “My intention is to keep this good momentum up and benefit the taxpayers,” he said.

    While Bilotta’s decision to blow the whistle at Novartis has yielded positive results, he said the process isn’t for everyone.

    “It is not an easy road — it’s very psychologically taxing,” Bilotta said. “You have to be very sincere in what you’re doing and be prepared to be opened up to a tremendous amount of scrutiny. Go with your convictions, but if you’re doing it for financial gain, it’s a mistake.”

    #117850
    Avatar photozn
    Moderator

    from ‘Code blue’: Texas COVID deaths higher than publicly reported – and spiking

    https://www.houstonchronicle.com/news/houston-texas/houston/article/As-COVID-19-continues-to-slam-Houston-the-death-15400462.php

    Centers for Disease Control and Prevention data shows Texas is one of 24 states that publicly reports only confirmed COVID deaths, not “probable” ones. And with rampant testing shortages in Texas, many patients likely died without being screened for the disease, experts said.

    Texas ranks 40th out of 50 states and the District of Columbia in deaths per 100,000 population on the CDC COVID tracer. But that is potentially misleading since it compares Texas with 27 states that include “probable cases.” Nearly one in five deaths reported in New York City, the national epicenter for COVID-19, was reported as a “probable.”

    #117837
    Avatar photozn
    Moderator

    What’s Missing From the Biden-Bernie Task Force Plan? Medicare for All.
    The recommendations are an improvement on Biden’s previous healthcare plans, but a public option won’t cut it. We need free, universal coverage.

    https://inthesetimes.com/article/22655/joe-biden-bernie-sanders-task-force-healthcare-medicare-for-all

    However beefy a public option turns out to be, there are things it can never do.

    On Wednesday, the “unity task forces” set up by presumptive Democratic presidential nominee Joe Biden rolled out a set of policy recommendations for the candidate, and, by extension, for the party writ large. Launched in May, the group behind the proposed platform was comprised of a core of establishment-aligned politicos as well as allies of Bernie Sanders, the primary’s runner-up whose campaign advanced an agenda squarely to the left of Biden.

    While the task forces provided recommendations on issues ranging from climate change to criminal justice, the healthcare group attracted much attention as observers wondered how the group would square the wide gap between Sanders’ unwavering calls for a single-payer Medicare for All system, and Biden’s commitment to maintaining the private insurance system enshrined by the Affordable Care Act (ACA).

    Unsurprisingly, the task force did not endorse Medicare for All, which would essentially liquidate the existing version of private health insurance and replace it with a single public system that covers everyone and provides all necessary and effective care free from the point of use. But the presence of former Michigan gubernatorial candidate and single-payer advocate Abdul El-Sayed as well as Rep. Pramila Jayapal (D-Wash.)—who each endorsed Sanders, and the latter of whom is the lead sponsor of the Medicare for All bill in the House—was evident in more left-leaning measures than Biden has previously embraced. If the healthcare platform as presented were to be fully implemented under a future President Biden, it would amount to a significant improvement on the status quo—albeit with persistent gaps that can’t be resolved without abolishing private health insurance as it’s currently constituted.

    The recommendations front-load a temporary phase of coronavirus-related emergency measures, many of which have emerged as consensus demands from Democrats—including free coronavirus testing irrespective of immigration status, federally-bankrolled expansion of contract tracing, and a period of 100% premium subsidies for those eligible for COBRA coverage throughout the duration of the pandemic. The document also calls for a special enrollment period for ACA marketplaces, which will include a stopgap low-fee platinum option for people who run out of, or don’t qualify for, several months of full COBRA subsidies.

    More broadly, the task force seeks to reinvest in critical public health infrastructure at the local and state level, much of which was financially hollowed out during the Great Recession and has been left in disrepair since. It also calls for permitting Medicare to negotiate prescription drug prices, funding for research into racial health inequities, repealing the Hyde amendment and securing protections for LGBTQ people that were rolled back under President Trump.

    The task force also advances a blueprint for a public option, which includes critical details that gesture toward left-wing activist pressure, as well as ambiguities that could bolster the sort of profit-seeking gamesmanship that renders the current system so dysfunctional.

    For starters, the proposal hints that the public option may actually be a set of options, à la Medicare, which offers “consumer choice” while in practice curbing access to care while lining insurers’ pockets. Still, according to the proposal, at least one public option plan available on the marketplaces must be publicly administered and have zero deductibles, which is far preferable to the kind of privately-administered “public option advantage” plans these recommendations leave the door open to. The public option, as laid out here, would also be extended for zero premiums to individuals who qualify for Medicaid but live in non-expansion states, automatically enroll low-income people who earn too much for Medicaid, and be available as an alternative to employer-based coverage. Meanwhile, the Medicare eligibility age will be lowered from 65 to 60, and barriers will be lowered for states seeking waivers to build state-based single-payer programs.

    All of these changes would be an improvement upon the healthcare system as it exists now, an abysmally low bar that Republicans are nonetheless desperate to limbo beneath. In the wake of their unsuccessful attempts to repeal and replace the ACA in 2017, the GOP has consistently chipped away at the law however possible, through pushing Medicaid work requirements, bottoming out budgets for navigators and advertising to help inform and guide patients through enrollment, and loosening restrictions on short-term junk plans. Even more gravely, the Trump administration recently encouraged the Supreme Court to strike down the entire ACA.

    But assessing just how much Biden’s task force’s plan would improve the lives of patients depends on details we simply don’t have. The proposal stipulates that premiums will be capped at 8.5% of income (more for a family), which could potentially mean that a slate of relatively robust public option plans would force private plans to improve substantially to compete. Or, more likely, private insurers could take a cue from Medicare Advantage and find ways to cherry-pick healthier patients while off-loading sicker ones onto the public program.

    Cost-sharing is also partially unresolved—a public option plan with zero deductibles, for example, may well entail higher copays and coinsurance, perhaps going so far as to foist enrollees into private supplemental plans parallel to “Medigap” coverage for Medicare recipients.

    Furthermore, the crucial issue of provider networks goes unmentioned. As networks have narrowed in recent years with insurers trying to save money by covering fewer and fewer providers, many ACA plans have failed to adequately cover certain types of care, like mental health. Traditional Medicare, by contrast, doesn’t have networks and thus affords patients free choice of providers. What kinds of benefits and cost-sharing will be applied to which public option plans will make a world of difference—and will require even more expertise to suss out than the notoriously confusing ACA exchanges already do.

    Ultimately, however beefy a public option turns out to be, there are things it can never do. By offering one more insurance product to a list of several others—even if it’s the best of the bunch—the public option does little to alleviate the misery of navigating the administrative quagmire endemic to our healthcare system. It still leaves gaps for patients to fall into, and forces them to beg claims assessors for coverage by phone. And it still casts us as healthcare consumers, shopping for the best-valued access to a foundational human need that shouldn’t be commodified to begin with.

    #117832
    Avatar photozn
    Moderator

    Study of 17 Million Identifies Crucial Risk Factors for Coronavirus Deaths

    link https://www.nytimes.com/2020/07/08/health/coronavirus-risk-factors.html

    An analysis of more than 17 million people in England — the largest study of its kind, according to its authors — has pinpointed a bevy of factors that can raise a person’s chances of dying from COVID-19, the disease caused by the coronavirus.

    The paper, published Wednesday in Nature, echoes reports from other countries that identify older people, men, racial and ethnic minorities, and those with underlying health conditions among the more vulnerable populations.

    “This highlights a lot of what we already know about COVID-19,” said Uchechi Mitchell, a public health expert at the University of Illinois at Chicago who was not involved in the study. “But a lot of science is about repetition. The size of the study alone is a strength, and there is a need to continue documenting disparities.”

    The researchers mined a trove of de-identified data that included health records from about 40% of England’s population, collected by the United Kingdom’s National Health Service. Of 17,278,392 adults tracked over three months, 10,926 reportedly died of COVID-19 or COVID-19-related complications.

    “A lot of previous work has focused on patients that present at hospital,” said Dr. Ben Goldacre of the University of Oxford, one of the authors on the study. “That’s useful and important, but we wanted to get a clear sense of the risks as an everyday person. Our starting pool is literally everybody.”

    Goldacre’s team found that patients older than 80 were at least 20 times more likely to die from COVID-19 than those in their 50s and hundreds of times more likely to die than those below the age of 40. The scale of this relationship was “jaw-dropping,” Goldacre said.

    Additionally, men stricken with the virus had a higher likelihood of dying than women of the same age. Medical conditions such as obesity, diabetes, severe asthma and compromised immunity were also linked to poor outcomes, in keeping with guidelines from the Centers for Disease Control and Prevention in the United States. And the researchers noted that a person’s chances of dying also tended to track with socioeconomic factors like poverty.

    The data roughly mirror what has been observed around the world and are not necessarily surprising, said Avonne Connor, an epidemiologist at Johns Hopkins University who was not involved in the study. But seeing these patterns emerge in a staggeringly large data set “is astounding” and “adds another layer to depicting who is at risk” during this pandemic, Connor said.

    Particularly compelling were the study’s findings on race and ethnicity, said Sharrelle Barber, an epidemiologist at Drexel University who was not involved in the study. Roughly 11% of the patients tracked by the analysis identified as nonwhite. The researchers found that these individuals — particularly Black and South Asian people — were at higher risk of dying from COVID-19 than white patients.

    That trend persisted even after Goldacre and his colleagues made statistical adjustments to account for factors like age, sex and medical conditions, suggesting that other factors are playing a major role.

    An increasing number of reports have pointed to the pervasive social and structural inequities that are disproportionately burdening racial and ethnic minority groups around the world with the coronavirus’s worst effects.

    Some experts pointed out flaws in the researchers’ methodology that made it difficult to quantify the exact risks faced by members of the vulnerable groups identified in the study. For instance, certain medical conditions that can exacerbate COVID-19, like chronic heart disease, are more prevalent among Black people than white people.

    The researchers removed such variables to focus solely on the effects of race and ethnicity. But because Black individuals are also more likely to experience stress and be denied access to medical care in many parts of the world, the disparity in rates of heart disease may itself be influenced by racism, said Usama Bilal, an epidemiologist at Drexel University who was not involved in the new analysis. Ignoring the contribution of heart disease, then, could end up inadvertently discounting part of the relationship between race and ethnicity and COVID-19-related deaths.

    The study was also not set up to conclusively show cause-and-effect relationships between risk factors and COVID-19 deaths.

    Regardless of the methodological drawbacks of this study, experts agree that “the causes of disparities, whether in COVID-19 or other aspects of health, are intricately linked to structural racism,” Mitchell said.

    In the United States, Latino and African American residents are three times as likely to become infected by the coronavirus as white residents, and nearly twice as likely to die.

    Many of these individuals work as front-line employees or are tasked with essential in-person jobs that prevent them from sheltering in place at home. Some live in multigenerational households that can compromise effective physical distancing. Others must cope with language barriers and implicit bias when they seek medical care.

    Any study publishing data on an ongoing and fast-shifting pandemic will inevitably be imperfect, said Julia Raifman, an epidemiologist at Boston University who was not involved in the study.

    But the new paper helps address “a real paucity of data on race,” Raifman added. “These disparities are not just happening in the United States.”

    With regard to the racial inequities in this pandemic, Barber said, “I think what we’re seeing is real, and it’s not a surprise. We can learn from this study and improve on it. It gives us clues into what might be happening.”

    #117802
    Avatar photozn
    Moderator

    from COVID-19 Cases Are Rising, So Why Are Deaths Flatlining?

    https://www.theatlantic.com/ideas/archive/2020/07/why-covid-death-rate-down/613945/

    For the past few weeks, I have been obsessed with a mystery emerging in the national COVID-19 data.

    Cases have soared to terrifying levels since June. Yesterday, the U.S. had 62,000 confirmed cases, an all-time high—and about five times more than the entire continent of Europe. Several U.S. states, including Arizona and Florida, currently have more confirmed cases per capita than any other country in the world.

    But average daily deaths are down 75 percent from their April peak. Despite higher death counts on Tuesday and Wednesday, the weekly average has largely plateaued in the past two weeks.

    What follows are five possible explanations for the case-death gap. Take them as complementary, rather than competing, theories.

    1. Deaths lag cases—and that might explain almost everything.

    You can’t have a serious discussion about case and death numbers without noting that people die of diseases after they get sick. It follows that there should be a lag between a surge in cases and a surge in deaths. More subtly, there can also be a lag between the date a person dies and the date the death certificate is issued, and another lag before that death is reported to the state and the federal government. As this chart from the COVID Tracking Project shows, the official reporting of a COVID-19 death can lag COVID-19 exposure by up to a month. This suggests that the surge in deaths is coming.

    In Arizona, Florida, and Texas, the death surge is already happening. Since June 7, the seven-day average of deaths in those hot-spot states has increased 69 percent, according to the COVID Tracking Project.

    The death lag is probably the most important thing to understand in evaluating the case-death gap. But it doesn’t explain everything. Even where deaths are rising, corresponding cases are rising notably faster.

    2. Expanded testing is finding more cases, milder cases, and earlier cases.

    … That’s just wrong. Since the beginning of June, the share of COVID-19 tests that have come back positive has increased from 4.5 percent to 8 percent. Hospitalizations are skyrocketing across the South and West. Those are clear signs of an underlying outbreak.

    Something subtler is happening. The huge increase in testing is an unalloyed good, but it might be tricking us with some confusing weeks of data.

    In March and April, tests were scarce, and medical providers had to ration tests for the sickest patients. Now that testing has expanded into communities across the U.S., the results might be picking up milder, or even asymptomatic, cases of COVID-19.

    The whole point of testing is to find cases, trace the patients’ close contacts, and isolate the sick. But our superior testing capacity makes it difficult to do apples-to-apples comparisons with the initial surge; it’s like trying to compare the height of two mountains when one of the peaks is obscured by clouds. The epidemiologist Ellie Murray has also cautioned that identifying new fatal cases of COVID-19 earlier in the victims’ disease process could mean a longer lag between detection and death. This phenomenon, known as “lead time bias,” might be telling us that a big death surge is coming.

    And maybe it is. Maybe this is all as simple as nationwide deaths are about to soar, again.

    But there are still three reasons to think that any forthcoming death surge could be materially different from the one that brutalized the Northeast in March and April: younger patients, better hospital outcomes, and summer effects.

    3. The typical COVID-19 patient is getting younger.

    The most important COVID-19 story right now may be the age shift.

    In Florida, the median age of new COVID-19 cases fell from 65 in March to 35 in June. In its latest daily report, the Florida Department of Health says the median age is still in the high 30s.* In Arizona, Texas, and California, young adults getting sick have been driving the surge.

    If the latest surge is concentrated among younger Americans, that would partly explain the declining death count. Young people are much less likely to die from this disease, even if they face other health risks. International data from South Korea, Spain, China, and Italy suggest that the COVID-19 case-fatality rate for people older than 70 is more than 100 times greater than for those younger than 40.

    The youth shift seems very real, but what’s behind it is harder to say. Maybe older Americans are being more cautious about avoiding crowded indoor spaces. Maybe news reports of young people packing themselves into bars explain the youth spike, since indoor bars are exquisitely designed to spread the virus. Or maybe state and local governments that rushed to reopen the economy pushed young people into work environments that got them sick. “The people in the service economy and the retail industry, they tend to be young, and they can’t work remotely,” says Natalie Dean, an assistant professor at the University of Florida. Texas Governor Greg Abbott blamed reckless young people for driving the spike, but the true locus of recklessness might be the governor’s mansion.

    No matter the cause, interpreting the “youth surge” as good news would be a mistake. Young people infected with COVID-19 still face extreme dangers—and present real danger to their close contacts and their community. “We see people in their 20s and 30s in our ICUs gasping for air because they have COVID-19,” James McDeavitt, the dean of clinical affairs at Baylor College of Medicine, told The Wall Street Journal. Young people who feel fine can still contract long-term organ damage, particularly to their lungs. They can pass the disease to more vulnerable people, who end up in the hospital; a youth surge could easily translate into a broader uptick some weeks from now. And the sheer breadth of the youth surge could force businesses to shut down, throwing millions more people into limbo or outright unemployment.

    4. Hospitalized patients are dying less frequently, even without a home-run treatment.

    So far, we’ve focused on the gap between cases and deaths. But there’s another gap that deserves our attention. Hospitalizations and deaths moved up and down in tandem before June. After June, they’ve diverged. National hospitalizations are rising, but deaths aren’t.

    The hospitalization and death data that we have aren’t good enough or timely enough to say anything definitive. But the chart suggests some good news (finally): Patients at hospitals are dying less.

    Indeed, other countries have seen the same. One study from a hospital in Milan found that from March to May, the mortality rate of its COVID-19 patients declined from 24 percent to 2 percent—”without significant changes in patients’ age.” British hospitals found that their hospital mortality rate has declined every month since April.

    So what’s going on? Maybe doctors are just getting smarter about the disease.

    In early 2020, the novelty of the coronavirus meant that doctors had no idea what to expect. Health-care professionals were initially shocked that what they assumed to be a respiratory disease was causing blood clots, microvascular thrombosis, and organ damage. But millions of cases and hundreds of white papers later, we know more. That’s how, for example, doctors know to prescribe the steroid dexamethasone to rein in out-of-control immune responses that destroy patients’ organs.

    Finally, it’s notable that mortality declined in Italian and British hospitals when they weren’t overrun with patients. This is another reason why flattening the curve isn’t just a buzzy slogan, but a matter of life and death. As hospitals across Texas and Arizona start to fill up, we’ll see whether hospital mortality increases again.

    5. Summer might be helping—but probably only a little bit.

    ….as more people wear masks and move their activities outside in the summer, they might come into contact with smaller infecting doses of COVID-19. Some epidemiologists have claimed that there is a relationship between viral load and severity. With more masks and more outdoor interactions, it’s possible that the recent surge is partly buoyed by an increase in these low-dosage cases.

    #117794
    Avatar photojoemad
    Participant

    URL = NYTIMES.com

    transcript was exported on Jun 15 2020 – view
    Speaker 1:
    ( silence)

    Speaker 1:
    Before they drive off, he’s parked righthere, its a fake bill from

    Kueng:
    The driver in there ?

    Lane: The blue Benz?

    Speaker 1:
    Which one?

    Speaker 3 :
    That blue one over there .

    Kueng
    Which one?

    Lane:
    27 -CR -20-12951
    Filedin DistrictCourt State ofMinnesota 7/7/2020 11:00 AM
    yup-yup Justhead back in. They’re moving around alot. Letmesee yourhands. George Floyd:
    Hey,man.I’m sorry! Lane:
    Stayinthe car,letmeseeyourotherhand. George Floyd:
    I’m sorry,I’m sorry! Lane:
    Letmeseeyourother hand! George Floyd:
    Please, Mr.Officer. Lane:
    Both hands. George Floyd:
    I didn’t do nothing. Lane:
    Put your fuckinghandsup rightnow ! Letme see your other hand. Shawanda Hill:
    lethim seeyourotherhand George Floyd :
    All right.WhatIdothough?WhatwedoMrOfficer? Lane:
    Putyourhand up there.Putyour fuckinghandupthere! Jesus Christ,keep your fucking handson the wheel
    George Floyd:
    got Lane:
    Axon
    crosstalk 00:02:00).
    EXHIBIT
    Defense 2
    Page 1 of 25
    latest version here.
    (Completed 06/10/20)
    Transcript by Rev.com
    the Gentlemen , sorry.

    27 -CR -20-12951
    This transcript was exported on Jun 15 , 2020 – view latest version here.
    Keep your fucking hands on thewheel. George Floyd:
    Yes, sir. I’m sorry , officer crosstalk 00:02:03) Lane:
    Who else is in the ? George Floyd:
    Thismy friend. Lane:
    Put your foot back in George Floyd:
    I’m sorry, so sorry.Goddangman.Man, got,i shotthesamewayMrOfficer,before. Lane:
    Okay. Wellwhen I say “Letmesee yourhands,” youput yourfucking handsup. George Floyd :
    Iam sosorry,Mrofficer.Dangman. Lane:
    You got him ? Put your hands on top ofyour head. George Floyd :
    Lasttime gotshotlikethatMrOfficer itwasthesamething Lane:
    Filedin DistrictCourt State ofMinnesota 7/7/2020 11:00 AM
    Handsontopofyourhead.Handson topofyearhead.Stepoutofthevehicle,andstepawayfromme, allright?
    George Floyd:
    Yes, sir. Lane:
    Step out and face away. Step outand face away . George Floyd:
    Okay,Mr.Officer,pleasedon’tshootme. Please,man. Lane:
    I’m not going to shoot you. Step out and away George Floyd:
    I’lllookatyou eye-to-eyeman.Pleasedon’tshootme,man. Lane:
    I’m notshootingyou,man. George Floyd
    I justlostmymom ,man. Lane
    320 were taking one out. Step out and face away . George Floyd:
    Man, I’m so sorry. Lane
    Step out and face away .
    Axon_Body_3_Video_2020-05-25_2008
    (Completed
    06/10/20 )
    TranscriptbyRev.com Page2of25

    27 -CR -20-12951
    This transcript was exported on Jun 15 , 2020 – view latest version here.
    George Floyd:
    Pleasedon’tshootme,Mr.Officer.Please, don’tshootmeman.Please. Can younotshootme,man? Lane:
    Step out and faceaway. I’m not shooting. Step out and face away. George Floyd:
    Okay, okay, okay. Please. Please, man. Please. Please. I didn’tknow man. Lane:
    Get outofthe car. George Floyd:
    I didn’tknow,ididn’tknowMr.Officer. ShawandaRenee Hill
    Stop resisting Floyd! Lane:
    Put your fucking hands behind yourback. Putyour handsbehind your back rightnow ! Kueng:
    Stopmoving. Stop! Put your handsbehind your back then ! Lane
    Filedin DistrictCourt State ofMinnesota 7/7/2020 11:00 AM
    Get his other arm George Floyd:
    I’m notgoingtodonothing. Kueng:
    Hey you come back ! Stay in the car! George Floyd
    00:03:24.
    I’m sorryMr.Officer, Shawanda Renee Hill
    What did you say sir? George Floyd:
    On man Kueng
    Stop resisting then . George Floyd:
    I’m not Kueng:
    Yes, you are. George Floyd
    getonmykneeswhatever.
    Ididn’t donothingwrongman.[inaudible00:03:38]. Kueng
    Stand up! George Floyd
    Please, please,man. Lane:
    Axon_Body_3_Video_2020-05-25_2008(Completed 06/10/20)
    Transcript by Rev.com
    Page 3 of 25

    27 -CR -20-12951
    This transcriptwas exported on Jun 15 2020 – view latest version here.
    Against thewall. Shawanda Renee Hill
    Whome? Lane:
    Yes.
    Shawanda Renee Hill
    What I do ? Lane:
    We’re figuring out what’s going on Drop the bag. ShawandaRenee Hill:
    Figure out what’s going on 00:03:54 . Lane:
    What’s the problem ? Shawanda Renee Hill:
    Somebody said something to him , it ain’t us. Speaker 7:
    Wewas getting aride, sir. Shawanda Renee Hill:
    just gotmy phone fixed. crosstalk 00:04:00 ). Speaker 7:
    You can ask Adam about us, Adam know me. Lane:
    Are you good? crosstalk 00:04:06 ]. You got ID Shawanda Renee Hill
    Come and getme, girl they going took Floyd to Jail, guna take Floyd to jail.
    Comeandgetme Speaker 7:
    YoucanaskMr.Adamaboutussir.YoucanaskMrAdamaboutme, coo.l Lane:
    DoyouhaveID? Shawanda Renee Hill:
    I’m on 38th and Chicago. 38th and Chicago. Lane:
    320 for code four Speaker 7
    YoucanaskMr.Adam aboutme,sir.Ijustcameandboughtatablet.AndwhenIboughtthetablet,it didn’twork orwhatever.
    Shawanda Renee Hill:
    OhmyGod,hedidn’t evendonothing. Speaker 7
    Here you go sir. Lane:
    Axon Body_3_Video_2020-05-25_2008
    Filedin DistrictCourt State ofMinnesota
    7/7/2020 11:00 AM
    (Completed
    06/10/20 ) TranscriptbyRev.com
    Page 4 of25

    27 -CR -20-12951
    This transcript was exported on Jun 15 2020 – view latest version here.
    Do you haveID ShawandaRenee Hill
    No I don’t.Myname’s Shawanda ReneeHill. Fuck, no. Lane :
    Okay . Speaker 7:
    Sirher andi were justgetting aride, MrAdam ,MrAdam knowsmeman. Shawanda Renee Hill
    justcameovertogetmyphone.Yousee don’thaveapurseornothing,andmydaughterisonher wayto getme
    Lane:
    What’s his deal? Shawanda Renee Hill:
    I don’tknow Speaker 7
    Mr.Adam knowsme,sir. crosstalk 00:04:50 Shawanda Renee Hill:
    That’smyex. Idon’tknow . Lane:
    Why’shegetting allsquirrelly and not showing us his hands, and justbeingallweird like that ? Shawanda Renee Hill:
    i have no clue, because he’s been shot before . Lane:
    Well get that,butstillwhen officers say,”Getoutofthe car.” Ishedrunk, isheonsomething? Shawanda Renee Hill:
    No,hegotathinggoing on,I’m tellingyouaboutthepolice. Lane:
    What does thatmean ? Shawanda Renee Hill
    Hehave problems all the timewhen they come, especially when that man put that gun likethat. It’s been one.
    Filedin DistrictCourt State ofMinnesota 7/7/2020 11:00 AM
    Lane:
    What’s your firstname? Shawanda Renee Hill:
    His name isGeorge Floyd. Lane:
    What isit? Speaker 7
    He’s a good guy. George Floyd she said. Lane:
    Can you spell that? Speaker 7:
    Axon_Body_3_Video_2020-05-25_2008 ( Completed
    06/10/20) Transcriptby Rev.com
    Page 5 of 25

    This transcriptwas exported on Jun 15
    I don’tknow how to spellGeorgesir. Lane:
    Hername. ShawandaReneeHill
    Ohmyname? Lane:
    Yeah , yeah ShawandaReneeHill:
    ShawandaReneeHil.l Lane:
    Can you spell it? Shawanda ReneeHill
    S-H-A-W -A-N-D-A. Lane:
    S-H-A-W ShawandaReneeHill
    A-N-D-A. Speaker 7
    Heallrightsir.Like said,butMr.Adams ShawandaReneeHill
    Yeah, heok. Lane:
    Kueng,justputhim in thecar.Shawandawhat? ShawandaRenee Hill
    Hill,orRenee, R-E-N-E-E. Lane:
    What’syourlastname? ShawandaRenee Hill
    Hill, H-I-L-L. Lane:
    And your date of birth ? Shawanda Renee Hill
    isya’llcomingto getme. 1/27/75. Okay. Lane:
    – view latest version here.
    27 -CR -20-12951
    Filedin DistrictCourt StateofMinnesota
    7/7/2020 11:00 AM
    Okaywellso here’sthething, someonepasseda fakebillin there.Wecomeoverhere,he starts grabbingforthekeysandallthatstuff, startsgettingweird,notshowingushishands.Idon’tknow
    what’s goingon, so you’re comingoutofthe car. So, just hang tightrighthere. Stayright here, please. George Floyd:
    Ouch, ouchman! Lane:
    What areyou on somethingrightnow ? George Floyd
    Axon_Body_3_Video_2020-05-25_2008
    (Completed
    06/10/20 ) TranscriptbyRev.com
    Page6 of25

    27 -CR -20-12951
    This transcriptwas exported on Jun 15 2020 – view latest version here.
    No, nothing. Kueng:
    Because you acting a little erratic. Lane:
    Let’s go. Let’s go George Floyd:
    I’m scared ,man Lane:
    Let’s go Kueng:
    You got foam around yourmouth , too ? George Floyd:
    Yes, I was just hooping earlier . Lane:
    Let’s go George Floyd:
    Man,allrightletmecalm downnow.I’m feelingbetternow. Lane :
    Keep walking . George Floyd:
    Can youdomeonefavorman? Lane:
    No, when we get to the car. Let’s get to the carman, comeon. Kueng:
    Stopmoving around George Floyd:
    man,Goddon’tleavememan.Pleaseman,pleaseman. Lane:
    Here.Iwanttowatch thatcartoo, so justgethim in. Kueng:
    Standup,stopfallingdown!Standup Stayonyourfeetandfacethecar door! George Floyd:
    Im claustrophobic man, please man , please . Lane
    you get a search on him Kueng
    No,notyet. George Floyd:
    just want totalk toyouman.Please,letmetalk to you.Please. Lane
    Kueng
    Axon Body_3_Video_2020-05-25_2008(Completed 06/10/20)
    Transcript by Rev.com
    Filedin DistrictCourt State ofMinnesota 7/7/2020 11:00 AM
    Page 7 of 25

    27 -CR -20-12951
    This transcript was exported on Jun 15, 2020 – view latest version here.
    You ain’t listening to nothing we’re saying. George Floyd
    know Speaker 8
    So we’re not going to listen to nothing you saying. Lane:
    Can you watch thatcar? Just make sure no one goes in it. George Floyd
    Im claustrophobic . Kueng:
    hear you, but you are going to face this door right now . Lane:
    Listen up, stop! George Floyd:
    illdoanything,illdoanythingy’alltellmetooman.I’m notresistingman.I’mnot!I’mnot!Youcanask him , they know me.
    Lane:
    check that side. George Floyd :
    Godman, won’t do nothinglike that.Why is this going on like this? Look at mywrist Mr.Officer, I’m not thatkind ofguy
    Lane:
    Check the other side. George Floyd:
    Mr.Officer,MrOfficer,I’m notthatkindofguy. Lane:
    Stop
    George Floyd:
    Please, I’m not that kind of guy,Mr.Officer. Please! Lane:
    Just face away George Floyd:
    Please,man. Don’t leavemebymyselfman, please, I’m just claustrophobic that’s it. Lane:
    Well, you’re still going in the car. Kueng
    Anything sharp on you? George Floyd:
    Iwon’t donothing to hurt you,MrOfficer. Kueng
    Do you have anything sharp on you ? George Floyd:
    Axon Body_3_Video_2020-05-25_2008
    ( Completed
    06/10/20 )
    Transcript by Rev.com
    Page 8 of 25
    Filedin DistrictCourt StateofMinnesota
    7/7/2020 11:00 AM

    27 -CR -20-12951
    This transcript was exported on Jun 15, 2020 – view latest version here.
    No, sir. Kueng:
    Not even like a comb or nothing George Floyd:
    Filedin DistrictCourt State ofMinnesota 7/7/2020 11:00 AM
    I don’thavenothing. Why y’alldoingmelikethis Mr.Officer? Please crack thewindow formeandstuff.
    am claustrophobicfor rea,lMr.Officer. Lane:
    You got him ? George Floyd:
    Could you please crack it for me, please? Lane:
    Yes, I’llcrack it.Iwill George Floyd
    Pleasestaywithmeman,thankyou.God,man.Ididn’tknow allthiswasgoingtohappenman.Please
    man 00:08:05 . I don’t want to do nothing to y’allman, nothing. Lane:
    You gotit? Kueng:
    yougettheinsideinnerpocketrealquickon yourside.I’m listening. George Floyd:
    understandthatpeopledo stuff,and Lane:
    Allright,he’sgood. justlookingforguns and whatever. George Floyd:
    Okay, okay, okay. Lane:
    grab aseat. George Floyd:
    Okay. Kueng:
    Why are you having trouble walking George Floyd:
    Because officer, inaudible 00:08:31]. Lane:
    I’llrollthe windowsdown, okay ? George Floyd:
    Please man, please don’t do this! Kueng:
    Take a seat! George Floyd
    I’m going in,Mr.Officer, I’m going in .
    Axon Body_3_Video_2020-05-25_2008
    ( Completed
    06/10/20 ) Transcriptby Rev.com
    Page 9 of 25

    27 -CR -20-12951
    This transcriptwas exported on Jun 15 2020 – view latest version here.
    Filedin DistrictCourt State ofMinnesota 7/7/2020 11:00 AM
    Kueng:
    No, you’renot! George Floyd:
    I’m gunagoin! Kueng:
    Take a seat! Lane:
    Grab a seat,man. George Floyd
    Why don’t y’all believeme, Mr.Officer? Kueng:
    Take a seat ! George Floyd:
    I’mnotthatkindofguy!I’m notthatkindofguy,man! Kueng:
    Takea seat! George Floyd
    Y’all goingto dieinhere! goingto die,man! Kueng:
    You need to take a seat right now ! George Floyd:
    And I just had man, don’t want to go back to that. Lane:
    Okay, rollthe windowsdown.Hey, listen ! George Floyd:
    Dang, man Lane:
    Listen ! George Floyd:
    I’m notthatkindofguy. Lane:
    I’llrollthewindowsdownifyouputyour legsin allright? George Floyd:
    [ inaudible 00:08:57 ] look at that , look at that . Look at it ! Speaker 8
    putthe air on.
    You’re not even listening.Wecan fix it, butnotwhile you’re standing out here. George Floyd:
    Okay,man.God,y’alldomebadman.Man, I don’twant to try to twin to try to win.
    Speaker 9
    Quit resistingbro. George Floyd:
    Axon_Body_3_Video_2020-05-25_2008(Completed 06/10/20) Transcriptby Rev.com
    crosstalk 00:09:09] I don’t want
    Page 10 of 25

    27-CR- 20-12951
    This transcriptwas exported on Jun 15 – view latest version here.
    I don’t want to win . I’m claustrophobic, and i gotanxiety, I don’twant to do nothing to them ! Lane
    I’llroll window down. George Floyd:
    Man, I’m scared as fuckman . Speaker 9
    That’s okay, 00:09:12 . George Floyd:
    inaudible 00:09:12 ]when I startbreathing it’s going to go off onme,man. Lane:
    Filedin DistrictCourt State ofMinnesota 7/7/2020 11:00 AM
    Pullyourlegsin George Floyd :
    Okay, okay, letme countto three. Letme count to three andthen Speaker 9:
    going in, please.
    You can’t win ! George Floyd:
    I’m not trying to win! man, he know it
    Lane:
    I’llgo to the other side inaudible 00:09:21 George Floyd:
    Heknow ittooMr.Officerdon’tdomelikethat,man. Kueng
    Getin the car.
    George Floyd :
    Can Italk to youplease? Kueng
    Ifyougetin this car,wecan talk! George Floyd:
    I’m claustrophobic Kueng
    I’m hearingyou,butyou’renotworkingwithme! George Floyd:
    God, claustrophobic. Lane:
    Plant your butt overhere, Kueng:
    Get in the car ! George Floyd:
    CanIgetin thefront,please? Kueng
    No, you’re not getting in the front.
    Axon_Body_3_Video_2020-05-25_2008
    get on the ground , anything. I’ll get crosstalk 00:09:14 I can’t stand this shit
    going to pullyou in.
    (Completed
    06/10/20 ) TranscriptbyRev.com
    Page 11of 25

    27 -CR -20-12951
    This transcriptwas exported on Jun 15, 2020 – view latestversionhere.
    George Floyd:
    I’m claustrophobic,Mr.Officer. Kueng
    Getin the car! George Floyd:
    Okay,man,okay!I’m notabadguyman! Kueng:
    Get in the car ! George Floyd:
    I’m nota bad guy! Man, [inaudible 00:10:02 . Please, Mr.Officer! Please ! Kueng:
    Take a seat ! George Floyd :
    Please! Please! No, inaudible 00:10:10 . Kueng:
    Take a seat. George Floyd:
    I can’t choke,Ican’t breatheMr.Officer!Please! Please! Kueng:
    Fine.
    George Floyd
    Filedin DistrictCourt State ofMinnesota 7/7/2020 11:00 AM
    Mywrist,mywristman. Okay, okay. I want to layon the ground.I want to layon the ground. I want to layon the ground!
    Lane:
    your getting in the squad. George Floyd :
    want to lay on the ground ! I’m going down, Kueng:
    Take asquat George Floyd
    I’m going down Speaker 9
    going down, I’m going down.
    Bro, you about tohave aheartattack and shitman,get in the car! George Floyd:
    I know I can’t breathe. I can’t breathe crosstalk 00:10:18 ] . Lane:
    Get him on the ground . George Floyd:
    Let go ofmeman , I can’t breathe. I can’t breathe. Lane:
    Take a seat George Floyd:
    Axon_Body_3_Video_2020-05-25_2008(Completed 06/10/20) TranscriptbyRev.com
    Page 12of25

    27 -CR -20-12951
    This transcript was exported on Jun 15 2020 – view latest version here.
    Filedin DistrictCourt State ofMinnesota 7/7/2020 11:00 AM
    Please,man. Please listen to me. Chauvin :
    Ishegoingto jail? George Floyd: Pleaselisten to me.
    Kueng
    He’s under arrest rightnow for forgery. George Floyd:
    Forgery forwhat? for what ? Lane:
    Let’stakehim outandjustMRE. George Floyd:
    can’t fucking breatheman.I can’t fucking breathe. Kueng:
    Here, Comeon out! George Floyd:
    inaudible 00:11:10) thank you. Thank you. Thao:
    Justlayhim ontheground. Lane:
    Can you just get up on the, I appreciate that, I do. Chauvin :
    Do you got your ah, restraint, Hobble? George Floyd:
    I can’tbreathe. I can’t breathe. I can’t breathe. Lane:
    Jesus Christ. George Floyd:
    can’t breathe. Lane:
    Thank you. George Floyd:
    I can’tbreathe. Kueng
    Stop moving George Floyd:
    Mama,mama, mama, mama. Kueng:
    [inaudible 00:11:45] one of the frontpouches George Floyd:
    Mama,mama, mama. Kueng:
    Axon_Body_3_Video_2020-05-25_2008 (Completed
    inaudible 00:11:04
    going on.
    06/10/20) TranscriptbyRev.com
    Page13 of 25

    27 -CR -20-12951
    This transcript was exported on Jun 15, 2020 – view latest version here.
    …on my right side bag. George Floyd:
    Mama,mama,mama. Lane:
    320 Can we get EMScode2, for one bleedingfrom themouth. Chauvin :
    Filedin DistrictCourt State ofMinnesota 7/7/2020 11:00 AM
    Your under arrest guy. George Floyd:
    Allright, allright. OhmyGod. I can’tbelievethis.I Chauvin :
    So your goingto jai.l Lane:
    Affirm . George Floyd:
    believe this.
    I can’t believe this man. Mom , I love you. [ Reese 00:12:09] I love you. Lane:
    You got 00:12:10). George Floyd:
    TellmykidsIlovethem.I’m dead Lane:
    Mine’sinmy side,it’s listed, it’s labeled. Itsays hobble, it’s in the top. George Floyd:
    Ican’tbreatheornothingman.Thiscold bloodedman.Ah- Chauvin :
    You’re doing a lotoftalking,man . George Floyd
    Mama, I love you. I can’t do nothing. Kueng:
    EMSison their way
    welldo you wantahobbleatthis point then? Lane:
    !Ah-Ah!Ah-Ah!
    Um ok , allriggt George Floyd:
    Myface is gone.
    can’t breathe. Lane:
    Can you getupon the sidewalkplease, onesideorthe other please? George Floyd:
    Myface is getting it bad. Lane:
    Here, should we gethis legs up, or is this good?
    Axon_Body_3_Video_2020-05-25_2008(Completed 06/10/20)
    Transcript by Rev.com
    00:12:33 . I can’t breathe man. Please! Please, letmestand. Please,man
    Page 14 of25

    27 -CR -20-12951
    This transcript was exported on Jun 15 , 2020 – view latest version here.
    Chauvin
    Leave him Kueng:
    Just leave him yep Chauvin :
    Just leave him Lane:
    Filedin DistrictCourt State ofMinnesota 7/7/2020 11:00 AM
    Allright.HopefullyPark’sstillsitting onthecar.Theywere,Hewasactingrealshadylikesomething’sin there .
    Thao
    Ishehighon something? Lane:
    I’m assuming so Kueng:
    Ibelieve so,we found a pipe. Lane:
    Hewouldn’t get outof the car. He wasn’t following instructions. [crosstalk 00:13:10). Yeah, it’s across the street Park’s watching it, two other people with him .
    George Floyd:
    Please, I can’tbreathe. Please,man. Pleaseman! Thao:DoyouhaveEMScoming code3?
    Lane:
    Ahcode2,wecanprobably stepitupthen. Yougotit?(crosstalk00:13:29 . George Floyd:
    Please ,man ! Thao:
    Relax! George Floyd:
    can’t breathe. Kueng
    You’re fine, you’re talking fine. Lane:
    Your talken , Deep breath . George Floyd:
    I can’t breathe. Ican’t breathe. Ah! I’llprobably just die this way. Thao:
    Relax
    George Floyd :
    can’t breathemy face. Lane :
    He’s got to be on something. Thao
    Axon_Body_3_Video_2020-05-25_2008 (Completed
    06/10/20 )
    TranscriptbyRev.com Page15of25

    This transcriptwas exportedon Jun 15
    What areyou on? George Floyd :
    breathe.Please, inaudible00:14:00 Speaker 9
    27 -CR -20-12951
    – view latestversion here.
    breathe.Shit.
    Filedin DistrictCourt State ofMinnesota 7/7/2020 11:00 AM
    Wellgetup andgetin thecar,man.Getupandgetinthecar. George Floyd:
    I will I can’tmove. Speaker 9:
    Lethim getinthecar. Lane :
    Wefoundaweed pipeonhim,theremightbesomethingelse,theremightbelikePCPorsomething.Is that the shaking of the eyesrightis PCP ?
    George Floyd :
    Myknee,myneck. Lane:
    Where their eyes like shakeback and forth really fast? George Floyd:
    Im through, through. I’m claustrophobic. Mystomach hurts. Myneckhurts. Everythinghurts. Ineed
    somewater or something, please. Please ?I can’t breathe officer. Chauvin :
    Then stop talking, stop yelling. George Floyd:
    You’re going to killme,man. Chauvin :
    Then stop talking, stop yelling, it takes a heck of a lot of oxygen to talk . George Floyd:
    Comeon,man.Oh, oh. crosstalk 00:15:03].I cannotbreathe.I cannotbreathe. Ah! They’llkillme. They’ll killme. I can’t breathe. I can’tbreathe. !
    Speaker 8
    We tried that for 10minutes. George Floyd :
    Ah! Ah! Please. Please. Please. Lane:
    Shouldwerollhim on hisside? Chauvin
    No,he’s stayingputwherewegothim . Lane:
    Okay. justworry aboutthe excited delirium orwhatever. Chauvin
    Well that’s why wegot the ambulance coming. Lane:
    Okay, isuppose.
    Axon_Body_3_Video_2020-05-25_2008(Completed 06/10/20) Transcriptby Rev.com
    Page 16 of 25

    27 -CR -20-12951
    transcript was exported on Jun 15, 2020 – view latest version here.
    Speaker 13:
    Filedin DistrictCourt State ofMinnesota
    7/7/2020 11:00 AM
    Gethim offtheground,bro.Gethim offtheground crosstalk00:16:16.Heain’tdoanyofthatshit.He a fuckingbum bro, he enjoyingthat shit rightnow bro. You couldhavefuckingputhim in the car by
    now,bro.He’snotresistingarrestornothing. inaudible00:16:48] bodylanguageiscrazy. crosstalk
    00:16:48] dudes at the academybro. you know thatbogusrightnow bro. Youknow it’sbogus. Youcan’t
    even look atmelike amanbecauseyou now bro.
    ShawandaReneeHill:
    He’s aboutto passout. Lane:
    I thinkhe’spassingout. Speaker 13
    He’snotevenbreathingright 00:16:58]
    Chauvin :
    you guys alright though ? Lane:
    00:16:48] bro. He’s not even resistingarrest right
    He’s breathing Kueng
    He’s breathing. crosstalk 00:17:26). Chauvin :
    Don’t comeover here. Don’t comeover here. Lane:
    Up on the sidewalk! Kueng :
    Weneedyoutokeepsomedistance. Speaker 14
    Ishe responsive? Chauvin :
    yea, we have an ambulance coming Speaker 14
    Doeshehave a pulse? Speaker 8
    Get off crosstalk 00:17:42 . Lane:
    Should we rollhim on his side? Speaker 13
    Axon_Body_3_Video_2020-05-25_2008
    (Completed
    06/10/20 ) Transcriptby Rev.com
    bro, you thinkthat’scool?Youthinkthat’scoo,lright?[crosstalk
    Yeah, Imeanmykneemightbea little scratched,butI’llsurvive. Speaker 13
    You’re a bum bro, you’re a bum for that. Can’t you be aman and see here he’s notbreathing rightnow . Lane:
    Page 17 of 25

    27 -CR -20-12951
    This transcript was exported on Jun 15, 2020 – view latest version here.
    He’s notresponsive rightnow, bro. Speaker 14
    Doeshe have a pulse? Speaker 13
    No, bro . Look at him , he’snot responsive right now , bro. Bro, are you serious? Lane:
    you gotone? Speaker 14:
    Letme see a pulse. Kueng
    i couldn’t fine one Speaker 13
    Filedin DistrictCourt State ofMinnesota 7/7/2020 11:00 AM
    Is he breathingright now ? Check his pulse. Check his pulse. Check his pulse. inaudible 00:18:19 check
    hispulse. crosstalk 00:18:19). Check hispulse, bro. inaudible 00:18:21] drugs bro. What you think that is? crosstalk 00:18:25). Youcallwhat youdoingokay?[inaudible00:18:25 .
    Speaker 14
    Yes, I am from Minneapolis. Speaker 15
    Okay, get off the sidewalk . Speaker 14:
    Showmehispulse. Check itrightfucking now . Speaker 15:
    Getback on the sidewalk. [crosstalk 00:18:33). Speaker 14
    He’s notmoving! Speaker 13:
    Bro, you’re a bum bro. You’re a bum bro. Speaker 14
    Checkhispulserightnow andtellmewhatitis. Tellmewhathispulseisrightnow. Speaker 13:
    Check his pulse. Bro, he has not moved ( crosstalk 00:19:43). Lane:
    What ?
    Dispatch: Squad 330 EMSis at Portland and 36th theywere advised of code 3. Lane:
    Therewere advisedwhat?
    Kueng
    Ofcode 3 Chauvin :
    Acknowledge that Dispatch:
    Axon_Body_3_Video_2020-05-25_2008(Completed 06/10/20) TranscriptbyRev.com
    Page 18 of 25

    -CR- 20-12951
    This transcriptwas exported on Jun 15, 2020 – view latest version here.
    Copy i was just giving you their updated location, they are en route. Lane:
    Filedin DistrictCourt State ofMinnesota 7/7/2020 11:00 AM
    Therewego. Speaker 13
    Bro , he was just moving when I walked up
    [inaudible 00:19:43 ]. Speaker 16:
    crosstalk 00:19:43 ]. Bro, he’s not fucking moving! Bro
    Get the fuck off of him what are you doing? crosstalk 00:19:43 . dying bro, what are you doing ? Lane:
    He’s not responsive right now , you guys probably want to crosstalk 00:19:44 ]. Yeah. Speaker 16
    Get off him ! crosstalk 00:19:53 . Lane:
    Should we get another car?Another car just for the crowd. inaudible 00:20:06 ) Chauvin :
    Let’s get him on inaudible 00:20:11 . Speaker 13
    inaudible 00:20:14 bro inaudible 00:20:16] like that. inaudible 00:20:17 thatman in front ofyou, bro ?He’s noteven fuckingmoving rightnow,bro. crosstalk 00:20:23).
    Lane:
    yourlightson again Speaker 17
    Youguys can get out oftheway. [crosstalk 00:21:11.
    Lane:
    Youwantoneofusto ridewith? Kueng:
    Yeah . Lane :
    Ridewith? Okay. Idon’t havemyphone so I’llbeBaker (crosstalk 00:21:48].What’sthat? Chauvin:
    Gelt them belted Down Kueng:
    Help getbelted down. Chauvin :
    Getbelted down Lane:
    yup, where we going ? Speaker 17
    We’re justgoing to be downthe street. Lane :
    Okay
    Axon_Body_3_Video_2020-05-25_2008(Completed 06/10/20)
    TranscriptbyRev.com Page19of25

    27 -CR -20-12951
    This transcriptwas exported on Jun 15, 2020 – view latest version here.
    Speaker 17
    You guyswantto shutthedoors, getout ofhere, andwe’re goingtogodownthe street. Lane:
    Filedin DistrictCourt State ofMinnesota 7/7/2020 11:00 AM
    Doyouwanthere orno? Speaker 17:
    Yeah , go to something, 40th , Tell fire where to go . Lane:
    Okay.Doyouwantmein thereorno? Speaker 17
    yea. Lane:
    Allright. Oops. Speaker 17:
    You’re fine. Kueng:
    Lane ? Lane :
    Yep Kueng:
    This yours ? Lane:
    Yeah,nope. Speaker 17:
    All rightwhatwas going on ? Lane:
    Itwas forgery report Speaker 17:
    Yep Lane:
    And he was just notcompliant with getting outof the car. Speaker 17
    Okay Lane:
    Weweretryingtogethim inthebackofthesquad,andhe Speaker 17:
    Yep. Lane:
    justbasicallyresisting.
    Hewasn’tshowingushishandsatfirst.Thenweweretryingto gethim intothesquad,hekickedhis way out,he was kickingon there. And we cameout the other side, and hewas fighting us, andwewere
    justbasicallyrestrainedhim untilyouguysgot . Speaker 17
    Okay . You do CPR
    Axon Body_3_Video_2020-05-25_2008 (Completed 06/10/20 )
    Transcriptby Rev.com Page 20 of 25

    27 -CR -20-12951
    This transcriptwas exported on Jun 15, 2020 – view latestversion here.
    Lane:
    Allright. You wantmedoing just compressions? Speaker 17:
    Just compressions for now please, thank you. Speaker 17:
    Okay.slide under. All right, keep doing compressions. Lane:
    Keep checking airway or just constant Speaker 17:
    Constant compressions. Lane:
    Constant compressions, all right. Speaker 17
    I can do an airwaycheckifyouwant inaudible00:23:53].Hehadtobedetained,physicalforce,and inaudible 00:24:05 .
    Lane:
    You got his arm in it? You good? Speaker 17
    Yep, just getthis bar uphere. Pullitout, inaudible00:24:41] there you go. Lane:
    Filedin DistrictCourt State ofMinnesota 11:00 AM
    Wantmetopullitout?Whatdoyouneed?Ithinkit’sthecloth which waydoesithook?Therewego, therewego. Fuck,sorry
    Speaker 17
    You told inaudible 00:24:54 right? Thank you. [ inaudible 00:24:54 . Lane:
    Should i still be touching him , or is that going to, electric go . Speaker 17
    Tell him to come code three we’re working an arrest. Do you need inaudible00:26:10 location 00:26:11].
    Dispatch:
    Squad 320 , if you would let know that EMS, Fire needs to go to Park and 36th, patient in full arrest now .
    Speaker 17:
    I told her. Oh (inaudible 00:26:34 Lane:
    Yeah Dispatch:
    320 Lane:
    320 . Dispatch:
    Canyouadvisethe
    department inaudible00:26:49).
    Axon Body_3_Video_2020-05-25_2008 (Completed 06/10/20 ) Transcriptby Rev.com
    Page 21of 25

    27 -CR -20-12951
    This transcript was exported on Jun 15 , 2020 – view latest version here.
    Lane:
    Filedin DistrictCourt State ofMinnesota
    7/7/2020 11:00 AM
    320BakertoAble,canyou,ifyou’restillonscene, withEMS,canyouadviseFire?Youguysneedme to do anything?
    Speaker 17
    You’re good, glove up why don’t you. Lane:
    Yeah. Youneedme to hold his airway or? Speaker 17
    No, onesecond Lane
    Okay . Speaker 17
    Okay, do this about every Lane:
    One pump? Speaker 17
    Every time this lights up give it a squeeze. Lane:
    One pump? Speaker 17
    Yep . Lane:
    All right Speaker 17
    Washe fighting with you guys for a long time? Lane :
    No.Imean littlebit,butnotalongtime,maybeaminuteortwo.Wewerejusttryingtogethim inthe
    squad, and then he cameout the other end, so wewere likewe’lljustwait. Speaker 17:
    A lot of activity prior? Lane:
    It took a bit to get him , I mean we got him out of the car and handcuffed him , and were walking him over there,walkingacrossthestreet. Youneedmeto trade places?
    Speaker 17
    Yeah inaudible 00:29:28 Lane:
    You guysneedmehere stiller? Speaker 17
    You’re good,we’re good thankyou. Lane:
    Okay . Speaker 17:
    Axon_Body_3_Video_2020-05-25_2008
    (Completed
    06/10/20 ) Transcriptby Rev.com
    Page 22 of 25

    This transcriptwas exported on Jun 15 2020 – view
    latest version here.
    27 -CR -20-12951
    Filedin DistrictCourt StateofMinnesota
    7/7/2020 11:00 AM
    There’s abagover Lane:
    320 Baker to Able, Speaker 19:
    00:30:09
    Lane:
    Oh. That’s fine, that’s good. Speaker 19
    Okay. inaudible 00:30:27 . So whathappened,more drama at Cup Foods? Lane:
    Cup Foods, yeah . It was just a forgery report, and that was the guy that they said was the person that had given them a fake bill. Wewent over there , and yeah just …
    Speaker 19:
    Wentbananas? Lane:
    be at Park and 36 when you’re done there. What’s that?Okay
    watch the foot pedal it’s down there [ inaudible 00:30:22 .
    Yeah.Imeanhewas… weretryingtogethim outofthecar,hekepthishandlikethisbasically, wasn’t showingmehis hands. So I’m like, “Letmesee yourother hand ” I gave him a couple commands forthat,hewouldn’tdoit,andthenhefinallydid.Sothenwe’relikeallrightwe’regoingtogethim out
    ofthecarrightnow.Becausehekeptlookingforthekey,Ithoughthewasgoingtotry anddriveoff. Speaker 19:
    geez. Lane :
    Yep . Speaker 19
    Man. Yeah, wedidn’t understand because itwas like come to the, so we’re there and the officers there are likenonono, andyeah, the crowdwasa little, yeah.
    Lane:
    Yeah Speaker 19
    Man, yuck. Lane:
    Notsure ifmycohort is cominghere. I gavemylocation. Otherwise, Imightjust ridewith them them there.
    Speaker 19
    Okay, Yeah. Lane:
    Was there a big crowd there then ? Speaker 19
    and help
    Yeah,moreinside.Wewaited…ournewSOPsareto ,towaitlikeifihavecootiesgoingon,solike captainusuallygoesinandmaybebringstherookie,itkindofdepends.Andthen 00:31:49]
    yeah we just waited because itwas like
    sitting here I’m like now it says code three, I just don’t understand. And then we figured outwhere it
    00:31:54] code2mouthinjury.Andthen aswe’re wasso,andthen one ofyourofficerswaslikehey,heyding-dongs,you’re atthewrongspot.”
    Axon_Body_3_Video_2020-05-25_2008 ( Completed 06/10/20 )
    TranscriptbyRev.com Page23of25

    This transcript was exported on Jun
    Lane:
    27 -CR -20-12951
    view latest version here.
    Filedin DistrictCourt StateofMinnesota
    7/7/2020 11:00 AM
    I’m notsureifhe’scomingherebut,ohyouguysstillhavetherolldown. Speaker 19
    Oh yeah, you know . Lane:
    Nice. Speaker 19:
    Nothing but the best. Yeah . Yeah , so he crashed in the inaudible 00:32:22 ] . I wonder what he was on . Lane:
    Not sure, but yeah he seemed very agitated and paranoid. Speaker 19
    That’s a shame. Lane:
    Yeah. Speaker 19
    Itseemslikeifit’switnessed, theresultscanbeprettygoodifthey’redoingCPRrightaway,sothat’s
    good. Because they get stuff going so quickly , … Lane
    Yeah . Speaker 19
    But yeah, they need more hands, that’s why . Dispatch :
    inaudible 00:33:25 ] please return to Cup foods inaudible 00:33:25 ] firefighter
    there. Check in with hermake sure she’s okay (inaudible 00:33:25 . Lane:
    They’re goingdown to county? Speaker 19
    00:33:25 ]
    They’re going to go down to county . I’m going back to Cup Foods. I’m just going to talk inaudible 00:33:30 ).
    Lane:
    Yeah .
    Speaker 19:
    We can take you there. Lane:
    I’lljust check and seeiftheywantmeto gowith. Do you guyswantmeridingwith or… Speaker 17
    No, be allright there plenty of people, thank you though . Lane:
    Allright. Yeah, if youdon’tmind giving mearide back up there. Speaker 19
    Noproblem . Yeah, inaudible 00:34:14 ). Lane:
    Axon Body_3_Video_2020-05-25_2008(Completed 06/10/20)
    Transcript by Rev.com
    Page 24 of25

    27 -CR -20-12951
    This transcriptwas exported on Jun 15 2020 – view latest version here.

    • This topic was modified 5 years, 8 months ago by Avatar photojoemad.
    #117755
    Avatar photozn
    Moderator

    Yeah, I’m glad they are keeping the burgandy and gold. I actually think thats important to the fans. And its one of my favorite color schemes. So there’s that.

    Snyder is such a piece of shit.

    w
    v

    My high school team (and I played on it for a couple of years–linebacker) was/is burgundy and gold. I’ve always loved burgundy and gold.

    We were called the Brebeuf Braves.

    The school was named after St. Jean de Brebeuf, who was martyred by the Iroquis.

    So “Braves” was an interesting nickname choice.

    A rich donor commissioned a painting in the school cafeteria of a patiently enduring St. Jean tied to a stake and being ruthlessly tortured by Iroquis…braves. The painting was wall sized and took up one entire whole end of the room.

    Fortunately, another rich donor gifted the school a huge curtain to close in front of the painting, so we could eat in peace.

    ==

    The Brebeuf Braves.

    Here’s St. Jean. This is not the painting I referred to obviously but they are of a kind. Our St. Jean had his eyes open looking heavenward in saintly forbearance etc.

    #117667
    Avatar photozn
    Moderator

    Coronavirus herd immunity may be ‘unachievable’ because antibodies disappear after a few weeks in some people

    more

    from COVID-19: Trying for herd immunity without vaccine ‘unethical’ and ‘unachievable

    https://www.bioworld.com/articles/436257-covid-19-trying-for-herd-immunity-without-vaccine-unethical-and-unachievable

    A large epidemiological study published in the July 6, 2020, advance online issue of The Lancet found that most individuals who became infected with SARS-CoV-2 developed antibodies to the virus, confirming that infection usually results in at least a short-term immune response.

    However, the results of antibody testing also showed that at least a third of SARS-CoV-2 infections were asymptomatic, and in some of those patients, the antibody response waned more quickly, potentially leaving them vulnerable to reinfection.

    Within Europe, Sweden’s attempt to achieve herd immunity via avoiding lockdowns for the general population has resulted in one of the highest per capita COVID-19 death rates of the world. But as of the end of April, around 7.4% of the Swedish population had antibodies to SARS-CoV-2.

    In a commentary that was published along with the ENE-COVID study results, researchers at the University of Geneva’s Center for Emerging Viral Diseases wrote that “any proposed approach to achieve herd immunity through natural infection is not only highly unethical, but also unachievable.”

    The authors of the study themselves made the same point. “Despite the high impact of COVID-19 in Spain” – which was the epicenter of the European outbreak after Lombardy, and has had the highest number of diagnosed cases of any country in the European Union – “prevalence estimates remain low and are clearly insufficient to provide herd immunity,” they wrote. Such herd immunity “cannot be achieved without accepting the collateral damage of many deaths in the susceptible population and overburdening of health systems.”

    #117551
    Avatar photowv
    Participant

    Fwiw:
    Study finds COVID-19 hospital patients who took hydroxychloroquine were less likely to die.
    link:https://www.washingtonexaminer.com/news/study-finds-covid-19-patients-who-took-hydroxychloroquine-were-less-likely-to-die

    Quick summary of results:
    Hospitalized Covid-19 patients in the Henry Ford Health System in southeast Michigan.

    18.1% of patients died overall.
    HCQ group: 13.5% died
    Azithromycin: 22.4% died
    HCQ+ Azithromycin: 20.1% died
    Neither drug: 26.4% died

    The study was “among one of the largest COVID-19 hospital patientcohorts (n=2,541) assembled in a single institution”
    Researchers attribute the success of the HCQ and HCQ combinations to early treatment….
    ————-

    #117543
    Avatar photozn
    Moderator

    from Rocketing Covid-19 infections expose Trump’s callous claim pandemic is ‘handled’

    https://www.cnn.com/2020/07/03/politics/donald-trump-coronavirus-texas-arizona-florida/index.html

    The United States, the world leader in Covid-19 infections and deaths, is reeling from an out-of-control resurgence of the virus that is racking up record numbers of 50,000-plus new infections each day now.
    Texas, Florida and Arizona — Republican-run states that most aggressively embraced Trump’s impatient demands to get the economy open again — are heading into what one expert warned is a viral threat that is approaching “apocalyptic” levels.

    Avatar photonittany ram
    Moderator

    I copied and pasted the article below but it looks wonky. The link has interactive graphics so that is the best way to read the article. ..

    https://www.nytimes.com/interactive/2020/04/30/opinion/coronavirus-covid-vaccine.html

    A vaccine would be the ultimate weapon against the coronavirus and the best route back to normal life. Officials like Dr. Anthony S. Fauci, the top infectious disease expert on the Trump administration’s coronavirus task force, estimate a vaccine could arrive in at least 12 to 18 months.

    The grim truth behind this rosy forecast is that a vaccine probably won’t arrive any time soon. Clinical trials almost never succeed. We’ve never released a coronavirus vaccine for humans before. Our record for developing an entirely new vaccine is at least four years — more time than the public or the economy can tolerate social-distancing orders.

    But if there was any time to fast-track a vaccine, it is now. So Times Opinion asked vaccine experts how we could condense the timeline and get a vaccine in the next few months instead of years.

    Here’s how we might achieve the impossible.

    Assume We Already Understand the Coronavirus
    Options to shorten the timeline
    Start trials early
    Rely on work from studying SARS and MERS to shorten preparations before clinical trials
    Click to turn on
    Don’t wait for academic research
    Skip to clinical phases using what we know about the coronavirus so far
    2020
    2022
    2024
    2026
    2028
    2030
    2032
    2034
    2036
    2038
    2040
    Today
    Academic research
    Pre-clinical
    Phase 1 trials
    Phase 2
    Phase 3
    Building factories
    Manufacturing
    Approval
    Distribution
    Vaccine by
    May 2036
    Academic research
    Pre-clinical
    Phase 1 trials
    Phase 2
    Phase 3
    Building factories
    Manufacturing
    Approval
    Distribution
    Normally, researchers need years to secure funding, get approvals and study results piece by piece. But these are not normal times.

    There are already at least 254 therapies and 95 vaccines related to Covid-19 being explored.

    “If you want to make that 18-month timeframe, one way to do that is put as many horses in the race as you can,” said Dr. Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine.

    Companies with vaccine trials underway
    Dozens of vaccines are starting clinical trials. Many use experimental RNA and DNA technology, which provides the body with instructions to produce its own antibodies against the virus.

    Select vaccines by clinical trial start date

    RNA and DNA vaccines

    Other vaccine types

    2020

    Feb.

    March

    April

    May

    June

    July

    Aug.

    Sept.

    Oct.

    Nov.

    Dec.

    CanSino and the A.M.M.S.

    Moderna

    BioNTech and Pfizer

    Inovio Pharmaceuticals

    Sinovac

    Wuhan Institute and Sinopharm

    U. of Oxford

    Uses 1 microgram of

    mRNA, meaning it

    could be more easily

    mass produced

    Imperial College

    Novavax

    CureVac

    Sanofi and GSK

    Exploring a new form of

    oral vaccine, which has

    never been licensed

    Vaxart

    Altimmune

    Janssen

    Note: Clinical trial start dates are approximate. Compiled by Robert van Exan.
    Despite the unprecedented push for a vaccine, researchers caution that less than 10 percent of drugs that enter clinical trials are ever approved by the Food and Drug Administration.

    The rest fail in one way or another: They are not effective, don’t perform better than existing drugs or have too many side effects.

    Less than 10 percent of drug trials are ultimately approved
    Probability of success at each phase of research

    37% fail

    Phase 1

    69% fail

    Phase 2

    42% fail

    Phase 3

    15% fail

    New Drug

    Application

    Approved

    Note: Between 2006 and 2015. Source: Biotechnology Innovation Organization, Biomedtracker, Amplion.
    Fortunately, we already have a head start on the first phase of vaccine development: research. The outbreaks of SARS and MERS, which are also caused by coronaviruses, spurred lots of research. SARS and SARS-CoV-2, the virus that causes Covid-19, are roughly 80 percent identical, and both use so-called spike proteins to grab onto a specific receptor found on cells in human lungs. This helps explain how scientists developed a test for Covid-19 so quickly.

    There’s a cost to moving so quickly, however. The potential Covid-19 vaccines now in the pipeline might be more likely to fail because of the swift march through the research phase, said Robert van Exan, a cell biologist who has worked in the vaccine industry for decades. He predicts we won’t see a vaccine approved until at least 2021 or 2022, and even then, “this is very optimistic and of relatively low probability.”

    And yet, he said, this kind of fast-tracking is “worth the try — maybe we will get lucky.”

    Years and years, at minimum
    The vaccine development process has typically taken a decade or longer.

    Varicella

    28 years

    FluMist

    28

    Human papillomavirus

    15

    Rotavirus

    15

    Pediatric combination

    11

    Covid-19 goal

    18 months

    Note: Rotavirus and HPV vaccines include time from filing of the first investigational new drug to approval. Source: “Plotkin’s Vaccines” (7th edition)
    The next step in the process is pre-clinical and preparation work, where a pilot factory is readied to produce enough vaccine for trials. Researchers relying on groundwork from the SARS and MERS outbreaks could theoretically move through planning steps swiftly.

    Sanofi, a French biopharmaceutical company, expects to begin clinical trials late this year for a Covid-19 vaccine that it repurposed from work on a SARS vaccine. If successful, the vaccine could be ready by late 2021.

    Move at ‘Pandemic Speed’ Through Trials
    Options to shorten the timeline
    Use ‘pandemic speed’ timeline
    Start subsequent steps before previous phases are completed
    Push to large-scale tests sooner
    Move more swiftly to Phase 3 trials by combining phases
    Use emergency provision
    Vaccinate front-line and essential workers early
    2020
    2022
    2024
    2026
    2028
    2030
    2032
    2034
    2036
    2038
    2040
    Today
    Academic research
    Pre-clinical
    Phase 1 trials
    Phase 2
    Phase 3
    Building factories
    Manufacturing
    Approval
    Distribution
    Vaccine by
    May 2036
    Academic research
    Pre-clinical
    Phase 1 trials
    Phase 2
    Phase 3
    Building factories
    Manufacturing
    Approval
    Distribution
    As a rule, researchers don’t begin jabbing people with experimental vaccines until after rigorous safety checks.

    They test the vaccine first on small batches of people — a few dozen during Phase 1, then a few hundred in Phase 2, then thousands in Phase 3. Months normally pass between phases so that researchers can review the findings and get approvals for subsequent phases.

    But “if we do it the conventional way, there’s no way we’re going to be reaching that timeline of 18 months,” said Akiko Iwasaki, a professor of immunobiology at Yale University School of Medicine and an investigator at the Howard Hughes Medical Institute.

    There are ways to slash time off this process by combining several phases and testing vaccines on more people without as much waiting.

    Last week the National Academy of Sciences showed an overlapping timeline, describing it as moving at “pandemic speed.”

    It’s here that talk of fast-tracking the timeline meets the messiness of real life: What if a promising vaccine actually makes it easier to catch the virus, or makes the disease worse after someone’s infected?

    That’s been the case for a few H.I.V. drugs and vaccines for dengue fever, because of a process called vaccine-induced enhancement, in which the body reacts unexpectedly and makes the disease more dangerous.

    Researchers can’t easily infect vaccinated participants with the coronavirus to see how the body behaves. They normally wait until some volunteers contract the virus naturally. That means dosing people in regions hit hardest by the virus, like New York, or vaccinating family members of an infected person to see if they get the virus next. If the pandemic subsides, this step could be slowed.

    “That’s why vaccines take such a long time,” said Dr. Iwasaki. “But we’re making everything very short. Hopefully we can evaluate these risks as they occur, as soon as possible.”

    This is where the vaccine timelines start to diverge depending on who you are, and where some people might get left behind.

    If a vaccine proves successful in early trials, regulators could issue an emergency-use provision so that doctors, nurses and other essential workers could get vaccinated right away — even before the end of the year. Researchers at Oxford announced this week that their coronavirus vaccine could be ready for emergency use by September if trials prove successful.

    So researchers might produce a viable vaccine in just 12 to 18 months, but that doesn’t mean you’re going to get it. Millions of people could be in line before you. And that’s only if the United States finds a vaccine first. If another country, like China, beats us to it, we could wait even longer while it doses its citizens first.

    You might be glad of that, though, if it turned out that the fast-tracked vaccine caused unexpected problems. Only after hundreds or thousands are vaccinated would researchers be able to see if a fast-tracked vaccine led to problems like vaccine-induced enhancement.

    “It’s true that any new technology comes with a learning curve,” said Dr. Paul Offit, the director of the Vaccine Education Center at the Children’s Hospital of Philadelphia. “And sometimes that learning curve has a human price.”

    Start Preparing Factories Now
    Options to shorten the timeline
    Make vaccines early
    Build and manufacture early, anticipating that factories will be useful for a future vaccine and that the product will clear regulatory hurdles
    Take a bet on a successful mRNA vaccine
    This experimental technology may be faster to produce than traditional vaccines
    2020
    2022
    2024
    2026
    2028
    2030
    2032
    2034
    2036
    2038
    2040
    Today
    Academic research
    Pre-clinical
    Phase 1 trials
    Phase 2
    Phase 3
    Building factories
    Manufacturing
    Approval
    Distribution
    Vaccine by
    May 2036
    Academic research
    Pre-clinical
    Phase 1 trials
    Phase 2
    Phase 3
    Building factories
    Manufacturing
    Approval
    Distribution
    Once we have a working vaccine in hand, companies will need to start producing millions — perhaps billions — of doses, in addition to the millions of vaccine doses that are already made each year for mumps, measles and other illnesses. It’s an undertaking almost unimaginable in scope.

    Companies normally build new facilities perfectly tailored to any given vaccine because each vaccine requires different equipment. Some flu vaccines are produced using chicken eggs, using large facilities where a version of the virus is incubated and harvested. Other vaccines require vats in which a virus is cultured in a broth of animal cells and later inactivated and purified.

    Those factories follow strict guidelines governing biological facilities and usually take around five years to build, costing at least three times more than conventional pharmaceutical factories. Manufacturers may be able to speed this up by creating or repurposing existing facilities in the middle of clinical trials, long before the vaccine in question receives F.D.A. approval.

    “They just can’t wait,” said Dr. Iwasaki. “If it turns out to be a terrible vaccine, they won’t distribute it. But at least they’ll have the capability” to do so if the vaccine is successful.

    The Bill and Melinda Gates Foundation says it will build factories for seven different vaccines. “Even though we’ll end up picking at most two of them, we’re going to fund factories for all seven, just so that we don’t waste time,” Bill Gates said during an appearance on “The Daily Show.”

    In the end, the United States will have the capacity to mass-produce only two or three vaccines, said Vijay Samant, the former head of vaccine manufacturing at Merck.

    “The manufacturing task is insurmountable,” Mr. Samant said. “I get sleepless nights thinking about it.”

    Consider just one seemingly simple step: putting the vaccine into vials. Manufacturers need to procure billions of vials, and billions of stoppers to seal them. Sophisticated machines are needed to fill them precisely, and each vial is inspected on a high-speed line. Then vials are stored, shipped and released to the public using a chain of temperature-controlled facilities and trucks. At each of these stages, producers are already stretched to meet existing demands, Mr. Samant said.

    It’s a bottleneck similar to the one that caused a dearth of ventilators, masks and other personal protective equipment just as Covid-19 surged across America.

    If you talk about vaccines long enough, a new type of vaccine, called Messenger RNA (or mRNA for short), inevitably comes up. There are hopes it could be manufactured at a record clip. Mr. Gates even included it on his Time magazine list of six innovations that could change the world. Is it the miracle we’re waiting for?

    Rather than injecting subjects with disease-specific antigens to stimulate antibody production, mRNA vaccines give the body instructions to create those antigens itself. Because mRNA vaccines don’t need to be cultured in large quantities and then purified, they are much faster to produce. They could change the course of the fight against Covid-19.

    “On the other hand,” said Dr. van Exan, “no one has ever made an RNA vaccine for humans.”

    Researchers conducting dozens of trials hope to change that, including one by the pharmaceutical company Moderna. Backed by investor capital and spurred by federal funding of up to $483 million to tackle Covid-19, Moderna has already fast-tracked an mRNA vaccine. It’s entering Phase 1 trials this year and the company says it could have a vaccine ready for front-line workers later this year.

    “Could it work? Yeah, it could work,” said Dr. Fred Ledley, a professor of natural biology and applied sciences at Bentley University. “But in terms of the probability of success, what our data says is that there’s a lower chance of approval and the trials take longer.”

    The technology is decades old, yet mRNA is not very stable and can break down inside the body.

    “At this point, I’m hoping for anything to work,” said Dr. Iwasaki. “If it does work, wonderful, that’s great. We just don’t know.”

    The fixation on mRNA shows the allure of new and untested treatments during a medical crisis. Faced with the unsatisfying reality that our standard arsenal takes years to progress, the mRNA vaccine offers an enticing story mixed with hope and a hint of mystery. But it’s riskier than other established approaches.

    Speed Up Regulatory Approvals
    Options to shorten the timeline
    Fast-track federal approvals
    Shorten approval window from a year to six months
    2020
    2022
    2024
    2026
    2028
    2030
    2032
    2034
    2036
    2038
    2040
    Today
    Academic research
    Pre-clinical
    Phase 1 trials
    Phase 2
    Phase 3
    Building factories
    Manufacturing
    Approval
    Distribution
    Vaccine by
    May 2036
    Academic research
    Pre-clinical
    Phase 1 trials
    Phase 2
    Phase 3
    Building factories
    Manufacturing
    Approval
    Distribution
    Imagine that the fateful day arrives. Scientists have created a successful vaccine. They’ve manufactured huge quantities of it. People are dying. The economy is crumbling. It’s time to start injecting people.

    But first, the federal government wants to take a peek.

    That might seem like a bureaucratic nightmare, a rubber stamp that could cost lives. There’s even a common gripe among researchers: For every scientist employed by the F.D.A., there are three lawyers. And all they care about is liability.

    Yet F.D.A. approvals are no mere formality. Approvals typically take a full year, during which time scientists and advisory committees review the studies to make sure that the vaccine is as safe and effective as drug makers say it is.

    While some steps in the vaccine timeline can be fast-tracked or skipped entirely, approvals aren’t one of them. There are horror stories from the past where vaccines were not properly tested. In the 1950s, for example, a poorly produced batch of a polio vaccine was approved in a few hours. It contained a version of the virus that wasn’t quite dead, so patients who got it actually contracted polio. Several children died.

    The same scenario playing out today could be devastating for Covid-19, with the anti-vaccination movement and online conspiracy theorists eager to disrupt the public health response. So while the F.D.A. might do this as fast as possible, expect months to pass before any vaccine gets a green light for mass public use.

    At this point you might be asking: Why are all these research teams announcing such optimistic forecasts when so many experts are skeptical about even an 18-month timeline? Perhaps because it’s not just the public listening — it’s investors, too.

    “These biotechs are putting out all these press announcements,” said Dr. Hotez. “You just need to recognize they’re writing this for their shareholders, not for the purposes of public health.”

    What if It Takes Even Longer Than the Pessimists Predict?
    Covid-19 lives in the shadow of the most vexing virus we’ve ever faced: H.I.V. After nearly 40 years of work, here is what we have to show for our vaccine efforts: a few Phase 3 clinical trials, one of which actually made the disease worse, and another with a success rate of just 30 percent.

    Deaths per year
    The number of deaths from Covid-19 in 2020 has surpassed the number of deaths per year from H.I.V./AIDS during the height of the crisis in the 1990s.

    60k deaths

    Deaths from

    Covid-19 in

    the U.S.

    50k

    40k

    Deaths from

    H.I.V./AIDS

    in the U.S.

    30k

    20k

    10k

    0

    1990

    2000

    2010

    2020

    Note: No H.I.V. death data available after 2018. Covid-19 deaths as of April 29. Source: Mortality Informatics and Research Analytics.
    Researchers say they don’t expect a successful H.I.V. vaccine until 2030 or later, putting the timeline at around 50 years.

    That’s unlikely to be the case for Covid-19, because, as opposed to H.I.V., it doesn’t appear to mutate significantly and exists within a family of familiar respiratory viruses. Even still, any delay will be difficult to bear.

    But the history of H.I.V. offers a glimmer of hope for how life could continue even without a vaccine. Researchers developed a litany of antiviral drugs that lowered the death rate and improved health outcomes for people living with AIDS. Today’s drugs can lower the viral load in an H.I.V.-positive person so the virus can’t be transmitted through sex.

    Therapeutic drugs, rather than vaccines, might likewise change the fight against Covid-19. The World Health Organization began a global search for drugs to treat Covid-19 patients in March. If successful, those drugs could lower the number of hospital admissions and help people recover faster from home while narrowing the infection window so fewer people catch the virus.

    Combine that with rigorous testing and contact tracing — where infected patients are identified and their recent contacts notified and quarantined — and the future starts looking a little brighter. So far, the United States is conducting fewer than half the number of tests required and we need to recruit more than 300,000 contact-tracers. But other countries have started reopening following exactly these steps.

    If all those things come together, life might return to normal long before a vaccine is ready to shoot into your arm.

    Stuart A. Thompson is a writer and the graphics director for Times Opinion.

    Source: Clinical trial medians from “Development Times and Approval Success Rates for Drugs to Treat Infectious Diseases”

    Stuart A. Thompson is a writer and the graphics director for Times Opinion.

    READ 785 COMMENTS

    More in Opinion

    • This topic was modified 5 years, 8 months ago by Avatar photonittany ram.
    #117276
    Avatar photozn
    Moderator

    ‘Like leaning into a left hook’: coronavirus calamity unfolds across divided US
    In a week that saw the worst day on record for new cases, Trump shrugs as experts warn Americans not to follow his lead

    https://www.theguardian.com/world/2020/jun/27/coronavirus-cases-us-trump-politics-masks

    A disaster is unfolding in Montgomery, Alabama, where Martin Luther King preached and where Rosa Parks was arrested for refusing to give up her seat on the bus. Hospitals are running short of drugs to treat Covid-19, intensive care units are close to capacity, and ventilators are running short.

    Between 85% and 90% of the very sick and dying are African American.

    Amid this gathering storm, the city council met to decide whether to require people to wear masks, a basic protection the US Centers for Disease Control and Prevention (CDC) strongly recommends. Doctors lined up to plead their case.

    “This is beyond an epidemic in this area,” said the pulmonologist Bill Saliski. “Our units are full of critically ill covid patients. We have to slow this down.”

    His colleague, Nina Nelson-Garrett, described watching undertakers carrying out corpses, 30 minutes apart.

    “Something as simple as a mask can save someone’s life,” she said.

    Dr Kim McGlothan recounted how she was frequently stopped by white people asking, “Is the media sensationalizing this, is it really as bad as they are making out?”

    McGlothan told the council: “People don’t believe the hype. Until you mandate masks, we won’t be able to stop this – we just won’t.”

    Then a black resident stood up. Six of his relatives had died from Covid-19. His brother was on a ventilator. “This is not about masks,” he said. “The question on the table is, ‘Do black lives matter?’ I lost six of my family to Covid. How would it feel if it was your family?”

    The council debated for two hours. White council members asked if young children could get carbon monoxide poisoning from masks – no, the doctors firmly told them – and spoke portentously about individual rights.

    “At the end of the day,” said councilman Brantley Lyons, “if a pandemic comes through, we do not throw our constitutional rights out the window.”

    When the vote was called, it divided on largely racial lines. Black members voted for masks, in order to prevent more families losing six loved ones. White members voted against masks, to preserve the fundamental right not to attach a cloth to your face.

    In a 4-4 tie, the ordinance failed. As he left the chamber, Dr Saliski uttered just one word: “Unbelievable.”

    Unbelievable accurately describes America today. The country is on the brink of a huge surge of Covid-19, as the virus tears through the heartlands while the president praises himself for having done “a great job” and blithely predicts the scourge will “fade away”.

    Ask Alabama whether the virus is fading away. Or Arizona, Florida, South Carolina or Texas. The disease is venting its fury on these states, which all reopened their economies – with Donald Trump’s avid blessing – before the contagion was contained.

    “Opening while cases are increasing is like leaning into a left hook,” said Tom Frieden, a former CDC director. “You are basically asking to get hit – and that’s what these states did.”

    Alabama is enduring a pummeling. It has recorded 32,000 cases and its curve is on a steep upward path.

    The Republican governor of Texas, Greg Abbott, who ushered in one of the earliest and most aggressive reopenings, insisted a few days ago that his state “remains wide-open for business”. Yet he has been unable to ignore reality: that the virus has spread its lethal tentacles to every corner of the state overwhelming hospitals to the point that Houston medical centers are running out of ICU beds. Now, once again, Texas’ bars are closing. One town, near Houston, has even brought in a curfew.

    The Lone Star state recorded 6,584 cases on Wednesday alone – a heart-sinking figure that makes its curve look almost vertical.

    Florida’s malaise would be wryly amusing were so many lives not at stake. On 20 May the conservative magazine the National Review ran the gloating headline: “Where Does Ron DeSantis Go to Get His Apology?” The article scolded liberal critics of the Republican governor’s lax approach to coronavirus – he famously allowed beaches to remain open in spring break and has permitted shops and restaurants to get back to business – for having got it wrong: there was no spike in Florida.

    On 20 May, Florida’s daily infection load stood at 527 new cases. Five weeks later, it reported a record 8,942 on Friday and broke the record again on Saturday with 9,585.

    ‘It’s getting worse, not better’

    Though states such as Florida and Texas are bearing the brunt of the beating, this is not a catastrophe that can be dismissed as the problem of just a few places. Across the nation, at terrifying speed, a similar picture is revealing itself.

    Every important data point, including positivity rates and hospitalizations, is surging across most states. A map produced by a team of epidemiologists and health experts, Covid Act Now, shows only four states, all in the north-east, including New York, which used to be at the center of the pandemic but has wrestled it under control, as being on track to contain the disease. Twenty-one states are at risk or facing active or imminent outbreaks.

    It is troubling enough that the US now has 2.4m confirmed cases – double the number of the next highest country in the world, Brazil, and almost certainly a huge underestimate. The death toll has passed 125,000, with another 20,000 at least expected this month.

    The death rate is still trending downwards – one bit of positive news in this sorry picture. But deaths lag behind confirmed cases by a month, and that spells trouble ahead.

    One crumb of comfort had been that for almost three months the daily rate of new infections held steady at around 20,000 cases a day. Then, two weeks ago, the monster began to stir.

    The tally of new cases ticked upwards, and on Thursday it reached a stomach-churning 40,000 – the worst day on record since the pandemic began.

    “It’s getting worse, not better,” said Frieden, who now heads the global health initiative Resolve to Save Lives. “The contrast with other countries is striking. South Korea had 30 cases a day and they flipped out. The US now has 30,000 cases a day and there are people shrugging and saying ‘It’s no big deal’.”

    Trump is shrugger-in-chief. When the president lured thousands of non-mask wearing supporters to a viral incubation party – he called it a rally – in Tulsa, Oklahoma, last Saturday, he told them that in his view testing for coronavirus was a “double-edged sword… When you do testing you are going to find more cases. So I told my people, slow the testing down.”

    Despite White House efforts to pass the comment off as a joke, it encapsulates the Trump administration’s approach towards this devastating crisis. Early on, Trump failed to marshal the full weight of the most powerful government on Earth against the virus. He lost six critical weeks.

    Even today, the 500,000 tests being carried out each day falls woefully short of the scale needed. Contact tracing – another crucial tool – is patchy at best, with signs that a growing number of Americans are unwilling to cooperate.

    Leading public health experts have watched aghast as Trump has done exactly what he said he would: put a dampener on data-driven efforts that could, over the course of the pandemic, potentially save hundreds of thousands of lives.

    “Everybody agrees we need a lot more testing,” said Ashish Jha, director of the Harvard Global Health Institute. “But when the conversation turns to, ‘Why can’t we ramp up the testing?’ there’s always the sense that the White House is not going to be happy to do what’s necessary. There’s real pushback against scientific leaders calling for action.”

    Evidence for such a pushback isn’t hard to find. There’s this week’s announcement that the Trump administration will soon end federal funding for 13 testing sites – seven in ravaged Texas.

    Then there’s the ghostlike absence of the CDC, one of the world’s leading public health agencies, which has fallen mute at the moment it is most needed. Frieden has become so frustrated by the booming silence of the institution he led for almost eight years, until Trump entered the White House, he has taken to publicising CDC research himself, in a desperate attempt to fill the void.

    When the Guardian put it to him that this was an extraordinary state of affairs, Frieden replied: “It feels a bit like North Korea, doesn’t it?”

    The most worrying aspect of the tone being set by Trump is that it is starting to shift the mindset of ordinary Americans. Everywhere you look there are anecdotal signs of people falling in line with the president – shrugging and saying it’s no big deal.

    That trend is very visible in Montgomery. In the end, the town’s African American mayor, Steven Reed, overruled the city council’s white members and introduced mandatory mask-wearing by executive fiat.

    But it will be an uphill battle persuading white townsfolk to abide by the ordinance. Brad Harper, a reporter with the Montgomery Advertiser, says he is struck whenever he goes into a Target or Walmart that almost all white shoppers go unmasked while black shoppers have their faces covered.

    On social media, people rant about masks as “muzzles” and “badges of submission”. “People get really angry about it, resisting even their doctors asking them to wear it,” Harper said. “They don’t see a protective device, as something that can save the people around you, they see it as an instrument of control.”

    All across the country, similar acts of personal rebellion are playing out. Residents of Palm Beach, Florida, erupted in anger against a mandatory mask order, calling it the “devil’s law” and an affront to “God’s breathing system”.

    Further up the Florida coast, in Jacksonville Beach, 16 friends decided to have a night out at an Irish pub – the entire group came down with the virus, as well as seven bar workers. A surprise birthday party in Texas led to 18 members of one family being infected.

    Crowds of unmasked people have been gathering in Las Vegas’s reopened casinos, and Covid-19 cases have soared. In Arizona, the Republican sheriff of Pinal county vowed not to enforce the lockdown on grounds of individual liberty, and promptly contracted the disease himself. Not to mention Cruisin’ Chubbys Gentleman’s Club, a strip club in Wisconsin that had its very own outbreak.

    ‘If you divide people, you allow divide and conquer’

    Everywhere you look there are indications America’s social contract – the idea that if we stand united we can defeat this terrible affliction – is breaking down.

    “If you divide people, you allow divide and conquer,” Frieden said. “This is us against them, humans against microbes. The more we are divided, the more microbes will conquer.”

    Wändi Bruine de Bruin, provost professor of public policy, psychology and behavioral science at the University of Southern California, has been tracking the changing public response since March. Through a rolling survey of 7,000 adults, she has found that most Americans – about 71% – still say they avoid public spaces and crowds. But the proportion is falling, fast, down from 92% in April.

    She puts the slide down to unclear messaging. “Messages and policies are no longer consistent. Some businesses are allowed to open, others not, and it’s not clear why. That leads to confusion, and anger. Some people start to think it’s not fair, others start to assume it’s not that important.”

    Jha said it was vital to acknowledge that most Americans, including many Republicans, have so far been compliant with stay-at-home orders. But he frets that a mindset is taking hold that the virus is somebody else’s problem.

    “I worry that it will take large numbers of people getting very sick, the hospitals filling up, for people to realise this is a pandemic, not a disease outbreak in New York or New Orleans. I hope it doesn’t come to that. I worry that it will.”

    The Guardian asked whether he was concerned about possible public resistance to renewed lockdown orders, should some states be forced back into extreme measures in the face of a Covid-19 explosion.

    “I do fear that,” he said. “For months there has been a concerted effort by a small minority to argue that this is overblown or a hoax. It will be difficult for Republican leaders to get people to change their views on this.”

    Jha checked himself, then added: “It’s a tiny minority. Unfortunately, it includes the president of the United States.”

    The good news is that scientists are very clear about what needs to be done. Frieden calls it the three Ws – wear a mask, wash your hands, watch your distance – combined with aggressive testing, contact tracing and isolation of the sick.

    If such measures can be introduced concertedly and quickly, both at federal and state level, public health experts are confident that all is not lost. The contagion could be contained and the economy slowly and relatively safely rebooted.

    But time is running out for America.

    “This is a long war and we are losing a lot of battles right now, because we are not fighting them,” Frieden said. “We are going to be paying for the mistakes we make today for months, or even years, to come.”

    #117268
    Avatar photozn
    Moderator

    Many of us know about Matt Waldman. Football guy, draft analyst.

    Here in a series of tweets, he feels compelled to address the big issues we’re seeing right now. It’s worth a read IMO. He talks about being the husband of a black woman and father of a black child in today’s USA.

    Matt Waldman@MattWaldman
    Seeing some of my colleagues talk about what it’s like being black in America–
    @DianteLee_ comes to mind prominently this afternoon, I’d like to offer a different perspective.

    Being white, growing up in the north and south, and becoming part of a black family. What you learn.

    The first thing you learn is that no matter how open-minded, loving, and book-educated you are, you are not ready for what you’ll experience once you become emotionally invested in the lives of people who are black.

    Seeing, experiencing, and feeling it on a visceral level.

    You will at first do what black people do as they’re growing up and first experiencing it: Wondering if what you experienced happened as you perceived it and trying to rationalize the motivations as not racist. Revisiting multiple times to make sure you’re not crazy.

    Black people revisit, replay, and analyze things that happen–even after experiencing events like it for decades.

    You learn there’s a constant state of questioning, analyzing, explaining (while angry). It’s stressful and wears you out.

    You learn why a lifetime of having to be on guard for the potential of significant danger to well-being physically, financially, and emotionally is a drain on mental, physical, and financial health–and considering how doctors have been mistrained (even recently)…

    about the pain tolerance, dosages, and overall untrue differences with black patients, it’s not surprising there’s a distrust of U.S. healthcare.

    BTW-I learned with one of my roommates in 1990 in Miami that if I didn’t barge past the ER front desk in an empty waiting room,

    my roommate, who waited 30 minutes with a medical emergency (I rushed him there) and was hyperventilating and sweating bullets was about two minutes from a stroke if I didn’t grab an annoyed doctor (once he saw my roommate–five folks were working on him immediately)

    Even w/that story, at 20 yrs old, having influential teachers talk to me about their life in America, reading Malcolm X, learning history beyond my high school curriculum, I still wanted to rationalize what my roommate went through.

    The truth: Being dangerously ill while black

    I learned how to have “the talks” with my kids about retail stores, police, school, and the parents of their white friends. Things I never had to consider growing up. Sometimes those talks happened after the fact with incidents that came earlier than I hoped to God would.

    Teacher putting my talkative kid in a desk and putting a tape perimeter around her to tell other kids not to interact with her and wanted her tested for a learning disability–when all she did was finish her assignments early (and correctly and consistently) and was bored.

    Cashier being rude to my girlfriend because the clerk shorted $20 at the grocery. The manager being ruder when summoned. Neither manager nor cashier offering the slightest apology after counting drawer and it being exactly $20 over.

    Countless times followed by retail clerks or front store security behaving brusquely until they realized I was with them and then behaving 180 degrees different. Cops thinking the way to behave with my executive wife whose family all earned college degrees was to speak ebonics

    Wife pulled over for alleged “rolling stops”, going through yellow lights, or going 5mph over the speed limit & questioned about the veracity of her ownership of the car because of the cognitive dissonance of her dark skin & German last name that’s on her license and insurance.

    Cops questioning that she owns the car even after they see the name match with the IDs. Cops following her home after everything checks out but they want to make sure that nice car is hers–the “don’t-fuck-with-me,” car that I would never have to drive for people at work to see

    that she’s not some charity case they hired but a star employee. Not to mention that her dad, sister, and brother were Baltimore PD. And they know police training has been cut well short of optimal in the past 15-20 years.

    My wife having to deal with “Cooper-like” women (not new) using tears as a weapon when they become threatened about my wife’s positive work relationships w/males at the job. And those males taking the bait because they don’t expect white women to be mature one but need rescuing.

    Ex-girlfriend and I once applied for same job. She had more desirable industry experience, called her first, talked salary, & scheduled interview. She arrived in a stunning Chanel suit–very interview appropriate. Hiring manager took one look at her, said job was filled, offered

    entry-level gig. Then manager called me, I went through three interviews–one was clearly a “does the owner give the stamp of approval that I’m a white male,” interview and was offered the job (I graphically told them what they could do with the offer).

    The dread I felt when my wife decided to take a drive in her new car and forgot to tell me she was doing so after she ran an errand at night and I thought she’d be home in 20 minutes. Me driving around the county looking for her because I hoped she wasn’t pulled over.

    My wife panicking and wanting to leave a concert when my daughter, a Marine, got pulled over for a traffic stop at night in a county that 15 years ago had signs that essentially told black people to leave at night.

    I notice how some people who are uncomfortable around blacks get tense and shaky and I have to be 1-2 steps ahead and wonder if this is the day I’m going to jail for my wife. I have learned how to take the temperature of a room in a way I never had to before.

    I notice black people taking the temperature of my behavior. Am I at ease and self-aware or am I going to be that guy trying to act black? Am I that guy who will treat my wife as some fetishized trophy? Am I the well-meaning but ignorant liberal social justice warrior 24/7?

    All of this is done out of protection and understandably so. Some have seen and experienced too much to even want to try with me. And I get that. Hate it’s that way, but I get it and know I can’t change that in one interaction–and in some cases, ever.

    What did I learn?

    Being outwardly and vocally hateful was wrong and made your family look bad but being exclusionary for ignorant reasons, telling jokes, reinforcing racism behind the scenes was intentionally and unintentionally encouraged.

    It’s the source of gaslighting.

    That racism was often tolerated by younger adults not to upset their older parents or authority figures in society with the purse strings.

    That it was ok to be friendly but not close to black people.

    That black entertainers were exceptional and not the norm. Ring a bell?

    That the norm was more like what I saw on the news. What did I see on the news? Murders, robbers, rioters in Miami reacting to police murder/brutality.

    I knew this wasn’t true. Didn’t change the emotional reactions I had from these being internalized. Sound familiar?

    Like many, these lessons created an ingrained fear. Fear of saying the wrong thing. Fear of being labeled a racist more than tacitly supporting racism. Fear of where to even begin with gaining real knowledge. It’s why so many never even begin.

    Fact is, 5 yrs ago the reactions to this behavior was met with a lot more resistance. Progress is sadly slow but it’s there. Feeling that helplessness is a part of honest recognition.

    Mostly, I’ve learned that I had to unlearn subtle and unintentional behaviors that I was taught that perpetuated systemic racism. Things family and authority taught. That it took time, effort, humility, and painful self-reflection. I’m still learning. We’re all still learning.

    And, it’s exhausting to explain as often as it needs to be explained to give someone uninitiated a clear picture. A clear picture you may not see immediately or in its totality. I’m not telling you how to be, just sharing how I’ve been. Hope it helps.

    #117067
    Avatar photozn
    Moderator

    Coronavirus Live Updates: U.S. Cases Near Record Level as Virus Surges in South and West
    New cases in the U.S. have reached their highest daily level since April.
    link https://www.nytimes.com/2020/06/24/world/coronavirus-updates.html

    ==

    New coronavirus cases in the U.S. soar to highest single-day total
    https://www.washingtonpost.com/nation/2020/06/24/coronavirus-live-updates-us/

    ==

    New York imposes quarantine on nine US states
    https://www.bbc.com/news/world-us-canada-53167780

    New York, New Jersey and Connecticut have asked people travelling from states where virus cases are rising to go into self-isolation for 14 days.

    ==

    ‘The explosion has to slow down’: Texas hospitals on edge as coronavirus cases surge
    “It’s not like I can triple my capacity overnight because we have a lot of other patients,” said a hospital administrator in Houston.
    https://www.nbcnews.com/news/latino/explosion-has-slow-down-texas-hospitals-edge-coronavirus-cases-surge-n1232053

    #117050
    Avatar photozn
    Moderator

    How Exactly Do You Catch Covid-19? There Is a Growing Consensus
    Surface contamination and fleeting encounters are less of a worry than close-up, person-to-person interactions for extended periods

    https://www.wsj.com/articles/how-exactly-do-you-catch-covid-19-there-is-a-growing-consensus-11592317650?fbclid=IwAR0fXjVEGJNUrd_DTKV2CTre_iIIihxOMFX2-fWAPkeE0EB6nX2m0My5h0U

    Six months into the coronavirus crisis, there’s a growing consensus about a central question: How do people become infected?

    It’s not common to contract Covid-19 from a contaminated surface, scientists say. And fleeting encounters with people outdoors are unlikely to spread the coronavirus.

    Instead, the major culprit is close-up, person-to-person interactions for extended periods. Crowded events, poorly ventilated areas and places where people are talking loudly—or singing, in one famous case—maximize the risk.

    These emerging findings are helping businesses and governments devise reopening strategies to protect public health while getting economies going again. That includes tactics like installing plexiglass barriers, requiring people to wear masks in stores and other venues, using good ventilation systems and keeping windows open when possible.

    Two recent large studies showed that wide-scale lockdowns—stay-at-home orders, bans on large gatherings and business closures—prevented millions of infections and deaths around the world. Now, with more knowledge in hand, cities and states can deploy targeted interventions to keep the virus from taking off again, scientists and public-health experts said.

    That means better protections for nursing-home residents and multigenerational families living in crowded conditions, they said. It also means stressing physical distancing and masks, and reducing the number of gatherings in enclosed spaces.

    “We should not be thinking of a lockdown, but of ways to increase physical distance,” said Tom Frieden, chief executive of Resolve to Save Lives, a nonprofit public-health initiative. “This can include allowing outside activities, allowing walking or cycling to an office with people all physically distant, curbside pickup from stores, and other innovative methods that can facilitate resumption of economic activity without a rekindling of the outbreak.”

    The group’s reopening recommendations include widespread testing, contact tracing and isolation of people who are infected or exposed.

    A Recipe for Infection
    Getting the Covid-19 virus involves three steps.

    1 Coughing, talking and breathing creates virus-carrying droplets of various sizes.

    2 Enough virus has to make itself over to you or build up around you over time to trigger an infection.

    3 The virus has to make its way into your respiratory tract and use the ACE-2 receptors there to enter cells and replicate.

    One important factor in transmission is that seemingly benign activities like speaking and breathing produce respiratory bits of varying sizes that can disperse along air currents and potentially infect people nearby.

    Health agencies have so far identified respiratory-droplet contact as the major mode of Covid-19 transmission. These large fluid droplets can transfer virus from one person to another if they land on the eyes, nose or mouth. But they tend to fall to the ground or on other surfaces pretty quickly.

    Some researchers say the new coronavirus can also be transmitted through aerosols, or minuscule droplets that float in the air longer than large droplets. These aerosols can be directly inhaled.

    That’s what may have happened at a restaurant in Guangzhou, China, where an infected diner who was not yet ill transmitted the virus to five others sitting at adjacent tables. Ventilation in the space was poor, with exhaust fans turned off, according to one study looking at conditions in the restaurant.

    Aerosolized virus from the patient’s breathing or speaking could have built up in the air over time and strong airflow from an air-conditioning unit on the wall may have helped recirculate the particles in the air, according to authors of the study, which hasn’t yet been peer-reviewed.

    Sufficient ventilation in the places people visit and work is very important, said Yuguo Li, one of the authors and an engineering professor at the University of Hong Kong. Proper ventilation—such as forcing air toward the ceiling and pumping it outside, or bringing fresh air into a room—dilutes the amount of virus in a space, lowering the risk of infection.

    Another factor is prolonged exposure. That’s generally defined as 15 minutes or more of unprotected contact with someone less than 6 feet away, said John Brooks, the Centers for Disease Control and Prevention’s chief medical officer for the Covid-19 response. But that is only a rule of thumb, he cautioned. It could take much less time with a sneeze in the face or other intimate contact where a lot of respiratory droplets are emitted, he said.

    Superspreaders

    At a March 10 church choir practice in Washington state, 87% of attendees were infected, said Lea Hamner, an epidemiologist with the Skagit County public-health department and lead author of a study on an investigation that warned about the potential for “superspreader” events, in which one or a small number of people infect many others.

    Members of the choir changed places four times during the 2½-hour practice, were tightly packed in a confined space and were mostly older and therefore more vulnerable to illness, she said. All told, 53 of 61 attendees at the practice were infected, including at least one person who had symptoms. Two died.

    Several factors conspired, Ms. Hamner said. When singing, people can emit many large and small respiratory particles. Singers also breathe deeply, increasing the chance they will inhale infectious particles.

    Similar transmission dynamics could be at play in other settings where heavy breathing and loud talking are common over extended periods, like gyms, musical or theater performances, conferences, weddings and birthday parties. Of 61 clusters of cases in Japan between Jan. 15 and April 4, many involved heavy breathing in close proximity, such as karaoke parties, cheering at clubs, talking in bars and exercising in gyms, according to a recent study in the journal Emerging Infectious Diseases.

    The so-called attack rate—the percentage of people who were infected in a specific place or time—can be very high in crowded events, homes and other spaces where lots of people are in close, prolonged contact.

    An estimated 10% of people with Covid-19 are responsible for about 80% of transmissions, according to a study published recently in Wellcome Open Research. Some people with the virus may have a higher viral load, or produce more droplets when they breathe or speak, or be in a confined space with many people and bad ventilation when they’re at their most infectious point in their illness, said Jamie Lloyd-Smith, a University of California, Los Angeles professor who studies the ecology of infectious diseases.

    But overall, “the risk of a given infected person transmitting to people is pretty low,” said Scott Dowell, a deputy director overseeing the Bill & Melinda Gates Foundation’s Covid-19 response. “For every superspreading event you have a lot of times when nobody gets infected.”

    The attack rate for Covid-19 in households ranges between 4.6% and 19.3%, according to several studies. It was higher for spouses, at 27.8%, than for other household members, at 17.3%, in one study in China.

    Rosanna Diaz lives in a three-bedroom apartment in New York City with five other family members. The 37-year-old stay-at-home mother was hospitalized with a stroke on April 18 that her doctors attributed to Covid-19, and was still coughing when she went home two days later.

    She pushed to get home quickly, she said, because her 4-year-old son has autism and needed her. She kept her distance from family members, covered her mouth when coughing and washed her hands frequently. No one else in the apartment has fallen ill, she said. “Nobody went near me when I was sick,” she said.

    Being outside is generally safer, experts say, because viral particles dilute more quickly. But small and large droplets pose a risk even outdoors, when people are in close, prolonged contact, said Linsey Marr, a Virginia Tech environmental engineering professor who studies airborne transmission of viruses.

    No one knows for sure how much virus it takes for someone to become infected, but recent studies offer some clues. In one small study published recently in the journal Nature, researchers were unable to culture live coronavirus if a patient’s throat swab or milliliter of sputum contained less than one million copies of viral RNA.

    Air travel is full of opportunities for coronavirus transmission. Touchless check-in, plexiglass shields, temperature checks, back-to-front boarding and planes with empty middle seats are all now part of the flying experience, and the future may bring even more changes. Illustration: Alex Kuzoian
    “Based on our experiment, I would assume that something above that number would be required for infectivity,” said Clemens Wendtner, one of the study’s lead authors and head of the department of infectious diseases and tropical medicine at München Klinik Schwabing, a teaching hospital at the Ludwig Maximilian University of Munich.

    He and his colleagues found samples from contagious patients with virus levels up to 1,000 times that, which could help explain why the virus is so infectious in the right conditions: It may take much lower levels of virus than what’s found in a sick patient to infect someone else.

    Changing policies

    Based on this emerging picture of contagion, some policies are changing. The standard procedure for someone who tests positive is to quarantine at home. Some cities are providing free temporary housing and social services where people who are infected can stay on a voluntary basis, to avoid transmitting the virus to family members.

    The CDC recently urged Americans to keep wearing masks and maintaining a distance from others as states reopen. “The more closely you interact with others, the longer the interaction lasts, the greater the number of people involved in the interaction, the higher the risk of Covid-19 spread,” said Jay Butler, the CDC’s Covid-19 response incident manager.

    If the number of Covid-19 cases starts to rise dramatically as states reopen, “more extensive mitigation efforts such as what were implemented back in March may be needed again,” a decision that would be made locally, he said.

    CDC guidelines for employers whose workers are returning include requiring masks, limiting use of public transit and elevators to reduce exposure, and prohibiting hugs, handshakes and fist-bumps. The agency also suggested replacing communal snacks, water coolers and coffee pots with prepacked, single-serve items, and erecting plastic partitions between desks closer than 6 feet apart.

    Current CDC workplace guidelines don’t talk about distribution of aerosols, or small particles, in a room, said Lisa Brosseau, a respiratory-protection consultant for the University of Minnesota’s Center for Infectious Disease Research and Policy.

    “Aerosol transmission is a scary thing,” she said. “That’s an exposure that’s hard to manage and it’s invisible.” Ensuring infected individuals stay home is important, she said, but that can be difficult due to testing constraints. So additional protocols to interrupt spread, like social distancing in workspaces and providing N95 respirators or other personal protective equipment, might be necessary as well, she said.

    Some scientists say while aerosol transmission does occur, it doesn’t explain most infections. In addition, the virus doesn’t appear to spread widely through the air.

    “If this were transmitted mainly like measles or tuberculosis, where infectious virus lingered in the airspace for a long time, or spread across large airspaces or through air-handling systems, I think you would be seeing a lot more people infected,” said the CDC’s Dr. Brooks.

    Sampling the air in high-traffic areas regularly could help employers figure out who needs to get tested, said Donald Milton, professor of environmental and occupational health at the University of Maryland School of Public Health.

    “Let’s say you detect the virus during lunchtime on Monday in a dining hall,” he said. “You could then reach out to people who were there during that time telling them that they need to get tested.”

    Erin Bromage, a University of Massachusetts Dartmouth associate professor of biology, has been fielding questions from businesses, court systems and even therapists after a blog post he wrote titled “The Risks—Know Them—Avoid Them” went viral.

    Courts are trying to figure out how to reconvene safely given that juries normally sit close together, with attorneys speaking to them up close, Dr. Bromage said. Therapists want to be able to hold in-person counseling sessions again. And businesses are trying to figure out what types of cleaning and disease-prevention methods in which to invest most heavily.

    He advises that while wiping down surfaces and putting in hand-sanitizer stations in workplaces is good, the bigger risks are close-range face-to-face interactions, and having lots of people in an enclosed space for long periods. High-touch surfaces like doorknobs are a risk, but the virus degrades quickly so other surfaces like cardboard boxes are less worrisome, he said. “Surfaces and cleaning are important, but we shouldn’t be spending half of our budget on it when they may be having only a smaller effect,” he said.

    Drugmaker Eli Lilly & Co. has a medical advisory panel that’s reading the latest literature on viral transmission, which it is using to develop recommendations for bringing back the company’s own workers safely.

    To go into production facilities, some of which are in operation now, scientists must don multiple layers of personal protective equipment, including gloves, masks, goggles and coveralls. That’s not abnormal for drug-development settings, said Lilly Chief Scientific Officer Daniel Skovronsky. “The air is extensively filtered. There’s lots of protection,” he said.

    The places he worries about are the break rooms, locker rooms and security checkpoints, where people interact. Those are spaces where the company has instituted social-distancing measures by staggering the times they are open and how many people can be there at once. Only a few cafeterias are open, and those that are have socially distanced seating. In bathrooms, only half the stalls are available to cut down on the number of people.

    “We’ll never be more open than state guidelines,” Dr. Skovronsky said, but “we’re often finding ourselves being more restrictive because we’re following the numbers.”

    #116466
    Avatar photozn
    Moderator

    Cases, Hospitalization Rates Climb In Previous Cold Spots In Post-Memorial Day Surge
    link https://khn.org/morning-breakout/cases-hospitalization-rates-climb-in-previous-cold-spots-in-post-memorial-day-surge/
    Public health experts are alarmed by several indicators such as hospitalization rates. Some states are nearing their ICU bed capacity, a warning sign from the early days of the pandemic. This week, confirmed cases in the U.S. climbed past 2 million and over 113,000 Americans have died.

    The Associated Press: Alarming Rise In Virus Cases As States Roll Back Lockdowns
    https://apnews.com/feb4c26d9364497cf82ee7c0c1b1b3d5
    States are rolling back lockdowns, but the coronavirus isn’t done with the U.S. Cases are rising in nearly half the states, according to an Associated Press analysis, a worrying trend that could intensify as people return to work and venture out during the summer. In Arizona, hospitals have been told to prepare for the worst. Texas has more hospitalized COVID-19 patients than at any time before. (Stobbe, 6/11)

    The Wall Street Journal: Covid-19 Hospitalizations Surge In Some States
    https://www.wsj.com/articles/covid-19-hospitalizations-surge-in-some-states-11591912459
    The post-Memorial Day outbreaks in states come roughly a month after stay-at-home orders were lifted. Experts urged people to continue to take the virus seriously and not take increased freedom as permission to stop wearing masks or resume gathering in large groups. Dr. Marc Boom, chief executive officer of the Houston Methodist hospital network, said he is concerned by the “array of indicators, all of which are starting to flash at us,” including increased cases, a rise in hospitalizations and a boost in the percentage of positive test results. (Collin and Findell, 6/11)

    #116434
    Avatar photozn
    Moderator

    The coronavirus pandemic isn’t ending — it’s surging

    https://www.washingtonpost.com/world/2020/06/11/coronavirus-pandemic-isnt-ending-its-surging/?fbclid=IwAR32qLZ4pR2z6D5hVoTwi58eshXJNugSBCKNCz7n7L4Tb4O4g3yQe5cPF4A&utm_campaign=wp_main&utm_medium=social&utm_source=facebook

    As restrictions are lifted around the world, the sense of urgency surrounding the novel coronavirus pandemic has weakened. Hundreds of millions of students have returned to school; restaurants, bars and other businesses are slowly reopening in many countries. In parts of Europe, vaccine researchers worry that they will not have enough sick people for testing.

    But this historic pandemic is not ending. It is surging. There were 136,000 new infections reported on Sunday, the highest single-day increase since the start of the pandemic. There are more than 7 million confirmed cases so far. The number of deaths is nearing half a million, with little sign of tapering off, and global health experts are continuing to sound the alarm.

    “By no means is this over,” Mike Ryan, the World Health Organization’s executive director, said Wednesday. “If we look at the numbers over the last number of weeks, this pandemic is still evolving. It is still growing in many parts of the world.”

    Latin America has emerged as a hot spot, currently accounting for almost half of global deaths by the Financial Times’ tally. The problem is particularly acute in Brazil, where the central government has maintained a hands-off attitude to the outbreak even as cases surged to almost 750,000, second only to the United States, but it has also hit countries, such as Peru, that took early steps against the virus.

    Cases have surged in South Asia. WHO officials urged Pakistan to lock down after officials declared a record number of new cases in the past 24 hours. India is facing a new wave of infection; a top official in Delhi on Wednesday said that cases were expected to soar above 500,000 by the end of next month. Indonesia had its biggest daily increase in coronavirus cases for a second consecutive day on Wednesday, with 1,241 new infections.

    Across sub-Saharan Africa, there are now more than 200,000 cases: There is widespread speculation that Pierre Nkurunziza, Burundi’s president, who died on Tuesday, was the first world leader to die of covid-19, though Burundian officials have said the cause of death was cardiac arrest.

    The scale of the coronavirus has made it hard to take in. “In the period of four months, it has devastated the world,” Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases, told CNN on Tuesday. “And it isn’t over yet.”

    Some nations that were devastated early in the pandemic look to be losing ground in their recovery. In Iran and the United States, two countries divided by geopolitical enmity, experts are united by fresh fears of a second wave; new cases in Iran have surged to record highs weeks after the country eased its lockdown.

    Some Iranian officials have blamed increased testing, which in itself raises questions about the first outbreak’s extent. “We don’t know if it will be a second wave, a second peak or a continuing first wave in some countries,” WHO chief scientist Soumya Swaminathan told CNBC.

    U.S. states are seeing an increasing number of patients since Memorial Day weekend, when many people socialized in groups in parts of the country, while there are new concerns that the anti-racism protests sparked by the death of George Floyd in Minneapolis could add to a nationwide surge.

    In the United States and elsewhere, the protests about injustice are partly fueled by the racial disparities seen in the outbreak. Protesters have attempted to maintain social distance and use masks and hand sanitizer — but that has not always proved possible.

    Public health experts have expressed understanding about the protests. “It doesn’t help to say police violence doesn’t matter,” Gregg Gonsalves, a professor of epidemiology at Yale, told New York Magazine. “The health disparities that have killed tens of thousands of people over a half a century don’t matter. We are saying we understand it matters; they’re public-health issues too.”

    But almost all experts acknowledge that mass protests are a risk — just as the reopening of the economy seen in many nations around the world, including the United States, carries risks. “The facts suggest that the U.S. is not going to beat the coronavirus,” the Atlantic’s Alexis Madrigal and Robinson Meyer write. “Collectively, we slowly seem to be giving up.”

    That demoralized attitude is reflected at the top of American politics: It has been more than a month since the Trump administration held a daily coronavirus task force briefing.

    What will it look like to finally beat the virus? We can see some glimpses of it, if we look hard enough: New Zealand declared itself coronavirus-free this week; Taiwan is close to that milestone too. Some smaller nations, like the Pacific island of Samoa, have avoided getting a single confirmed case.

    But until the pandemic is pushed back globally, these victories are fragile. We’ve seen this year how easily the virus can travel to a country and, once inside, spread furiously. Even for countries without the virus, the economic pain is still there.

    The Organization for Economic Co-operation and Development on Wednesday predicted that there would probably be a drop of 6 percent in global economic productivity this year, among the worst declines in a century. If there is a second wave, the drop would be worse — 7.6 percent — the organization said, with unemployment at 10 percent in developed countries in 2020 and little improvement next year.

    Even in newly reopened New Zealand, that impact is evident. Officials in Auckland said this week that foot traffic and spending in the central business district were only 40 percent of what they had been before the virus. “When you’ve normally got an inner-city workforce in excess of 138,000 people, coupled with international tourists, that’s a major change in customers,” one told the New Zealand Herald.

    There are some reasons to be hopeful. A study by Britain’s Cambridge and Greenwich universities released Wednesday suggested that widespread mask wearing could help prevent a second wave as damaging as the first. Vaccine trials are beginning and many hope that the ambitious, accelerated development timetables will produce results as soon as the end of the year.

    But there is still much we don’t know and little reason to feel triumphant right now. “This microscopic virus has humbled all of us,” WHO Director-General Tedros Adhanom Ghebreyesus said Wednesday.

    Avatar photozn
    Moderator

    Many of us know about Matt Waldman. Football guy, draft analyst.

    Here in a series of tweets, he feels compelled to address the big issues we’re seeing right now. It’s worth a read IMO. He talks about being the husband of a black woman and father of a black child in today’s USA.

    Matt Waldman@MattWaldman
    Seeing some of my colleagues talk about what it’s like being black in America–
    @DianteLee_ comes to mind prominently this afternoon, I’d like to offer a different perspective.

    Being white, growing up in the north and south, and becoming part of a black family. What you learn.

    The first thing you learn is that no matter how open-minded, loving, and book-educated you are, you are not ready for what you’ll experience once you become emotionally invested in the lives of people who are black.

    Seeing, experiencing, and feeling it on a visceral level.

    You will at first do what black people do as they’re growing up and first experiencing it: Wondering if what you experienced happened as you perceived it and trying to rationalize the motivations as not racist. Revisiting multiple times to make sure you’re not crazy.

    Black people revisit, replay, and analyze things that happen–even after experiencing events like it for decades.

    You learn there’s a constant state of questioning, analyzing, explaining (while angry). It’s stressful and wears you out.

    You learn why a lifetime of having to be on guard for the potential of significant danger to well-being physically, financially, and emotionally is a drain on mental, physical, and financial health–and considering how doctors have been mistrained (even recently)…

    about the pain tolerance, dosages, and overall untrue differences with black patients, it’s not surprising there’s a distrust of U.S. healthcare.

    BTW-I learned with one of my roommates in 1990 in Miami that if I didn’t barge past the ER front desk in an empty waiting room,

    my roommate, who waited 30 minutes with a medical emergency (I rushed him there) and was hyperventilating and sweating bullets was about two minutes from a stroke if I didn’t grab an annoyed doctor (once he saw my roommate–five folks were working on him immediately)

    Even w/that story, at 20 yrs old, having influential teachers talk to me about their life in America, reading Malcolm X, learning history beyond my high school curriculum, I still wanted to rationalize what my roommate went through.

    The truth: Being dangerously ill while black

    I learned how to have “the talks” with my kids about retail stores, police, school, and the parents of their white friends. Things I never had to consider growing up. Sometimes those talks happened after the fact with incidents that came earlier than I hoped to God would.

    Teacher putting my talkative kid in a desk and putting a tape perimeter around her to tell other kids not to interact with her and wanted her tested for a learning disability–when all she did was finish her assignments early (and correctly and consistently) and was bored.

    Cashier being rude to my girlfriend because the clerk shorted $20 at the grocery. The manager being ruder when summoned. Neither manager nor cashier offering the slightest apology after counting drawer and it being exactly $20 over.

    Countless times followed by retail clerks or front store security behaving brusquely until they realized I was with them and then behaving 180 degrees different. Cops thinking the way to behave with my executive wife whose family all earned college degrees was to speak ebonics

    Wife pulled over for alleged “rolling stops”, going through yellow lights, or going 5mph over the speed limit & questioned about the veracity of her ownership of the car because of the cognitive dissonance of her dark skin & German last name that’s on her license and insurance.

    Cops questioning that she owns the car even after they see the name match with the IDs. Cops following her home after everything checks out but they want to make sure that nice car is hers–the “don’t-fuck-with-me,” car that I would never have to drive for people at work to see

    that she’s not some charity case they hired but a star employee. Not to mention that her dad, sister, and brother were Baltimore PD. And they know police training has been cut well short of optimal in the past 15-20 years.

    My wife having to deal with “Cooper-like” women (not new) using tears as a weapon when they become threatened about my wife’s positive work relationships w/males at the job. And those males taking the bait because they don’t expect white women to be mature one but need rescuing.

    Ex-girlfriend and I once applied for same job. She had more desirable industry experience, called her first, talked salary, & scheduled interview. She arrived in a stunning Chanel suit–very interview appropriate. Hiring manager took one look at her, said job was filled, offered

    entry-level gig. Then manager called me, I went through three interviews–one was clearly a “does the owner give the stamp of approval that I’m a white male,” interview and was offered the job (I graphically told them what they could do with the offer).

    The dread I felt when my wife decided to take a drive in her new car and forgot to tell me she was doing so after she ran an errand at night and I thought she’d be home in 20 minutes. Me driving around the county looking for her because I hoped she wasn’t pulled over.

    My wife panicking and wanting to leave a concert when my daughter, a Marine, got pulled over for a traffic stop at night in a county that 15 years ago had signs that essentially told black people to leave at night.

    I notice how some people who are uncomfortable around blacks get tense and shaky and I have to be 1-2 steps ahead and wonder if this is the day I’m going to jail for my wife. I have learned how to take the temperature of a room in a way I never had to before.

    I notice black people taking the temperature of my behavior. Am I at ease and self-aware or am I going to be that guy trying to act black? Am I that guy who will treat my wife as some fetishized trophy? Am I the well-meaning but ignorant liberal social justice warrior 24/7?

    All of this is done out of protection and understandably so. Some have seen and experienced too much to even want to try with me. And I get that. Hate it’s that way, but I get it and know I can’t change that in one interaction–and in some cases, ever.

    What did I learn?

    Being outwardly and vocally hateful was wrong and made your family look bad but being exclusionary for ignorant reasons, telling jokes, reinforcing racism behind the scenes was intentionally and unintentionally encouraged.

    It’s the source of gaslighting.

    That racism was often tolerated by younger adults not to upset their older parents or authority figures in society with the purse strings.

    That it was ok to be friendly but not close to black people.

    That black entertainers were exceptional and not the norm. Ring a bell?

    That the norm was more like what I saw on the news. What did I see on the news? Murders, robbers, rioters in Miami reacting to police murder/brutality.

    I knew this wasn’t true. Didn’t change the emotional reactions I had from these being internalized. Sound familiar?

    Like many, these lessons created an ingrained fear. Fear of saying the wrong thing. Fear of being labeled a racist more than tacitly supporting racism. Fear of where to even begin with gaining real knowledge. It’s why so many never even begin.

    Fact is, 5 yrs ago the reactions to this behavior was met with a lot more resistance. Progress is sadly slow but it’s there. Feeling that helplessness is a part of honest recognition.

    Mostly, I’ve learned that I had to unlearn subtle and unintentional behaviors that I was taught that perpetuated systemic racism. Things family and authority taught. That it took time, effort, humility, and painful self-reflection. I’m still learning. We’re all still learning.

    And, it’s exhausting to explain as often as it needs to be explained to give someone uninitiated a clear picture. A clear picture you may not see immediately or in its totality. I’m not telling you how to be, just sharing how I’ve been. Hope it helps.

    Avatar photozn
    Moderator

    Coronavirus is reportedly killing young people at unprecedented rates in developing countries

    https://www.businessinsider.com/washington-post-coronavirus-young-people-developing-world-2020-5

    Younger people are dying at unprecedented rates from COVID-19, the disease caused by the novel coronavirus, as developing countries become new hotspots for the pandemic, The Washington Post reported.

    As the coronavirus has been ravaging countries in the developing world like Brazil and India, young people make up a population of the victims and hospitalized patients at a rate unseen in previous epicenters, according to the report.

    In Brazil, people under 50 account for 5% of deaths, ten times greater than that recorded in Italy or Spain, the Post reported, and in Mexico, nearly one-fourth of the dead were aged between 25 and 49. In India, another rising hotspot, officials reported this month that nearly half of the dead were younger than 60, according to the Post.

    The same trends can be seen in hospitalizations for patients with extreme cases, the Post reported, like in Brazil’s Rio de Janeiro state, where more than two-thirds of hospitalizations are for people younger than 49.

    The Post wrote that experts point to existing issues like overwhelmed healthcare, extreme poverty, and inequality as exacerbating factors in the death tolls recorded in developing countries.

    In India, the explosion of cases in Mumbai has been connected to the dense cityscape and the conditions in areas like Dharavi, Asia’s largest slum, where hospitals are overwhelmed, police forces overextended, and social distancing is impossible, the New York Times reported.

    Though authorities announced in the initial weeks of the pandemic that older individuals were the most at-risk of death from the novel coronavirus, the past few months have provided widespread evidence that infection and serious cases are likely to strike younger people between 20 and 44 and analysis like the Post’s highlights the grim effect socioeconomic factors have on who is more likely to dodge or survive the virus.

    In the US, officials have identified sharply higher rates of coronavirus infections and deaths among non-white Americans in preliminary data that have been connected to higher rates of co-morbid diseases and other issues like limited access to healthcare.

    After initial numbers from states like Michigan, Illinois, and North Carolina reported last month showed African Americans were by far the hardest hit by the coronavirus, experts clarified that the pandemic did not run through all communities equally.

    A recent study by amfAR in coordination with a team of epidemiologists and clinicians from four US universities reported by CNN concluded that a wide array of “structural factors including health care access, density of households, unemployment, pervasive discrimination and others drive these disparities, not intrinsic characteristics of black communities or individual-level factors.”

    In the developing world, the coronavirus is killing far more young people

    https://www.washingtonpost.com/world/the_americas/coronavirus-brazil-killing-young-developing-world/2020/05/22/f76d83e8-99e9-11ea-ad79-eef7cd734641_story.html?utm_campaign=wp_main&utm_medium=social&utm_source=twitter

    RIO DE JANEIRO — When the coronavirus first came to Brazil and a call went out for volunteers to work the critical care wards, Isabella Rêllo analyzed the risks. She was 28. She lived alone. She didn’t have preexisting conditions.

    So while older physicians stepped back from the front lines of the coronavirus response, Rêllo stepped up.

    Soon Rêllo, a pediatrician, was treating dozens of coronavirus patients. But they weren’t who she’d expected. This patient was only 30 years old. That one was 32. Nearly half the people she was seeing were young, she said, and many were dying. The narrative seared into the global consciousness in the early months of the pandemic — that the virus spared the young and ravaged the elderly — was not what she was watching unfold in Brazil.

    The young were at risk. She was at risk.

    Isabella Rêllo, 28, thought her youth made her safe from the coronavirus. She was shocked to see how many younger people are dying.

    “One patient was young, apparently healthy,” she said. “He was so sick, with so many complications. I thought, ‘This could be me. He could be my friend.’ The quickness that this kills people, including the young, has been a shock.”

    As the coronavirus escalates its assault on the developing world, the victim profile is beginning to change. The young are dying of covid-19, the disease caused by the novel coronavirus, at rates unseen in wealthier countries — a development that further illustrates the unpredictable nature of the disease as it pushes into new cultural and geographic landscapes.

    In Brazil, a dying man and a desperate search for an open bed

    In Brazil, 15 percent of deaths have been people under 50 — a rate more than 10 times greater than in Italy or Spain. In Mexico, the trend is even more stark: Nearly one-fourth of the dead have been between 25 and 49. In India, officials reported this month that nearly half of the dead were younger than 60. In Rio de Janeiro state, more than two-thirds of hospitalizations are for people younger than 49.

    Sign up for our Coronavirus Updates newsletter to track the outbreak. All stories linked in the newsletter are free to access.

    “This is new terrain compared to what’s happened in other countries,” said Daniel Soranz, the former municipal health minister in Rio de Janeiro. “Brazil is a very important country to be looking at.”

    Analysts say the emerging data suggests many of the problems that have long troubled the developing world — intractable poverty, extreme inequality, fragile health systems — are increasing vulnerability to the disease. In countries with more poverty and fewer resources, people who might have survived elsewhere are instead dying.

    George Gray Molina, chief economist for the United Nations Development Program, said poverty is triggering “compounding effects.” Because population density is so much higher in much of the developing world — and because so many people must keep working to survive — a far greater share of the population ends up being exposed to the virus.

    The virus then spreads through a population that’s less resilient. People in the developing world grapple not only with the diseases that have long been associated with it — malaria, dengue, tuberculosis, HIV/AIDS — but increasingly with those more closely associated with wealthier countries. Rates of diabetes, obesity and hypertension are surging. But treatment for many such illnesses is lacking.

    When newly infected coronavirus patients already weakened by preexisting conditions seek treatment, they find hospital systems that are overwhelmed and unequipped to handle the deluge of patients.

    “It all points to social economic status and poverty,” Gray Molina said. The positive benefits associated with the developing world, such as younger populations, are being “wiped out.”

    “As this plays out,” he said, “we will see a balancing of the scales.”

    When the coronavirus hit Brazil, it was an infection of the rich. Brought in by travelers to the United States and Europe, the coronavirus circulated primarily among the wealthy and connected. The Brazilian senate leader caught it. So did President Jair Bolsonaro’s press secretary. The Rio de Janeiro Country Club along Ipanema beach, one of Brazil’s most exclusive clubs, suffered a devastating outbreak.

    Domingos Alves, a data scientist with the University of São Paulo, has been tracking the virus here since those early weeks. The pattern in Brazil at first mirrored that in the developed world: The dead were almost exclusively elderly. Coronavirus patients were flocking to private hospitals, and anyone who needed a hospital bed received one.

    But by early April, as the virus began seeping into the favelas and slums of São Paulo and Rio, and the public hospital system started buckling, Alves noticed a sharp shift in the data. Younger people were being hospitalized at higher rates. People younger than 49 were dying. The disease was reaching lower into the demographic pyramid. The victim profile was changing.

    Public health experts: Coronavirus could overwhelm the developing world

    “Our country is made up of various smaller countries,” Alves said. “When you walk through Rio de Janeiro, you go through places that have the characteristics of Switzerland to places more like the Congo, all in the same city.”

    Cátia Simone de Lima Passos, 48, has lived her entire life in a part of the city no one would confuse for Switzerland. Every day, she and her daughter, Agatha, 25, would ride crowded buses through northern Rio to the medical clinic where they worked in the favela of Maré. Lima said they did everything they could to stay safe. They doused their hands in sanitizer. They wore masks. Her asthmatic daughter stayed home from work for weeks.

    But they both got the coronavirus and were hospitalized. Lima, after 10 days in the hospital, survived. Her daughter didn’t. Now Lima spends her days isolated in her house, alone and unable to grieve with loved ones, trying to understand why a virus that everyone said would kill only the elderly had taken her daughter but spared her.

    The unexpected cruelty of it, she said. It’s more than she can bear.

    “My house is empty,” she said. “We were partners in life.”

    Bolsonaro, a global leader in minimizing the virus, repeats a mantra: Only the elderly are at risk. So the best policy is to isolate only them. He has called it “vertical isolation.”

    “What has happened in the world has shown that the people at risk are older than 60,” he declared in a national address in late March. “So why close the schools?”

    The contradictory messaging in Brazil — between local leaders begging people to stay inside and a president calling people to return to the streets — has fueled widespread confusion. As the virus explodes here, cresting 300,000 cases and 19,000 dead, people are increasingly ignoring isolation guidelines. The beach boardwalks in Rio de Janeiro are packed on weekends. The typical infected person infects nearly three others, according to researchers at Imperial College London, one of the world’s highest rates.

    While other countries look to open up, Brazil can’t find a way to shut down

    Pedro Archer, a physician at a public hospital in Rio, said his young patients have been stunned by their illness. Some had parroted Bolsonaro, who has repeatedly belittled the illness as a “gripezinha” — a little flu. Until they got sick.

    “I have people say to me, ‘I really had thought this was only a gripezinha, and now I see this is serious,’ ” Archer said. “I’ve seen people dying who have said the same thing.”

    Others keep going out because they must. Government aid — around $105 per month for informal workers — has for many been either blocked by bureaucratic hurdles or woefully insufficient. Buses are still filled with people heading to work. Lines of people waiting for emergency funds have snaked around banks.

    “Young people are dying at a higher rate because they are coming into contact with the virus many times more, because of their working and living conditions,” said Ligia Bahia, a public health professor at the Federal University of Rio de Janeiro. “Doormen are still working. Housekeepers are still working. . . . Their viral load, their exposure, is greater.”

    Marcelo Mitidieri, a 48-year-old father of two, understood the risks but continued working as a driver to support his family. He fell sick in late April. He could scarcely breathe. He had pain in his chest. His daughter took him to a medical clinic in the impoverished Rio neighborhood of Engenho de Dentro, but it had only three respirators and three hospital beds. They had no room for him. So he sat in a broken chair for 24 hours, wheezing, texting his daughter Marcela and waiting.

    Limits on coronavirus testing in Brazil are hiding the true dimensions of Latin America’s largest outbreak

    “They want to bring me into the emergency room,” he wrote to his daughter. “But there is no equipment.”

    “Try to be calm,” pleaded Marcela, hopeful his age would save him. “Inhale and exhale. You are strong, and we are together on this.”

    “I’m very ill,” he responded in his last message before his death.

    Marcela now seethes. “If he’d gotten better treatment, he would be with me now,” she said.

    All of it has left Rêllo, the 28-year-old pediatrician who volunteered to treat coronavirus patients, terrified. But she kept working — until earlier this week, when she started to feel ill.

    A dry cough. Sneezing. Body aches. A test soon confirmed her fears: She’d caught the virus. She doesn’t know what it will do to her. She’s young, but she says she no longer believes that’s enough.

    She says she thinks of others whom she treated. She knows what they looked like.

    “Like me,” she said.

    Avatar photozn
    Moderator

    Evidence is growing that when masks are worn by nearly everyone, it can slow coronavirus transmission.
    Masks help stop the spread of coronavirus – the science is simple and I’m one of 100 experts urging governors to require public mask-wearing

    https://theconversation.com/masks-help-stop-the-spread-of-coronavirus-the-science-is-simple-and-im-one-of-100-experts-urging-governors-to-require-public-mask-wearing-138507?fbclid=IwAR1F3fS-wsAD8605JV66yyxx_TlRKJTuCSj1NL1v1sgDqch3LM8eqXizlk8

    I’m a data scientist at the University of San Francisco and teach courses online in machine learning for fast.ai. In late March, I decided to use public mask-wearing as a case study to show my students how to combine and analyze diverse types of data and evidence.

    Much to my surprise, I discovered that the evidence for wearing masks in public was very strong. It appeared that universal mask-wearing could be one of the most important tools in tackling the spread of COVID-19. Yet the people around me weren’t wearing masks and health organizations in the U.S. weren’t recommending their use.

    I, along with 18 other experts from a variety of disciplines, conducted a review of the research on public mask-wearing as a tool to slow the spread SARS-CoV-2. We published a preprint of our paper on April 12 and it is now awaiting peer review at the Proceedings of the National Academy of Sciences.

    Since then, there have been many more reviews that support mask-wearing. https://onlinelibrary.wiley.com/doi/full/10.1111/resp.13834

    On May 14, I and 100 of the world’s top academics released an open letter to all U.S. governors asking that “officials require cloth masks to be worn in all public places, such as stores, transportation systems, and public buildings.”

    Currently, the U.S. Centers for Disease Control and Prevention recommends that everyone wears a mask – as do the governments covering 90% of the world’s population – but, so far, only 12 states in the U.S. require it. In the majority of the remaining states, the CDC recommendation has not been enough: Most people do not currently wear masks. However, things are changing fast. Every week more and more jurisdictions require mask use in public. As I write this, there are now 94 countries that have made this move. https://airtable.com/shreZdkFaYZqfpEqU/tbl5o6qUd54BL9wkw

    So what is this evidence that has led myself and so many scientists to believe so strongly in masks?

    The evidence

    The research that first convinced me was a laser light-scattering experiment. Researchers from the National Institutes of Health used lasers to illuminate and count how many droplets of saliva were flung into the air by a person talking with and without a face mask. https://www.nejm.org/doi/10.1056/NEJMc2007800 The paper was only recently published officially, but I saw a YouTube video showing the experiment in early March. The results are shockingly obvious in the video. When the researcher used a simple cloth face cover, nearly all the droplets were blocked. https://www.youtube.com/watch?time_continue=19&v=UNHgQq0BGLI&feature=emb_title

    This evidence is only relevant if COVID-19 is transmitted by droplets from a person’s mouth. It is. https://www.thestar.com/opinion/letters_to_the_editors/2020/05/09/evidence-shows-covid-19-is-almost-exclusively-spread-by-droplets.html There are many documented super-spreading cases connected with activities – like singing in enclosed spaces – that create a lot of droplets.

    The light-scattering experiment cannot see “micro-droplets” that are smaller than 5 microns and could contain some viral particles. But experts don’t think that these are responsible for much COVID-19 transmission.

    While just how much of a role these small particles play in transmission remains to be seen, recent research suggests that cloth masks are also effective at reducing the spread of these smaller particles. In a paper that has not yet been peer-reviewed, researchers found that micro-droplets fell out of the air within 1.5 meters of the person who was wearing a mask, versus 5 meters for those not wearing masks. When combined with social distancing, this suggests that masks can effectively reduce transmission via micro-droplets.

    Another recent study showed that unfitted surgical masks were 100% effective in blocking seasonal coronavirus in droplets ejected during breathing. https://www.nature.com/articles/s41591-020-0843-2

    If only people with symptoms infected others, then only people with symptoms would need to wear masks. But experts have shown that people without symptoms pose a risk of infecting others. In fact, four recent studies show that nearly half of patients are infected by people who do not themselves have symptoms.

    This evidence seems, to me, clear and simple: COVID-19 is spread by droplets. We can see directly that a piece of cloth blocks those droplets and the virus those droplets contain. People without symptoms who don’t even know they are sick are responsible for around half of the transmission of the virus.

    We should all wear masks.

    Against the tide

    After going through all of this strong evidence in late March and early April, I wondered why mask-wearing was controversial amongst health organizations in the Western world. The U.S. and European CDCs did not recommend masks, and neither did nearly any western government except for Slovakia and Czechia, which both required masks in late March.

    I think there were three key problems.

    The first was that most researchers were looking at the wrong question – how well a mask protects the wearer from infection and not how well a mask prevents an infected person from spreading the virus. Masks function very differently as personal protective equipment (PPE) versus source control.

    Masks are very good at blocking larger droplets and not nearly as good at blocking tiny particles. When a person expels droplets into the air, they quickly evaporate and shrink to become tiny airborne particles called droplet nuclei. These are extremely hard to remove from the air. However, in the moist atmosphere between a person’s mouth and their mask, it takes nearly a hundred times as long for a droplet to evaporate and shrink into a droplet nuclei.

    This means that nearly any kind of simple cloth mask is great for source control. The mask creates humidity, this humidity prevents virus-containing droplets from turning into droplet nuclei, and this allows the fabric of the mask to block the droplets.

    Unfortunately, nearly all of the research that was available at the start of this pandemic focused on mask efficacy as PPE. This measure is very important for protecting health care workers, but does not capture their value as source control. On Feb. 29, the U.S. surgeon general tweeted that masks “are NOT effective in preventing general public from catching #Coronavirus.” This missed the key point: They are extremely effective at preventing its spread, as our review of the literature showed.

    The second problem was that most medical researchers are used to judging interventions on the basis of randomized controlled trials. These are the foundation of evidence based medicine. However, it is impossible and unethical to test mask-wearing, hand-washing or social distancing during a pandemic.

    Experts like Trisha Greenhalgh, the author of the best-selling textbook “How to Read a Paper: The Basics of Evidence Based Healthcare,” are now asking, “Is Covid-19 evidence-based medicine’s nemesis?” She and others are suggesting that when a simple experiment finds evidence to support an intervention and that intervention has a limited downside, policymakers should act before a randomized trial is done.

    The third problem is that there is a shortage of medical masks around the world. Many policymakers were concerned that recommending face coverings for the public would lead to people hoarding medical masks. This led to seemingly contradictory guidance where the CDC said there was no reason for the public to wear masks but that masks needed to be saved for medical workers. The CDC has now clarified its stance and recommends the public use of homemade masks while saving higher-grade masks for medical professionals.

    Results of mask-wearing

    There are numerous studies that suggest if 80% of people wear a mask in public, then COVID-19 transmission could be halted. https://arxiv.org/abs/2003.07353 Until a vaccine or a cure for COVID-19 is discovered, cloth face masks might be the most important tool we currently have to fight the pandemic.

    Given all of the laboratory and epidemiological evidence, the low cost of wearing masks – which can be made at home with no tools – and the potential to slow COVID-19 transmission with widescale use, policymakers should ensure that everyone wears a mask in public.

    #115115
    Avatar photozn
    Moderator

    How close is a coronavirus vaccine?

    https://www.politifact.com/article/2020/may/12/how-close-coronavirus-vaccine/?fbclid=IwAR3C9KZNWoyobmHbkywCVke_bGQZ3lF8VPGUMm_xjejkmxXcNEhm-M4Vaf0

    • The long-cited 12-to-18 month timeline to an effective vaccine is probably still on track, though meeting that deadline will require everything going right.

    • There are more than 100 vaccine projects under way across the globe. At least eight efforts have moved to the early clinical trial phase.

    • Based on the emerging evidence, experts are cautiously optimistic about whether a vaccine could confer at least some immunity, and that mutations in the virus won’t be too fast to stymie vaccine development.

    Americans are counting on a safe and effective vaccine against the novel coronavirus. Two months into the pandemic, is the U.S. and the world any closer to one?

    The short answer is yes, experts say. But creating an effective vaccine will still require a lot to go right.

    There are more than 100 vaccine projects under way worldwide, according to the World Health Organization. At least eight of them have moved to the early clinical trial phase. Four of these vaccines were created in China, one in the U.K, one in the European Union, and two in the United States. Others could move to clinical trials in the coming months.

    Having so many potential vaccines in the testing phase is impressive, experts say, considering the short time scientists have known about the novel coronavirus.

    “Multiple groups from government, industry, and academia have come together to forge partnerships that advance candidate vaccines,” said Matthew B. Laurens, an associate professor of pediatrics at the University of Maryland School of Medicine’s Center for Vaccine Development and Global Health. “The shift from other research activities to this urgent public health crisis is both encouraging and exactly what needs to happen.”

    In early April, Kathleen M. Neuzil, director of the Center for Vaccine Development and Global Health at the University of Maryland School of Medicine, told PolitiFact that if all went well, there might be five or six vaccines in trials within six months. Five weeks later, there are already more than that undergoing trials.

    Officials including Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, have remained consistent in their estimation of the timeline for creating a workable vaccine: 12 to 18 months. That’s a much shorter time frame than for previous vaccines, which have taken between four years and several decades. But given the intense pressure of the coronavirus pandemic, standard development and production models are being telescoped.

    Here’s the state of play on coronavirus vaccine research, and how developments in the past two months have changed the outlook.

    What are the leading vaccine candidates?
    The one that has attracted the most attention so far is being developed by researchers at Oxford University in the U.K.

    It uses a weakened version of a common cold virus that has been modified so it doesn’t cause sickness in humans. Researchers then added proteins, known as antigens, from the novel coronavirus, in the hope that these could prime the human immune system to fight the virus once it encounters it.

    Testing by the U.S. National Institutes of Health found that one dose of the vaccine prevented rhesus macaque monkeys from getting sick after being exposed to large amounts of the virus. The vaccine has now moved on to clinical trials with 6,000 volunteers.

    The Oxford team is working in partnership with global pharmaceutical giant AstraZeneca to manufacture several million doses by September — an even faster timetable than the 12-to-18 month goal.

    “That’s pretty out in front, so they must be very confident,” said William Schaffner, a professor of preventive medicine and infectious diseases at Vanderbilt University Medical Center.

    Several other vaccine efforts have moved forward as well. Some are using a different approach that uses genetic material, known as mRNA, that provides the instructions for a body to produce the needed antigens themselves. This is a relatively untested approach to vaccination, but if it works, it has aspects that could simplify the manufacturing process.

    One of the vaccine candidates using this method is being developed by the U.S. pharmaceutical company Moderna. Backed by federal funding, the vaccine has been approved for a second round of clinical trials. If successful, a third trial could come this summer. The company has partnered with a Swiss company, Lonza Ltd., to produce as many as a billion doses annually.

    Another mRNA vaccine is being developed by drug giant Pfizer and BioNTech, a German company. Clinical trials are under way.

    Meanwhile, Inovio Pharmaceuticals, a U.S. company, is working on a vaccine that uses a similar approach to mRNA but using DNA material instead. This effort is receiving funding from the Bill and Melinda Gates Foundation and the Department of Defense, among others.

    Then there are the four vaccines being tested in China. Three of these use a more traditional vaccine method that involves a killed, and thus safe, version of the novel coronavirus. Another one uses a similar approach to the Oxford group.

    Other companies are expected to start trials within months.

    The pharmaceutical company Johnson & Johnson, in conjunction with a division of the U.S. Department of Health & Human Services, has chosen a lead candidate for its vaccine. It has not yet begun clinical trials, but executives have publicly pledged to start producing it late this year and to deliver 1 billion doses in 2021, assuming it’s shown to be safe and effective.

    And the French company Sanofi is aiming to begin clinical trials this year for a vaccine it is developing that’s a variation on one originally used against SARS, an earlier coronavirus that caused outbreaks in Asia two decades ago.

    The fact that several vaccine approaches are being tested, with more on the way, is a positive development, since it means we aren’t putting all of our eggs in one basket.

    Should we worry about recent findings about coronavirus immunity and mutations?
    One concern is whether, and how long, a person will have immunity from the coronavirus after either being infected. If the coronavirus doesn’t inspire immunity of any significant length, that would undercut the idea of attacking it with a vaccine.

    We don’t know the answer yet, but scientists are seeing preliminary evidence that infection or a vaccine could confer at least some immunity.

    For instance, a study by Chinese researchers published in Nature Medicine found that all 285 patients hospitalized with severe COVID-19 had developed a specific antibody against the novel coronavirus called IgM within two to three weeks of their first symptoms. The National Institutes of Health touted the finding as suggesting that “the immune systems of people who survive COVID-19 have been primed to recognize (the virus) and possibly thwart a second infection.”

    Another concern is that the novel coronavirus, like many other viruses, is mutating over time. If the virus changes enough, that could become a problem that bedevils vaccine researchers.

    Experts hope the rate of change from mutations will stay manageable.

    “There’s some fuzziness around the edges, but basically the virus is remaining stable,” Schnaffner said. “This does not seem to be a virus that flips around and mutates a lot, like the seasonal flu. It doesn’t seem to be enough to cast a pall over the vaccine effort.”

    Is the 12-to-18 month timeline still on track?
    In normal times, a vaccine trial occurs in several phases. But the coronavirus pandemic has thrown this longstanding model out the window, with each phase of the process needing to be shorter or handled on parallel tracks. The federal government has launched “Operation Warp Speed” to fast-track vaccine efforts, with a goal of 300 million doses available by January 2021.

    Experts applaud efforts to create manufacturing and distribution capacity ahead of a vaccine being approved for wide use. Several pharmaceutical companies are moving forward with facilities, and the Gates Foundation is planning to fund factories for up to seven vaccines. A nagging problem, however, could be a shortage of appropriate packaging, akin to the shortages in swabs and reagents that have hampered the rollout of wide-scale testing.

    One possibility for shortening the timeline is the use of “human challenge” studies, in which otherwise healthy, lower-risk volunteers are deliberately infected with the virus. This can produce much faster findings than simply waiting for the volunteers to encounter the virus in ordinary life. This approach was successful in the recent FDA approval of Vaxchora, a vaccine developed to prevent cholera, Laurens said.

    All told, experts still have their eye on the 12-to-18 month goal.

    “It’s predicated on absolutely everything going right,” Schnaffner said. “So it’s optimistic. But I don’t think it’s too optimistic.

    #114983
    Avatar photoZooey
    Moderator

    https://news.yahoo.com/conservative-victimhood-complex-made-america-095001554.html

    The conservative victimhood complex has made America impossible to govern
    The Week
    Ryan Cooper
    •May 14, 2020

    The United States has had the worst national response to the coronavirus pandemic among rich nations largely because President Trump is an incompetent leader whose narcissism means he can focus on little beyond his own approval ratings. From the start of the crisis to today, he has completely failed to take the virus seriously, and refused to do anything meaningful to stop it. It was his job to protect America, and he can’t do the job.

    But Trump’s appalling failure is only the most visible part of a vast ocean of right-wing dysfunction. For conservative zealots and media figures, the pandemic is quickly becoming just another culture war battleground — an axis of postmodern symbolic conflict, another vent for bottomless grievance, and fuel for a screeching victimhood complex. The practical effect will be to fuel infection and hamstring economic recovery. It’s a stark obstacle before fixing this or any other crisis.

    Let’s take mask-wearing. As research about the coronavirus has developed, the effectiveness of masks in slowing the spread of the disease has become clear, above all in confined indoor spaces. Studies have found that being outdoors is relatively low-risk, and most infections happen when people are in proximity to each other indoors for a long time — but also that masks can drastically reduce the possibility of infecting others if you happen to be contagious. Offices, public transportation, stores, restaurants, church services, and especially homes are where most transmission happens. Wearing a mask whenever one is indoors around strangers is a cheap and no-consequence way of protecting one’s community — even if it only helps a little, it’s a minuscule inconvenience.

    Yet a developing narrative on the right holds that masks are a sign of weakness and cowardice. Trump refuses to wear one even to set an example, reportedly because he thinks it will make him look bad. Senator Rand Paul (R-Ky.) refuses to wear one even though it is not clear he is permanently immune after recovering from the disease. Vice President Pence refused to wear one even while visiting COVID-19 patients. On Fox News, Laura Ingraham defended Pence from critics, saying “They’ll say this whole mask thing is settled science just like they do with climate change. Of course, it’s not and they know it,” despite having previously endorsed wearing them. (Naturally, after two cases of coronavirus cropped up in the White House last week, all staffers are now required to wear masks when in the building.)

    Further down the conservative food chain, anti-mask fulmination has gotten more extreme and much weirder. First Things editor R.R. Reno claimed on Twitter that “Masks=enforced cowardice.” A city order in Stillwater, Oklahoma requiring masks in businesses was quickly reversed when conservative lunatics threatened violence against workers trying to enforce the rule. The conservative base is taking the elite cue — in a recent poll, just 47 percent of Republicans report wearing masks in public, against 69 percent of Democrats. At New York, Ed Kilgore reports that in a suburban Georgia grocery store, conservatives glared daggers at him for wearing a mask.

    Something similar is holding true with pandemic control measures like business closures. Smallish groups of mask-less protesters have swarmed state capitols across the country, demanding the economy be somehow reopened. When one Dallas salon owner refused to obey business closure rules and was locked up for a week, Texas Governor Greg Abbott quickly reversed his own action. “Throwing Texans in jail who have had their businesses shut down through no fault of their own is nonsensical, and I will not allow it to happen,” he said. The salon owner, of course, successfully claimed victimhood and collected over half a million dollars from a crowdfunding campaign (which very well might have been the entire point).

    It shouldn’t be surprising that the reality of masks and other pandemic control measures is the precise opposite of the conservative agitprop line. Most masks and lockdown orders are primarily a way to protect others, not just yourself — which you would think would be exactly in line with purported conservative values of traditional masculinity. But facts have never stood in the way of the conservative persecution complex. Nothing gets their blood flowing like playing martyr before imaginary liberal tyranny. Casting oneself as Anne Frank for having to wear a two-dollar cloth mask at Walmart during the worst pandemic in a century would be a stretch for most people in the world, but not American movement conservatives.

    This instinct is strengthened by how badly Trump has botched the crisis. He is the hero-president, the man before whom all Republicans must bow five times per day. His gargantuan, world-historical failure cannot be admitted, but neither can it be avoided. Therefore scapegoats and distractions must be found to relieve the cognitive dissonance. The virus is fake, or it only kills worthless old people, or it’s a Chinese conspiracy. Measures to fight it are howling liberal tyranny, even if it’s Republican governors enacting them.

    Conservative media probably just can’t help itself. The entire “perpetual misinformation machine,” as Alex Pareene calls it, runs on whipping elderly white conservatives into a frothing rage over whatever is happening. Plus today, the president and half of the Republican congressional caucus are themselves eager right-wing propaganda addicts, forming a perfectly-sealed loop of insanity. It was likely inevitable that the pandemic would get sucked into the hysteria industrial complex, because that’s what right-wing media does with everything.

    Already this has created an ideal coronavirus transmission pool — a critical mass of right-wing extremists who are unwilling to obey government pandemic control measures and are convinced personal measures to do so are beta male cowardice. Many will become sick as a result, and some will die — but not only conservatives, as the virus will infect any available host. This will keep the pandemic raging, and hence further delay the restoration of the economy.

    A different president who wasn’t an addle-brained dolt would certainly have done something to fight the pandemic. But he or she still would have run directly into the conservative lunacy problem. It’s hard to see how America can be governed when much of the country has taken leave of its senses.

Viewing 30 results - 151 through 180 (of 934 total)